0001193125-23-286491.txt : 20231201 0001193125-23-286491.hdr.sgml : 20231201 20231130192548 ACCESSION NUMBER: 0001193125-23-286491 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231201 DATE AS OF CHANGE: 20231130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Investcorp India Acquisition Corp CENTRAL INDEX KEY: 0001852889 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41383 FILM NUMBER: 231457135 BUSINESS ADDRESS: STREET 1: CENTURY YARD, CRICKET SQUARE STREET 2: ELGIN AVENUE, PO BOX 1111 CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1102 BUSINESS PHONE: 3459495122 MAIL ADDRESS: STREET 1: CENTURY YARD, CRICKET SQUARE STREET 2: ELGIN AVENUE, PO BOX 1111 CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1102 FORMER COMPANY: FORMER CONFORMED NAME: Investcorp Acquisition Corp. DATE OF NAME CHANGE: 20210323 10-Q 1 d559923d10q.htm 10-Q 10-Q
Table of Contents
0001852889--12-31falseQ300-0000000Cricket Square Elgin AvenueOn March 22, 2022, the Company surrendered 718,750 shares of Class B ordinary shares as a result of updated terms of the proposed public offering. All share amounts and related information have been retroactively restated to reflect the surrender. Includes an aggregate of up to 843,750 shares that are subject to forfeiture if the over-allotment option is not exercised in full by the underwriter (see Note 8). On May 12, 2022, the underwriter exercised the full over-allotment option.Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the statements of operations. 0001852889 2022-12-31 0001852889 2023-09-30 0001852889 2022-07-01 2022-09-30 0001852889 2023-07-01 2023-09-30 0001852889 2023-01-01 2023-09-30 0001852889 2022-01-01 2022-09-30 0001852889 2022-01-01 2022-12-31 0001852889 2022-04-01 2022-06-30 0001852889 2023-01-01 2023-03-31 0001852889 2023-04-01 2023-06-30 0001852889 2022-03-01 2022-03-31 0001852889 2022-01-01 2022-03-31 0001852889 2022-08-31 2022-08-31 0001852889 2023-08-11 0001852889 2023-08-11 2023-08-11 0001852889 2021-12-31 0001852889 2022-09-30 0001852889 2022-03-31 0001852889 2023-06-30 0001852889 2022-06-30 0001852889 2023-03-31 0001852889 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001852889 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001852889 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001852889 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2022-07-01 2022-09-30 0001852889 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001852889 us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001852889 us-gaap:CommonClassBMember 2023-01-01 2023-09-30 0001852889 ivca:PublicWarrantsMember us-gaap:IPOMember 2023-01-01 2023-09-30 0001852889 ivca:PrivatePlacementWarrantsMember us-gaap:IPOMember 2023-01-01 2023-09-30 0001852889 us-gaap:IPOMember 2023-01-01 2023-09-30 0001852889 us-gaap:IPOMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001852889 ivca:PrivatePlacementWarrantsMember ivca:SponsorMember 2023-01-01 2023-09-30 0001852889 us-gaap:OverAllotmentOptionMember 2023-01-01 2023-09-30 0001852889 ivca:PublicWarrantsMember 2023-01-01 2023-09-30 0001852889 ivca:PrivatePlacementWarrantsMember 2023-01-01 2023-09-30 0001852889 ivca:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsEighteenPointZeroZeroMember ivca:PublicWarrantsMember 2023-01-01 2023-09-30 0001852889 ivca:PublicWarrantsMember ivca:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsTenPointZeroZeroMember 2023-01-01 2023-09-30 0001852889 ivca:SponsorMember 2023-01-01 2023-09-30 0001852889 ivca:PublicWarrantsMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001852889 srt:MaximumMember ivca:ProposedOfferingMember 2023-01-01 2023-09-30 0001852889 ivca:ProposedOfferingMember ivca:SponsorMember 2023-01-01 2023-09-30 0001852889 ivca:SponsorMember ivca:WorkingCapitalLoansMember 2023-01-01 2023-09-30 0001852889 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001852889 ivca:ClassaOrdinaryShareAndRedeemableWarrantMember 2023-01-01 2023-09-30 0001852889 us-gaap:CommonClassBMember 2023-07-01 2023-09-30 0001852889 us-gaap:CommonClassAMember 2023-07-01 2023-09-30 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2023-07-01 2023-09-30 0001852889 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001852889 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001852889 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001852889 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001852889 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001852889 us-gaap:OverAllotmentOptionMember us-gaap:CommonClassAMember 2022-05-12 2022-05-12 0001852889 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-05-12 2022-05-12 0001852889 ivca:SponsorMember ivca:PrivatePlacementWarrantsMember 2022-05-12 2022-05-12 0001852889 us-gaap:OverAllotmentOptionMember ivca:SponsorMember ivca:PrivatePlacementWarrantsMember 2022-05-12 2022-05-12 0001852889 ivca:SponsorMember us-gaap:CommonClassBMember 2021-03-12 2021-03-12 0001852889 us-gaap:CommonClassBMember ivca:SponsorMember 2022-03-01 2022-03-31 0001852889 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2022-03-01 2022-03-31 0001852889 ivca:AgreementToContributeToTheTrustAccountMember ivca:SponsorMember 2023-08-11 2023-08-11 0001852889 us-gaap:CommonClassBMember ivca:SponsorMember 2022-03-22 2022-03-22 0001852889 us-gaap:SubsequentEventMember 2023-10-11 2023-10-11 0001852889 us-gaap:SubsequentEventMember 2023-11-13 2023-11-13 0001852889 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001852889 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2023-04-01 2023-06-30 0001852889 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001852889 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001852889 us-gaap:CommonClassAMember 2023-09-30 0001852889 us-gaap:USTreasurySecuritiesMember 2023-09-30 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001852889 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member ivca:PublicWarrantsMember 2023-09-30 0001852889 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001852889 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001852889 us-gaap:MeasurementInputExercisePriceMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001852889 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001852889 us-gaap:MeasurementInputSharePriceMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2023-09-30 0001852889 us-gaap:IPOMember us-gaap:CommonClassAMember 2023-09-30 0001852889 us-gaap:CommonClassBMember 2023-09-30 0001852889 ivca:ProposedOfferingMember 2023-09-30 0001852889 us-gaap:CommonClassAMember ivca:PublicWarrantsMember 2023-09-30 0001852889 us-gaap:IPOMember 2023-09-30 0001852889 ivca:PublicWarrantsMember ivca:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsEighteenPointZeroZeroMember 2023-09-30 0001852889 srt:MaximumMember ivca:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsTenPointZeroZeroMember ivca:PublicWarrantsMember 2023-09-30 0001852889 ivca:PublicWarrantsMember ivca:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsTenPointZeroZeroMember 2023-09-30 0001852889 srt:MaximumMember us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2023-09-30 0001852889 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-09-30 0001852889 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-09-30 0001852889 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-09-30 0001852889 ivca:SponsorMember 2023-09-30 0001852889 ivca:SponsorMember ivca:WorkingCapitalLoansMember 2023-09-30 0001852889 ivca:ExtensionLoansMember 2023-09-30 0001852889 ivca:AdministrativeServicesAgreementMember 2023-09-30 0001852889 us-gaap:CommonClassAMember 2022-12-31 0001852889 us-gaap:USTreasurySecuritiesMember 2022-12-31 0001852889 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2022-12-31 0001852889 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member ivca:PublicWarrantsMember 2022-12-31 0001852889 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001852889 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001852889 us-gaap:MeasurementInputSharePriceMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001852889 us-gaap:MeasurementInputExpectedTermMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001852889 us-gaap:OverAllotmentOptionMember 2022-12-31 0001852889 us-gaap:CommonClassBMember 2022-12-31 0001852889 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-12-31 0001852889 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-12-31 0001852889 ivca:SponsorMember 2022-12-31 0001852889 ivca:ExtensionLoansMember 2022-12-31 0001852889 ivca:AdministrativeServicesAgreementMember 2022-12-31 0001852889 us-gaap:IPOMember us-gaap:CommonClassAMember 2022-05-12 0001852889 us-gaap:CommonClassBMember ivca:SponsorMember 2022-03-31 0001852889 us-gaap:CommonClassBMember srt:MaximumMember us-gaap:OverAllotmentOptionMember 2022-03-31 0001852889 ivca:UnsecuredPromissoryNoteMember ivca:SponsorMember 2021-03-12 0001852889 ivca:AgreementToContributeToTheTrustAccountMember ivca:SponsorMember 2023-08-11 0001852889 us-gaap:CommonClassAMember 2023-08-11 0001852889 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember srt:MaximumMember 2022-03-22 0001852889 us-gaap:CommonClassBMember ivca:SponsorMember 2022-03-22 0001852889 us-gaap:CommonClassAMember 2023-11-30 0001852889 us-gaap:CommonClassBMember 2023-11-30 0001852889 ivca:SponsorMember 2023-08-09 0001852889 us-gaap:SubsequentEventMember ivca:TwoThousandAndTwentyThreePromissoryNoteMember ivca:SponsorMember 2023-10-10 0001852889 ivca:SponsorMember ivca:TwoThousandAndTwentyThreePromissoryNoteMember us-gaap:SubsequentEventMember 2023-11-09 0001852889 us-gaap:SubsequentEventMember ivca:TwoThousandAndTwentyThreePromissoryNoteMember ivca:SponsorMember 2023-10-10 2023-10-10 0001852889 ivca:SponsorMember ivca:TwoThousandAndTwentyThreePromissoryNoteMember us-gaap:SubsequentEventMember 2023-11-09 2023-11-09 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2022-01-01 2022-06-30 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2022-09-30 0001852889 us-gaap:RetainedEarningsMember 2022-09-30 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-09-30 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2023-09-30 0001852889 us-gaap:RetainedEarningsMember 2023-09-30 0001852889 us-gaap:RetainedEarningsMember 2022-12-31 0001852889 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001852889 us-gaap:RetainedEarningsMember 2023-03-31 0001852889 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-03-31 0001852889 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001852889 us-gaap:RetainedEarningsMember 2021-12-31 0001852889 us-gaap:RetainedEarningsMember 2022-03-31 0001852889 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001852889 us-gaap:RetainedEarningsMember 2022-06-30 0001852889 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2023-06-30 0001852889 us-gaap:RetainedEarningsMember 2023-06-30 0001852889 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-06-30 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2021-12-31 0001852889 us-gaap:FairValueInputsLevel3Member ivca:PrivateWarrantsMember 2022-06-30 iso4217:USD xbrli:shares utr:Day utr:Year xbrli:pure iso4217:USD xbrli:shares utr:Y
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
 
10-Q
 
 
(Mark One)
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
September 30,
2023
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
 
                    
 
to
 
                    
Commission File Number
 
001-41383
 
 
INVESTCORP INDIA ACQUISITION CORP
(Exact name of registrant as specified in its charter)
 
 
 
Cayman Islands
 
N/A
(State or other jurisdiction of
incorporation or organization)
 
(IRS Employer
Identification No.)
Century Yard, Cricket Square
Elgin Avenue
PO Box 1111
George Town
Grand Cayman, Cayman Islands
 
KY1-1102
(Address of principal executive offices and zip code)
(302)
 
738-7210
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class
 
Trading
Symbols
 
Name of Each Exchange
on Which Registered
Units, each consisting of one Class A ordinary share and
one-half
of one redeemable warrant
 
IVCAU
 
The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share
 
IVCA
 
The Nasdaq Stock Market LLC
Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share
 
IVCAW
 
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
 
S-T
 
(Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
 
non-accelerated
 
filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
 
12b-2
 
of the Exchange Act:
 
Large accelerated filer      Accelerated filer  
       
Non-accelerated
filer
     Smaller reporting company  
       
         Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
Indicate by check mark whether the registrant is a shell company (as defined in Rule
 
12b-2
 
of the Exchange Act).    Yes      No  ☐
As of November 30
, 2023, there were 9,789,446 Class A ordinary shares, par value $0.0001, and 6,468,750 of the registrant’s Class B ordinary shares, par value $0.0001 per share, issued and outstanding.
 
 
 


Table of Contents

INVESTCORP INDIA ACQUISITION CORP

TABLE OF CONTENTS

 

          Page  
PART I. FINANCIAL INFORMATION   
Item 1.    Financial Statements      1  
     Condensed Balance Sheets as of September 30, 2023 (Unaudited) and December 31, 2022    1  
     Condensed Statements of Operations for the three and nine months ended September 30, 2023 (Unaudited) and
September 30, 2022 (Unaudited)
   2  
     Condensed Statements of Changes in Stockholders’ Deficit for the three and nine months ended September 30, 2023
(Unaudited) and September 30, 2022 (Unaudited)
   3  
     Condensed Statements of Cash Flows for the nine months ended September 30, 2023 (Unaudited) and
September 30, 2022 (Unaudited)
   4  
     Notes to Condensed Financial Statements (Unaudited)    5  
Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations      19  
Item 3.    Quantitative and Qualitative Disclosures About Market Risk      24  
Item 4.    Controls and Procedures      24  
PART II. OTHER INFORMATION   
Item 1.    Legal Proceedings      25  
Item 1A.    Risk Factors      25  
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities      25  
Item 3.    Defaults Upon Senior Securities      25  
Item 4.    Mine Safety Disclosures      26  
Item 5.    Other Information      26  
Item 6.    Exhibits      27  


Table of Contents
http://fasb.org/us-gaap/2023#RelatedPartyMemberhttp://fasb.org/us-gaap/2023#RelatedPartyMemberP3DP3Dhttp://www.ivcau.com/20230930#FormationsCostsAndOperatingExpenses
PART I—FINANCIAL INFORMATION
ITEM 1.
FINANCIAL STATEMENTS.
INVESTCORP INDIA ACQUISITION CORP
CONDENSED BALANCE SHEETS
 
    
September 30,
2023

(Unaudited)
   
December 31,
2022
 
ASSETS
                
Current Assets
                
Cash
   $ 30,414     $ 635,565  
Other assets – current
     317,822       509,987  
    
 
 
   
 
 
 
Total current assets
     348,236       1,145,552  
Other assets –
non-current
              183,345  
Investments held in Trust Account
     106,318,563       270,278,722  
    
 
 
   
 
 
 
Total Assets
  
$
106,666,799
 
 
$
271,607,619
 
    
 
 
   
 
 
 
LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS’ DEFICIT
                
Current Liabilities
                
Accrued expenses
   $ 536,304     $ 206,748  
Promissory note – related party
     200,000       —    
Due to Sponsor
     39,435       42,424  
    
 
 
   
 
 
 
Total current liabilities
     775,739       249,172  
Warrant liability
     2,031,751       1,479,713  
    
 
 
   
 
 
 
Total Liabilities
  
 
2,807,409
 
 
 
1,728,885
 
    
 
 
   
 
 
 
Commitments and Contingencies (Note 6)
           
Class A common stock: 9,789,446 and 25,875,000 shares subject to possible redemption at September 30, 2023 and December 31, 2022, respectively
     106,318,563       270,278,722  
Shareholders’ Deficit
                
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none outstanding
                  
Class A ordinary shares, $0.0001 par value; 479,000,000
 s
hares authorized; none issued or outstanding
                  
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 6,468,750 shares issued and outstanding
(1)
     647       647  
Additional paid in capital
                  
Accumulated deficit
     (2,459,901     (400,635
    
 
 
   
 
 
 
Total Shareholders’ Deficit
  
 
(2,459,254
)
 
 
 
(399,988
    
 
 
   
 
 
 
Total Liabilities and Shareholders’ Deficit
  
$
106,666,799
 
 
$
271,607,619
 
    
 
 
   
 
 
 
 
(1)
On March 22, 2022, the Company surrendered 718,750 shares of Class B ordinary shares as a result of updated terms of the proposed public offering. All share amounts and related information have been retroactively restated to reflect the surrender. Includes an aggregate of up to 843,750 shares that are subject to forfeiture if the over-allotment option is not exercised in full by the underwriter (see Note 8). On May 12, 2022, the underwriter exercised the full over-allotment option.
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
1

INVESTCORP INDIA ACQUISITION CORP
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
 
    
Three Months Ended

September 30,
   
Nine Months Ended
September 30,
 
    
2023
   
2022
   
2023
   
2022
 
Formation costs and operating expenses
   $ 461,510     $ 273,246     $ 1,307,228     $ 796,793  
    
 
 
   
 
 
   
 
 
   
 
 
 
Loss from operations
  
$
(461,510
)
 
$
(273,246
)
 
$
(1,307,228
)
 
 
$
(796,793
Other income:
                                
Interest earned on investments held in Trust Account
     2,503,463       1,204,462       8,614,558       1,466,458  
Change in fair value of warrant liability
     (831,938     1,451,250       (552,038     2,902,500  
    
 
 
   
 
 
   
 
 
   
 
 
 
Other income
     1,671,525       2,655,712       8,062,520       4,368,958  
    
 
 
   
 
 
   
 
 
   
 
 
 
Net income
  
$
1,210,015
 
 
$
2,382,466
 
 
$
6,755,292
 
 
$
3,572,165
 
    
 
 
   
 
 
   
 
 
   
 
 
 
Weighted average shares outstanding of Class A ordinary shares
     18,274,134       25,875,000       23,341,378       13,364,011  
Basic and diluted net income per ordinary share, Class A ordinary shares
   $ 0.05     $  0.07     $ 0.23     $ 0.18  
  
 
 
   
 
 
   
 
 
   
 
 
 
Weighted average shares outstanding of Class B ordinary shares (1)
     6,468,750       6,468,750       6,468,750       6,682,005  
Basic and diluted net income per ordinary share, Class B ordinary shares
  
$
0.05
   
$
 0.07
   
$
0.23
 
 
$
0.18
 
  
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
On March 22, 2022, the Company surrendered 718,750 shares of Class B ordinary shares as a result of updated terms of the proposed public offering. All share amounts and related information have been retroactively restated to reflect the surrender. Includes an aggregate of up to
843,750
shares that are subject to forfeiture if the over-allotment option is not exercised in full by the underwriter (see Note 8). On May 12, 2022, the underwriter exercised the full over-allotment option.
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
2

INVESTCORP INDIA ACQUISITION CORP
CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ DEFICIT
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023
(UNAUDITED)
 
    
Class B Ordinary

Shares
    
Additional
Paid-in

Capital
    
Accumulated
Deficit
   
Total
Shareholders’
Deficit
 
    
Shares
    
Amount
 
Balance — December 31, 2022
  
 
6,468,750
 
  
$
647
 
  
$
  
 
  
$
(400,635
 
$
(399,988
Accretion of Class A ordinary shares subject to possible redemption
     —          —                    (2,889,862     (2,889,862
Net income
     —          —          —          2,012,699       2,012,699  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance — March 31, 2023
  
 
6,468,750
 
  
$
647
 
  
$
 —  
 
  
$
(1,277,798
 
$
(1,277,151
Accretion of Class A ordinary shares subject to possible redemption
     —          —                    (3,221,233     (3,221,233
Net income
     —          —          —          3,532,578       3,532,578  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance — June 30, 2023
  
 
6,468,750
 
  
$
647
 
  
 
—  
 
  
 
(966,453
 
 
(965,806
Accretion of Class A ordinary shares subject to possible redemption
     —          —          —          (2,703,463     (2,703,463
Net Income
     —          —          —          1,210,015       1,210,015  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance — September 30, 2023
  
 
6,468,750
 
  
 
647
 
  
 
—  
 
  
 
(2,459,901
 
 
(2,459,254
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ DEFICIT
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022
(UNAUDITED)
 
    
Class B Ordinary
Shares
    
Additional
Paid-in

Capital
   
Accumulated
Deficit
   
Total
Shareholders’
Deficit
 
    
Shares
    
Amount
 
Balance — December 31, 2021
  
 
6,468,750
 
  
$
647
 
  
$
24,353
 
 
$
(3,587
 
$
21,413
 
Net loss
     —          —                                
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Balance — March 31, 2022
  
 
6,468,750
    
$
647
    
$
24,353
 
 
$
(3,587
 
$
21,413
 
Excess cash received over fair value for private placement warrants
     —          —          12,870,000               12,870,000  
Accretion of Class A ordinary shares subject to possible redemption
     —          —          (12,894,353     (3,684,712     (16,579,065
Net Income
     —          —          —         1,189,699       1,189,699  
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Balance — June 30, 2022
  
 
6,468,750
 
  
$
647
 
  
$
  
 
 
$
(2,498,600
 
$
(2,497,953
Accretion of Class A ordinary shares subject to possible redemption
     —          —          —         (1,204,462     (1,204,462
Net Income
     —          —          —         2,382,466       2,382,466  
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Balance — September 30, 2022
  
 
6,468,750
 
  
$
647
 
  
$
—  
 
 
$
(1,320,596
 
$
(1,319,949
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
3

INVESTCORP INDIA ACQUISITION CORP
CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)
 
    
Nine Months Ended

September 30, 2023
   
Nine Months Ended
September 30, 2022
 
Cashflow from Operating Activities:
                
Net income
   $ 6,755,292     $ 3,572,165  
Adjustments to reconcile net income to net cash used in operating activities:
                
Change in fair value of warrant liability
     552,038       (2,902,500
Interest earned on investments held in Trust Account
     (8,614,558     (1,466,458
Changes in operating assets and liabilities:
                
Other assets
     375,510       (826,074
Accrued expenses
     329,556       78,150  
Due to Sponsor
     (2,989     (302,528
    
 
 
   
 
 
 
Net cash used in operating activities
  
 
(605,151
 
 
(1,847,245
    
 
 
   
 
 
 
Cashflow from Investing Activities:
                
Investment of cash into Trust Account
     172,774,717       (266,512,500
Cash deposited in Trust Account
     (200,000     —    
    
 
 
   
 
 
 
Net cash provided by (used in) investing activities
  
 
172,574,717
   
 
(266,512,500
    
 
 
   
 
 
 
Cashflow from Financing Activities:
                
Payments to Redeeming Shareholders
     (172,774,717     —    
Proceeds from Sale of Units, net of underwriting discounts paid
             253,575,000
 
Proceeds from promissory note – related party
     200,000        
Proceeds from sale of Private Placements Warrants
     —         16,087,500  
Advances from Sponsor
     —         25,000  
Payment of offering costs
     —         (469,891
    
 
 
   
 
 
 
Net cash (used in) provided by financing activities
  
 
(172,574,717
 
 
269,217,609
 
    
 
 
   
 
 
 
Net Change in Cash
  
 
(605,151
 
 
857,864
 
Cash at the beginning of the period
     635,565        
    
 
 
   
 
 
 
Cash at the end of the period
  
$
30,414
 
 
$
857,864
 
    
 
 
   
 
 
 
Non-cash
investing and financing activities:
                
            
 
 
 
Accretion of Class A ordinary shares subject to possible redemption
   $ 8,814,558     $  —    
    
 
 
   
 
 
 
Deferred offering costs paid through Due to Sponsor
   $         $ 325,765  
  
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
4

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Investcorp India Acquisition Corp (the “Company”) is a blank check company incorporated in the Cayman Islands on February 19, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. On January 11, 2022, the Company changed its name from Investcorp Acquisition Corp. to Investcorp India Acquisition Corp.
As of September 30, 2023, and for the period from February 19, 2021 (inception) through September 30, 2023, the Company had not yet commenced any operations. All activity for the period from February 19, 2021 (inception) through September 30, 2023, relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) and identifying a target for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.
The registration statement for the Company’s Initial Public Offering was declared effective on May 9, 2022. On May 12, 2022, the Company consummated the Initial Public Offering of 22,500,000 unit (the “Units” and, with respect to the shares of Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $225,000,000. Additionally, the underwriter exercised their over-allotment option in full, resulting in an additional 3,375,000 Units issued for an aggregate amount of $33,750,000, which is described in Note 3.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 14,400,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to ICE I Holdings Pte. Ltd. (the “Sponsor”), generating gross proceeds of $14,400,000. In connection with the underwriter’s exercise of their over-allotment option, the Company also consummated the sale of an additional 1,687,500 Private Placement Warrants at $1.00 per Private Placement Warrant generating total proceeds of $1,687,500, which is described in Note 4.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (less any taxes payable on interest earned on the Trust Account) at the time of the signing a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the Proposed Offering, management has agreed that $10.30 per Unit sold in the Proposed Offering, including the proceeds from the sale of the Private Placement Warrants, will be held in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule
2a-7
under the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.
The Company provides its holders of the outstanding Public Shares (the “public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.
If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Certificate of Incorporation provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent.
 
5


The public shareholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.30 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These Class A ordinary shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Proposed Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”
If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.
The Company’s Sponsor has agreed (a) to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Certificate of Incorporation with respect to the Company’s
pre-Business
Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Founder Shares) into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek shareholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating to shareholders’ rights of
pre-Business
Combination activity and (d) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Proposed Offering if the Company fails to complete its Business Combination.
On August 11, 2023 shareholders of the Company held an extraordinary general meeting of shareholders (the “Extraordinary General Meeting”). At the Extraordinary General Meeting, the Company’s shareholders approved the proposal to amend the Company’s Amended and Restated Memorandum and Articles of Association to give the Company the right to extend the date by which it has to consummate a business combination from August 12, 2023 to August 12, 2024.
In connection with the Extension Amendment Proposal, the Sponsor has agreed to contribute (each such contribution, a “Contribution”) into the Company’s Trust Account the lessor or (x) an aggregate of $100,000 or (y) $0.025 per share for each Class A ordinary share included as a part of the units sold in the Company’s initial public offering (including any shares issued in exchange thereof) that are not redeemed at the Extraordinary General Meeting for each monthly period (commencing on August 12, 2023 and ending on the 12th day of each subsequent month), or portion thereof, until the earlier of the completion of the initial business combination or August 12, 2024. Additionally, the maximum aggregate Contributions to the Trust Account shall not exceed $1,200,000 based on up to twelve monthly Contributions through August 12, 2024.
At the Extraordinary General Meeting, the shareholders of record were provided the opportunity to exercise their redemption rights (the “Extension Amendment Proposal”). Holders of 16,085,554 shares of Class A ordinary shareholders exercised their right to redemption at a per share redemption price of approximately $10.74. On August 18, 2023, a total of $172,774,717 in redemption payments were made in connection with this redemption. Following the redemption, the Company had a total of 9,789,446 shares of Class A ordinary shares outstanding.
If the Company is unable to complete a Business Combination within the combination period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a
per-
share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholder’s rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. In the event the Company does not complete a Business Combination within the Combination Period, and in such event, the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Initial Offering price per Unit of $10.00.
 
6


The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.30 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.30 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriter of Proposed Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure its shareholders that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Liquidity, Capital Resources, and Going Concern Consideration
As of September 30, 2023, the Company had $30,414 in cash and a working capital deficit of $427,503.
The Company’s liquidity needs up to September 30, 2023, had been satisfied by funds from the Sponsor to cover certain offering expenses. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company a Working Capital Loans, as defined below (see Note 5). As of September 30, 2023, there were no amounts outstanding under any Working Capital Loans.
Prior to the completion of the Initial Public Offering, the Company lacked the liquidity it needed to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statement. However, the Company completed its Initial Public Offering, as detailed in Note 3, which generated capital in excess of the funds deposited into a trust account. This excess capital may be used by the Company for general working capital purposes.
In connection with the Company’s assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”)
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The Company originally had until August 12, 2023, 15 months from the closing of the IPO, to consummate a Business Combination. As approved by its shareholders, the Company extended the time to complete a Business Combination to August 12, 2024, 23 months from the closing of the IPO). It is uncertain that the Company will be able to consummate a Business Combination by the specified period. If a Business Combination is not consummated by August 12, 202
4, there will be a mandatory liquidation and subsequent dissolution. The liquidity condition and date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern one year from the date that this financial statement is issued. This financial statement does not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
Risks and Uncertainties
Management is currently evaluating the impact of the
COVID-19
pandemic and geopolitical instability, such as the military conflict in Ukraine and the Middle East, and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Proposed Offering, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
The Inflation Reduction Act of 2022, enacted in August 2022, imposes a 1% excise tax on the fair market value of stock repurchased by “covered corporations” beginning in 2023, with certain exceptions (the “Excise Tax”). The Excise Tax is imposed on the repurchasing corporation itself, not its shareholders. Because we are a “blank check” Cayman Islands corporations with no subsidiaries or previous merger or acquisition activity, we are not currently a “covered corporation” for this purpose. The amount of the Excise Tax is generally equal to 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, there are certain other exceptions to the Excise Tax. The U.S. Department of the Treasury has been given authority to issue regulations or other guidance to carry out, and to prevent the avoidance of, the Excise Tax. The Treasury and the IRS recently have issued preliminary guidance regarding the application of this excise tax, but there can be no assurance that this guidance will be finally adopted in its current form. A repurchase that occurs in connection with a business combination with a U.S. target company might be subject to the Excise Tax, depending on the structure of the business combination and other transactions that might be engaged in during the relevant year.
 
7

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchanges Commission (“SEC”).
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of September 30, 2023 and December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Use of Credit Risk
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $30,414 and $635,565 cash and no cash equivalents as of September 30, 2023, and December 31, 2022, respectively.
Investments Held in Trust Account
As of September 30, 2023, and December 31, 2022, the Company had $106,318,563 and $270,278,722, respectively, held in money market funds, which are invested primarily in U.S. Treasury Securities.
 
8

Income Taxes
The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes”, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company has completed a nexus study and believes that it is appropriately filing tax returns in which it has nexus.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income Per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings per Share”. The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 843,750 Class B ordinary shares that are subject to forfeiture if the over- allotment option is not exercised by the underwriter (see Note 8). Diluted net income per share reflects the potential dilution that could occur if warrants were to be exercised or converted or otherwise resulted in issuance of Ordinary Shares that then shared in the earnings of the entity. As the exercise of the warrants are contingent upon the completion of a business combination, they have not been included in the calculation of diluted net income per share. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except share amounts) for the three and nine months ended September 30, 2023, and September 30, 2022:
 
    
For the Three Months Ended

September 30,
 
    
2023
    
2022
 
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
 
Basic and diluted net income per ordinary share
                                   
Numerator:
                                   
Allocation of net income, as adjusted
   $  893,670      $ 316,345      $ 1,905,973      $  476,493  
Denominator:
                                   
Basic and diluted weighted average shares outstanding
     18,274,134        6,468,750        25,875,000        6,468,750  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net income per ordinary share
   $  0.05      $  0.05      $ 0.07      $  0.07  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
9


    
For the Nine Months Ended

September 30,
 
    
2023
    
2022
 
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
 
Basic and diluted net income per ordinary share
                                   
Numerator:
                                   
Allocation of net income, as adjusted
   $ 5,289,404      $ 1,465,888      $ 2,381,443      $ 1,190,722  
Denominator:
                                   
Basic and diluted weighted average shares outstanding
     23,341,378        6,468,750        13,364,011        6,682,005  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net income per ordinary share
   $  0.23      $  0.23      $ 0.18      $  0.18  
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.
 
   
Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.
 
   
Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.
 
   
Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.
Offering Costs Associated with the Initial Public Offering
The Company complied with the requirements of the ASC
340-10-S99-1
and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consists of legal, accounting, underwriting fees and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounted to $6,037,027, which was charged to shareholders’ equity upon the completion of the Initial Public Offering.
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”). Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as stockholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, the Class A ordinary shares is subject to possible redemption and is presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
 
10


The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital (to the extent available) and accumulated deficit.
As of September 30, 2023, the Class A ordinary shares subject to possible redemption reflected in the balance sheet is reconciled in the following table:
 
Gross Proceeds
   $ 258,750,000  
Less:
        
Proceeds allocated to Public Warrants
     (2,587,500
Total stock issuance costs
     (5,967,069
Plus:
        
Accretion of carrying value to redemption value
     20,083,291  
    
 
 
 
Class A ordinary shares subject to possible redemption at December 31, 2022
  
$
270,278,722
 
Plus:
        
Accretion of carrying value to redemption value
     8,814,558  
Less:
        
Shares redeemed in August 2023
     (172,774,717
    
 
 
 
Class A ordinary shares subject to possible redemption at September 30, 2023
  
$
 106,318,563
 
    
 
 
 
Warrant Liability
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional
paid-in
capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a
non-cash
gain or loss on the statements of operations. The fair value of the warrants was estimated using a Modified Binomial Option Pricing model (see Note 9).
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or
non-current
based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
 
11


Recently Issued Accounting Standards
In August 2020, the FASB issued Accounting Standards Update (“ASU”)
2020-06,
Debt — Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic
815-40)
(“ASU 2020-06”)
to simplify accounting for certain financial instruments. ASU
2020-06
eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU
2020-06
amends the diluted earnings per share guidance, including the requirement to use the
if-converted
method for all convertible instruments. The new standard is effective for companies that are SEC filers (except for smaller reporting companies) for fiscal years beginning after December 15, 2021, and interim periods within that year, and two years later for other companies. Companies can early adopt the standard at the start of a fiscal year beginning after December 15, 2020. The standard can either be adopted on a modified retrospective or a full retrospective basis. The Company is still evaluating the impact on the Company’s financial statements.
Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
NOTE 3. INITIAL PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company sold 25,875,000 Units at a purchase price of $10.00 per Unit. Each Unit consisted of one Class A ordinary share, $0.0001 par value, and
one-half
of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note 8).
NOTE 4. PRIVATE PLACEMENT
The Sponsor purchased an aggregate of 16,087,500 Private Placement Warrants at a price of $1.00 per warrant, in a private placement that closed simultaneously with the closing of the Initial Public Offering.
Each Private Placement Warrant is identical to the warrants offered in the Initial Public Offering, except there will be no redemption rights or liquidating distributions from the trust account with respect to Private Placement Warrants, which will expire worthless if the Company does not consummate a Business Combination within the Combination Period.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On March 12, 2021, the Company issued an aggregate of 7,187,500 Class B ordinary shares (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. In March 2022, our sponsor surrendered, for no consideration, 718,750 founder shares, resulting in our sponsor holding 6,468,750 founder shares for an aggregate purchase price of $25,000 or approximately $0.039 per share. The Founder Shares include an aggregate of up to 843,750 shares subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment was not exercised in full or in part, so that the Sponsor will collectively own, on an
as-converted
basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering.
As a result of the underwriter’s election to exercise their over-allotment option simultaneously with the Initial Public Offering, 843,750 Founder Shares are no longer subject to forfeiture.
The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 120 days after the Business Combination, the Founder Shares will be released from the
lock-up.
Promissory Note — Related Party
On March 12, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Proposed Offering pursuant to a promissory note (the “Note”). The Note is
non-interest
bearing and is payable on the earlier of (i) December 31, 2021 (which was amended to September 30, 2022, on January 25, 2022) or (ii) the consummation of the Initial Proposed Offering. As of September 30, 2023, and December 31, 2022, there were no amounts outstanding on the Note and it is no longer available to the Company.
 
12


Working Capital Loans
In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $3,000,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of September 30, 2023, and December 31, 2022, the Company has not drawn on the Working Capital Loans.
Due to Sponsor
The Sponsor has paid expenses on behalf of the Company prior to the Company’s Initial Public Offering. This amount is not interest bearing and due on demand by the Sponsor. As of September 30, 2023, and December 31, 2022, there was $39,435 and $42,424 due to Sponsor, respectively.
Extension Loans — related party
If the Company anticipates that it may not be able to consummate its initial business combination within 15 months, the Company may, but is not obligated to, extend the period of time to consummate a Business Combination by an additional three months on two separate occasions (for a total of up to 21 months to complete a business combination). In order to extend the time available for us to consummate a Business Combination, the Sponsor (or its affiliates or designees), upon five days advance notice prior to the applicable deadline, must deposit into the Trust Account $2,587,500 ($0.10 per share), on or prior to the date of the applicable deadline. Any such payments would be funded from the proceeds of a
non-interest-bearing
loan between the Sponsor and the Company (the “Extension Loans”). Such Extension Loans may be convertible into warrants, at a price of $1.00 per warrant at the option of the lender. The terms of the warrants would be identical to the terms of the private placement warrants. If the Company completes a Business Combination, the Company would repay such Extension Loans out of the proceeds of the trust account released to the Company. There were no amounts outstanding on the extension loans as of September 30, 2023, and December 31, 2022.
As a result of the shareholders’ vote held on August 11, 2023, the Company has agreed to contribute (each such contribution, a “Contribution”) into the Company’s Trust Account the lessor or (x) an aggregate of $100,000 or (y) $0.025 per share for each Class A ordinary share included as a part of the units sold in the Company’s IPO (including any shares issued in exchange thereof) that are not redeemed at the Meeting for each monthly period (commencing on August 12, 2023 and ending on the 12th day of each subsequent month), or portion thereof, until the earlier of the completion of the initial business combination or August 12, 2024. For the avoidance of doubt, the maximum aggregate Contributions to the Trust Account shall not exceed $1,200,000 based on up to twelve monthly Contributions through August 12, 2024.
Promissory Note
On August 9, 2023, the Sponsor agreed to loan the Company an aggregate of up to $1,200,000 to cover expenses related to the Contributions (the “2023 Note”). The note is
non-interest
bearing and is payable on the earlier of (i) August 12, 2024, or (ii) the consummation of a Business Combination. Upon receiving notice of the closing of a Business Combination, the Sponsor shall convert the unpaid principal balance of the 2023 Note into a number of
non-transferable,
non-redeemable
ordinary shares of the Company equal to (x) the principal amount of the 2023 Note being converted, divided by (y) the conversion price of $10.00, rounded up to the nearest whole number of shares. As of September 30, 2023, the outstanding principal balance was $200,000
. Subsequently, on October 10, 2023 and November 9, 2023 the Company made additional draw downs on the Promissory Note of $100,000
each month to fund month extension requirements.
Administrative Services Agreement
Commencing on the date of the Initial Public Offering and until completion of the Company’s initial business combination or liquidation, the Company will make a payment of a monthly fee of $10,000 to the Sponsor for office space, utilities and secretarial and administrative services provided to the Company. As of September 30, 2023 and December 31, 2022, there was $90,000 and $60,000 recorded in accrued expenses, respectively.
 
13

NOTE 6. COMMITMENTS AND CONTINGENCIES
Registration Rights
The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans and Extension Loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Proposed Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to our Class A ordinary shares). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriter a
45-day
option to purchase up to 3,375,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The over-allotment option was exercised simultaneously with the Initial Public Offering.
NOTE 7. WARRANT LIABILITY
The Company accounts for the 29,025,000 warrants issued in connection with the Initial Public Offering (the 16,087,500 Private Warrants and the 12,937,500 Public Warrants) in accordance with the guidance contained in ASC 480 and ASC
815-40,
Derivatives and Hedging. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value. This liability is subject to
re-measurement
at each balance sheet date. With each such remeasurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations.
The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the ordinary share warrants. At that time, the portion of the warrant liability related to the ordinary share warrants will be reclassified to additional
paid-in
capital.
Warrants — Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable 30 days after the consummation of a Business Combination. The Public Warrants will expire
five years
from the consummation of a Business Combination or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.
The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. The Company will use its best efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.
Redemption of warrants when the price per Class A ordinary share equals or exceeds $
18.00
. Once the warrants become exercisable, the Company may redeem the Warrants for redemption:
 
   
in whole and not in part;
 
   
at a price of $
0.01
per Public Warrant;
 
   
upon not less than
30
days’ prior written notice of redemption to each warrant holder and
 
14

   
if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $
18.00
per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any
20
trading days within a
30
-trading
day period ending three business days before the Company sends the notice of redemption to the warrant holders.
The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the
30
-day
redemption period. If and when the warrants become redeemable by us, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
Redemption of warrants when the price per Class A ordinary share equals or exceeds $
10.00
. Once the Warrants become exercisable, the Company may redeem the Warrants for redemption:
 
   
in whole and not in part;
 
   
at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth under “Description of Securities — Warrants — Public Shareholders’ Warrants” based on the redemption date and the “fair market value” of our Class A ordinary shares (as defined below) except as otherwise described in “Description of Securities — Warrants — Public Shareholders’ Warrants”;
 
   
if, and only if, the closing price of our Class A ordinary shares equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Shareholders’ Warrants — Anti-dilution Adjustments”) for any 20 trading days within the
30-trading
day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and
 
   
if the closing price of our Class A ordinary shares for any
20
trading days within a
30
-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $
18.00
per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “— Warrants — Public Shareholders’ Warrants — Anti-Dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.
If and when the Public Warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of ordinary shares upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification.
The exercise price and number of Class A ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.
In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such
 
15

initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.
The Private Placement Warrants will be identical to the Public Warrants included in the Units being sold in the Proposed Offering, except that the Private Placement Warrants will and the ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be
non-redeemable
so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
NOTE 8. SHAREHOLDERS’ DEFICIT
Preference Shares — The Company is authorized to issue 1,000,000 preference shares of $0.0001 par value. At September 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.
Class A Ordinary Shares — The Company is authorized to issue up to 479,000,000 Class A ordinary shares, $0.0001 par value. Holders of the Company’s ordinary shares are entitled to one vote for each share. At September 30, 2023, and December 31, 2022, there were 9,789,446 and 25,875,000 Class A ordinary shares issued and outstanding, respectively.
Class B Ordinary Shares — The Company is authorized to issue up to 20,000,000 Class B ordinary shares, $0.0001 par value. Holders of the Company’s ordinary shares are entitled to one vote for each share. At September 30, 2023 and December 31, 2022, there were 6,468,750 Class B ordinary shares issued and outstanding, respectively.
On March 22, 2022, the Sponsor surrendered, for no consideration, 718,750 Class B ordinary shares, resulting in our sponsor holding 6,468,750 founder shares issued and outstanding, of which an aggregate of up to 843,750 shares subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment is not exercised in full or in part, so that the Sponsor will collectively own, on an
as-converted
basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. As a result of the underwriter’s election to exercise their over-allotment option simultaneously with the Initial Public Offering, 843,750 Founder Shares are no longer subject to forfeiture.
The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the completion of our Business Combination on a
one-for-one
basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional Class A ordinary shares, or equity linked securities, are issued or deemed issued in connection with the initial Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as converted basis, 20% of the sum of the total number of all ordinary shares outstanding as of the Initial Public Offering plus all Class A ordinary shares and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be issued, to any seller in a Business Combination, and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their Class B ordinary shares into an equal number of Class A ordinary shares, subject to adjustment as provided above, at any time.
The Company may issue additional ordinary shares or preference shares to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.
NOTE 9. FAIR VALUE MEASUREMENTS
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
  Level 1:  
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
 
16

 
Level 2:  
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
 
  Level 3:  
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
As of September 30, 2023, and December 31, 2022, investments held in the Trust Account were comprised of $106,318,563 and $270,278,722 in money market funds, which are invested primarily in U.S. Treasury Securities, respectively. The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
    
Level
    
September 30, 2023
    
December 31, 2022
 
Assets:
                          
Investments held in Trust Account
     1      $ 106,318,563      $ 270,278,722  
Liabilities:
                          
Public Warrants
     1      $ 905,625      $ 675,338  
Private Warrants
     3      $ 1,126,125      $ 804,375  
Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. During the period there were no transfers to/from Levels 1 and 3.
The Company established the initial fair value of the warrants on May 12, 2022, the date of the consummation of the Company’s IPO. The Company used a Binomial Option Pricing model to value the warrants. The Company allocated the proceeds received from (i) the sale of the Units (which is inclusive of one share of Class A ordinary shares and
one-half
of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of Class B ordinary shares, first to the warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A ordinary shares subject to possible redemption (temporary equity), Class A ordinary shares (permanent equity) and Class B ordinary shares (permanent equity) based on their relative fair values at the initial measurement date.
The following table provides quantitative information regarding Level 3 fair value measurements:
 
    
September 30,
2023
   
December 31,
2022
 
    
Private
Warrants
   
Private
Warrants
 
Stock Price
   $  10.81     $  10.34  
Exercise Price
   $  11.50     $  11.50  
Risk-free rate of interest
     4.60 %     3.99 %
Volatility
     0.50 %     0.50 %
Term
     1.5 years       2.8 years  
The Private Placement Warrants were initially and subsequently valued using a Binomial Option Pricing model, which is considered to be a Level 3 fair value measurement. The fair value of Public Warrants issued in connection with the Initial Public Offering were initially measured using a Binomial Option Pricing model and at September 30, 2023 and December 31, 2022 are measured based on the listed market price of such warrants, a Level 1 measurement.
 
17

 
The Binomial Option Pricing model’s primary unobservable input utilized in determining the fair value of the Warrants is the expected volatility as of the IPO date was derived from observable warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing.
The following table presents a summary of the changes in the fair value of the Private Placement Warrants, Level 3 liabilities, measured on a recurring basis.

 
 
  
Private Warrants
 
Fair value as of January 1, 2022
  
$
  
 
Initial measurement on May 12, 2022 warrants issued
  
 
3,217,500
 
Changes in fair value (1)
  
 
(804,375
 
  
 
 
 
Fair value as of June 30, 2022
  
$
2,413,125
 
Changes in fair value (1)
  
 
(804,375
 
  
 
 
 
Fair value as of September 30, 2022
  
$
1,608,750
 
 
  
 
 
 
 
Fair value as of January 1, 2023
  
$
804,375
 
Changes in fair value (1)
  
 
321,750
 
 
  
 
 
 
Fair Value as of March 3
1
, 2023
  
$
1,126,125
 
 
  
 
 
 
Change in fair value (1)
  
 
(482,625
 
  
 
 
 
Fair Value as of June 30, 2023
  
$
643,500
 
 
  
 
 
 
Change in fair value (1)
  
 
482,625
 
 
  
 
 
 
Fair value as of September 30, 2023
  
$
1,126,125
 
 
  
 
 
 
 
(1)
Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the statements of operations.
NOTE 10. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date
that
the unaudited condensed financial statements were issued. Based upon this review, other than below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.
On October 10, 2023 and November 9, 2023 the Company made additional draw downs on the Promissory Note (“2023 Note”) of $100,000
each month to fund month extension requirements.
On October 11, 2023 and November 13, 2023 the Company deposited $100,000
each month into the Trust Account in order to effect the third and fourth subsequent one month extensions of the Revised Extension Deadline, which extended the deadline to consummate the Business Combination to December 12, 2023. 
 
18
 


Table of Contents
ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Investcorp India Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to ICE I Holdings Pte. Ltd. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Overview

We are a blank check company incorporated on February 19, 2021, as a Cayman Islands exempted company and formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Annual Report as our “initial business combination”. While we may pursue an initial business combination target in any industry, we intend to focus our search on companies within the Indian market. We intend to effectuate our initial business combination using remaining cash in the trust account from the proceeds of the offering and the private placement of the Private Placement Warrants (as defined below), the proceeds of the sale of our shares in connection with our initial business combination (pursuant to forward purchase agreements or backstop agreements we may enter into following the consummation of the Initial Public Offering or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing.

Recent Developments

On August 11, 2023 shareholders of the Company held an Extraordinary General Meeting. At the Extraordinary General Meeting, the Company’s shareholders approved the proposal to amend the Company’s Amended and Restated Memorandum and Articles of Association to give the Company the right to extend the date by which it has to consummate a business combination from August 12, 2023 to August 12, 2024.

In connection with the Extension Amendment Proposal, the Sponsor has agreed to contribute into the Company’s Trust Account the lessor or (x) an aggregate of $100,000 or (y) $0.025 per share for each Class A ordinary share included as a part of the units sold in the Company’s initial public offering (including any shares issued in exchange thereof) that are not redeemed at the Extraordinary General Meeting for each monthly period (commencing on August 12, 2023 and ending on the 12th day of each subsequent month), or portion thereof, until the earlier of the completion of the initial business combination or August 12, 2024. Additionally, the maximum aggregate Contributions to the Trust Account shall not exceed $1,200,000 based on up to twelve monthly Contributions through August 12, 2024.

At the Extraordinary General Meeting, the shareholders of record were provided the opportunity to exercise their redemption rights. Holders of 16,085,554 shares of Class A ordinary shareholders exercised their right to redemption at a per share redemption price of approximately $10.74. On August 18, 2023, a total of $172,774,717 in redemption payments were made in connection with this redemption. Following the redemption, the Company had a total of 9,789,446 shares of Class A ordinary shares outstanding.

On October 11, 2023 and November 13, 2023 the Company deposited $100,000 each month into the Trust Account in order to effect the third and fourth subsequent one month extensions of the Revised Extension Deadline, which extended the deadline to consummate the Business Combination to December 12, 2023.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities for the period from February 19, 2021 (inception) through September 30, 2023, were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and after our Initial Public Offering, identifying target companies for a business combination. We do not expect to generate any operating revenues until after the completion of our initial business combination. We generate non-operating income in the form of interest income on cash and cash equivalents held after the Initial Public Offering. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as due diligence expenses.

 

19


Table of Contents

For the three months ended September 30, 2023, we had net income of $1,210,015, which consists of operating costs of $461,510, loss due to change in fair value of warrants of $831,938, offset by interest earned from investments held in the Trust Account of $2,503,463. For the three months ended September 30, 2022, we had a net income of $2,382,466, which consists of operating costs of $273,246, offset by interest earned from investments held in the Trust Account of $1,204,462 and change in fair value of warrants of $1,451,250.

For the nine months ended September 30, 2023, we had net income of $6,755,292, which consists of operating costs of $1,307,228, loss due to change in fair value of warrants of $552,038, offset by interest earned from investments held in the Trust Account of $8,614,558. For the nine months ended September 30, 2022, we had a net income of $3,572,165, which consists of operating costs of $796,793, offset by interest earned from investments held in the Trust Account of $1,466,458 and change in fair value of warrants of $2,902,500.

Liquidity, Capital Resources, and Going Concern Consideration

As of September 30, 2023, the Company had $30,414 in cash and a working capital deficit of $427,503.

On May 12, 2022, we consummated the Initial Public Offering of 22,500,000 Class A Public Shares at $10.00 per Public Share, generating gross proceeds of $225,000,000. Additionally, the underwriter exercised their over-allotment option, resulting in an additional 3,375,000 Units issued for an aggregate amount of $33,750,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 14,400,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to ICE I Holdings Pte, Ltd. (the “Sponsor”), generating gross proceeds of $14,400,000. In connection with the underwriter’s exercise of their over-allotment option, the Company also consummated the sale of an additional 1,687,500 Private Placement Warrants at $1.00 per Private Placement Warrant generating total proceeds of $1,687,500.

For the nine months ended September 30, 2023, cash used in operating activities was $605,151. Net income of $6,755,292 was affected by a gain on the change in the fair value of the warrant liability of $552,038 and interest income of $8,614,558. Changes in operating assets and liabilities used $702,077 of cash for operating activities.

For the nine months ended September 30, 2022, cash used in operating activities was $1,847,245. Net income of $3,572,165 was affected by a gain on the change in the fair value of the warrant liability of $2,902,500 and interest income of $1,466,458. Changes in operating assets and liabilities used $1,050,452 of cash for operating activities.

As of September 30, 2023, we had investments held in the Trust Account of $106,318,563. Interest income on the balance in the Trust Account may be used by us to pay taxes. We intend to use substantially all of the funds held the Trust Account and the proceeds from the sale of the forward purchase shares to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

As of September 30, 2023, we had cash of $30,414 held outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, properties, or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $3,000,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.

In connection with the Company’s assessment of going concern considerations in accordance with ASU 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until August 12, 2024, 23 months from the closing of the IPO, to consummate a Business Combination unless an extension is granted. It is uncertain that the Company will be able to consummate an initial Business Combination within this time. If an initial Business Combination is not consummated within this time, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should an initial Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after August 12, 2024.

 

20


Table of Contents

Off-Balance Sheet Arrangements

As of September 30, 2023, and December 31, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual obligations.

Contractual Obligations

We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or other long-term liabilities, other than described below:

Registration Rights

The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants) will have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements

Working Capital Loans

In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $3,000,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.

Promissory Note—Related Party

On March 12, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note is non-interest bearing and is payable on the earlier of (i) December 31, 2021 (which was amended to September 30, 2022, on January 25, 2022), or (ii) the consummation of the Initial Public Offering. As of September 30, 2023 and December 31, 2022, there were no amounts outstanding on the Note and it is no longer available to the Company.

Promissory Note

On August 9, 2023, the Sponsor agreed to loan the Company an aggregate of up to $1,200,000 to cover expenses related to the Contributions (the “2023 Note”). The note is non-interest bearing and is payable on the earlier of (i) August 12, 2024, or (ii) the consummation of a Business Combination. Upon receiving notice of the closing of a Business Combination, the Sponsor shall convert the unpaid principal balance of the 2023 Note into a number of non-transferable, non-redeemable ordinary shares of the Company equal to (x) the principal amount of the 2023 Note being converted, divided by (y) the conversion price of $10.00, rounded up to the nearest whole number of shares. As of September 30, 2023, the outstanding principal balance was $200,000. Subsequently, on October 10, 2023 and November 9, 2023 the Company made additional draw downs on the Promissory Note of $100,000 to fund month extension requirements.

Underwriter’s Agreement

The Company granted the underwriter a 45-day option to purchase up to 3,375,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. Concurrently with the consummation of the IPO, the underwriters exercised the over- allotment option to purchase an additional 3,375,000 units.

 

21


Table of Contents

Critical Accounting Estimates

This management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with GAAP. The preparation of our financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued expenses. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The Company has identified the following as its critical accounting estimates:

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, the Class A ordinary shares is subject to possible redemption and is presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

On August 11, 2023 shareholders of the Company held an extraordinary general meeting of shareholders (the “Extraordinary General Meeting”). At the Extraordinary General Meeting, the Company’s shareholders approved the proposal to amend the Company’s Amended and Restated Memorandum and Articles of Association to give the Company the right to extend the date by which it has to consummate a business combination from August 12, 2023 to August 12, 2024. At the Extraordinary General Meeting, the shareholders of record were provided the opportunity to exercise their redemption rights (the “Extension Amendment Proposal”). Holders of 16,085,554 shares of Class A ordinary shareholders exercised their right to redemption at a per share redemption price of approximately $10.74. On August 18, 2023, a total of $172,774,717 in redemption payments were made in connection with this redemption. Following the redemption, the Company had a total of 9,789,446 shares of Class A ordinary shares outstanding.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital (to the extent available) and accumulated deficit.

Warrants

The Company accounts for the Warrants as either equity-classified or liability-classified instruments based on an assessment of the specific terms of the Warrants and the applicable authoritative guidance in ASC 480, and ASC 815. The assessment considers whether they are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification under ASC 815, including whether the Warrants are indexed to the Company’s own ordinary shares and whether the holders of the Warrants could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of issuance of the Warrants and as of each subsequent quarterly period end date while the Warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, such warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, such warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of liability-classified warrants are recognized as a non-cash gain or loss on the statements of operations.

JOBS Act

On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As such, our financial statements may not be comparable to companies that comply with public company effective dates.

 

22


Table of Contents

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

 

23


Table of Contents
ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

 

ITEM 4.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our current chief executive officer and chief financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2023, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act.

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Based on this evaluation, our chief executive officer and chief financial officer have concluded that, during the period covered by this report, our disclosure controls and procedures were not effective as of September 30, 2023, because of an identified material weakness in our internal control over financial reporting. The material weakness identified relates to an ineffective review control to prevent or detect a material misstatement, which resulted in a material adjustment to accrued expenses in relation to the filing of its Form 8-K on May 26, 2022.

The Company, with the oversight of its Audit Committee, is actively undertaking remediation efforts to address the material weakness identified above and is developing measures and controls to prevent a re-occurrence of such a deficiency in the future.

The Company is committed to maintaining an effective internal control environment, and although it has made progress in this area, additional steps need to be taken, as indicated above, and sufficient time needs to elapse before management can conclude that the newly implemented controls are operating effectively and that the material weakness has been adequately remediated.

Management’s Report on Internal Controls Over Financial Reporting

This Quarterly Report on Form 10-Q does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of our independent registered public accounting firm due to a transition period established by rules of the SEC for newly public companies.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

24


Table of Contents

PART II - OTHER INFORMATION

 

ITEM 1.

LEGAL PROCEEDINGS

None.

 

ITEM 1A.

RISK FACTORS

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in (i) our final prospectus for our Initial Public Offering filed with the SEC on May 10, 2022, and (ii) our annual report on Form 10-K filed with the SEC on April 17, 2023. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in (i) our final prospectus for our Initial Public Offering filed with the SEC on May 10, 2022 or (ii) our annual report on Form 10-K filed with the SEC on April 17, 2023, except we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

 

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Unregistered Sales of Equity Securities

In March 2021, our Sponsor purchased 7,187,500 Class B ordinary shares, par value $0.0001, for an aggregate price of $25,000. In March 2022, our sponsor surrendered, for no consideration, 718,750 founder shares, resulting in our sponsor holding 6,468,750 founder shares for an aggregate purchase price of $25,000 or approximately $0.039 per share.

On May 12, 2022, we consummated the Initial Public Offering of 22,500,000 unit, at $10.00 per Unit, generating gross proceeds of $225,000,000. Additionally, the underwriter exercised their over-allotment option, resulting in an additional 3,375,000 Units issued for an aggregate amount of $33,750,000.

Simultaneously with the closing of the Initial Public Offering, pursuant to the Private Placement Warrants Purchase Agreements, the Company completed the private sale of 16,087,500 warrants to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $16,087,500. The Private Placement Warrants are identical to the Warrants included as part of the Units sold in the IPO.

No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

Use of Proceeds

In connection with the Initial Public Offering, we incurred offering costs of $6,037,027, consisting of $5,175,000 of underwriting fees, and $862,027 of other offering costs. After deducting the underwriting discounts and commissions and the Initial Public Offering expenses, $266,512,500 of the net proceeds from our Initial Public Offering and from the Private Placement of the Private Placement Warrants was placed in the Trust Account. The net proceeds of the Initial Public Offering and certain proceeds from the sale of the Private Placement Warrants are held in the Trust Account and invested as described in the initial public offering prospectus.

There has been no material change in the planned use of the proceeds from the Initial Public Offering and Private Placement.

 

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

None.

 

25


Table of Contents
ITEM 4.

MINE SAFETY DISCLOSURES

Not applicable.

 

ITEM 5.

OTHER INFORMATION

None.

 

26


Table of Contents
ITEM 6.

EXHIBITS

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

Exhibit
No.
   Description
  31.1*    Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  31.2*    Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  32.1**    Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  32.2**    Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS    Inline XBRL Instance Document
101.CAL    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH    Inline XBRL Taxonomy Extension Schema Document
101.DEF    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB    Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE    Inline XBRL Taxonomy Extension Presentation Linkbase Document
104    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

*

Filed herewith.

**

These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

 

27


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

INVESTCORP INDIA ACQUISITION CORP

  
/s/ Nikhil Kalghatgi    November 30, 2023

Name: Nikhil Kalghatgi

  

Title: Principal Executive Officer

  

 

28

EX-31.1 2 d559923dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Nikhil Kalghatgi, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Investcorp India Acquisition Corp;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

b) (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 30, 2023

 

By:   /s/ Nikhil Kalghatgi
 

Nikhil Kalghatgi

 

Chief Executive Officer

 

(Principal Executive Officer)

EX-31.2 3 d559923dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Dean Clinton, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Investcorp India Acquisition Corp;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

b) (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 30, 2023

 

By:   /s/ Dean Clinton
  Dean Clinton
  Principal Financial Officer
  (Principal Accounting Officer)
EX-32.1 4 d559923dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Investcorp India Acquisition Corp (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Nikhil Kalghatgi Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: November 30, 2023

By:   /s/ Nikhil Kalghatgi
 

Nikhil Kalghatgi

 

Principal Executive Officer

EX-32.2 5 d559923dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Investcorp India Acquisition Corp (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Dean Clinton, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: November 30, 2023

By:   /s/ Dean Clinton
  Dean Clinton
  Chief Financial Officer
  (Principal Accounting Officer)
EX-101.SCH 6 ivca-20230930.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Condensed Statements Of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Condensed Statements Of Operations (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Condensed Statement Of Changes In Shareholders' Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Condensed Statements Of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Description of Organization and Business Operations link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Initial Public Offering link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Private Placement link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Warrant Liability link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Shareholders' Deficit link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Description of Organization and Business Operations - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Summary of Significant Accounting Policies - Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Share (Details) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Summary of Significant Accounting Policies - Schedule of Class A Ordinary Shares Subject to Possible Redemption Reflected in Balance Sheet (Details) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Initial Public Offering - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Private Placement - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Warrant Liability - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Shareholders' Deficit - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Fair Value Measurements - Schedule of Company's Liabilities Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Fair Value Measurements - Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs (Details) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Fair Value Measurements - Schedule of Change in Fair Value of Private Placement Warrants, Level 3 Liabilities, Measured on a Recurring Basis (Details) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 ivca-20230930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 ivca-20230930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 ivca-20230930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 ivca-20230930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover Page - shares
9 Months Ended
Sep. 30, 2023
Nov. 30, 2023
Document Information [Line Items]    
Document Type 10-Q  
Entity Registrant Name INVESTCORP INDIA ACQUISITION CORP  
Entity Central Index Key 0001852889  
Entity Filer Category Non-accelerated Filer  
Current Fiscal Year End Date --12-31  
Amendment Flag false  
Document Period End Date Sep. 30, 2023  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Entity File Number 001-41383  
Entity Tax Identification Number 00-0000000  
Entity Address, Address Line One Century Yard  
Entity Address, Address Line Two Cricket Square Elgin Avenue  
Entity Address, Address Line Three PO Box 1111  
Entity Address, City or Town George Town  
Entity Address, Country KY  
Entity Address, Postal Zip Code KY1-1102  
City Area Code 302  
Local Phone Number 738-7210  
Entity Current Reporting Status Yes  
Entity Shell Company true  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Incorporation, State or Country Code E9  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Class A Ordinary Share and Redeemable Warrant    
Document Information [Line Items]    
Title of 12(b) Security Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant  
Security Exchange Name NASDAQ  
Trading Symbol IVCAU  
Class A Ordinary Shares    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   9,789,446
Title of 12(b) Security Class A ordinary shares, par value $0.0001 per share  
Security Exchange Name NASDAQ  
Trading Symbol IVCA  
Class B Ordinary Shares    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   6,468,750
Redeemable Warrants    
Document Information [Line Items]    
Title of 12(b) Security Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share  
Security Exchange Name NASDAQ  
Trading Symbol IVCAW  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets    
Cash $ 30,414 $ 635,565
Other assets – current 317,822 509,987
Total current assets 348,236 1,145,552
Other assets – non-current 0 183,345
Investments held in Trust Account 106,318,563 270,278,722
Total Assets 106,666,799 271,607,619
Current Liabilities    
Accrued expenses 536,304 $ 206,748
Promissory note – related party $ 200,000  
Notes Payable, Current, Related Party, Type [Extensible Enumeration] Related Party [Member] Related Party [Member]
Due to Sponsor $ 39,435 $ 42,424
Total current liabilities 775,739 249,172
Warrant liability 2,031,751 1,479,713
Total Liabilities 2,807,409 1,728,885
Commitments and Contingencies (Note 6)
Class A common stock: 9,789,446 and 25,875,000 shares subject to possible redemption at September 30, 2023 and December 31, 2022, respectively 106,318,563 270,278,722
Shareholders' Deficit    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none outstanding 0 0
Additional paid in capital 0 0
Accumulated deficit (2,459,901) (400,635)
Total Shareholders' Deficit (2,459,254) (399,988)
Total Liabilities and Shareholders' Deficit 106,666,799 271,607,619
Class A Ordinary Shares    
Shareholders' Deficit    
Common stock 0 0
Class B Ordinary Shares    
Shareholders' Deficit    
Common stock $ 647 $ 647
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Balance Sheets (Parenthetical) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Preferred stock, par value per share $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Class A Ordinary Shares    
Shares subject to possible redemption $ 9,789,446 $ 25,875,000
Common stock, par value per share $ 0.0001 $ 0.0001
Common stock, shares authorized 479,000,000 479,000,000
Common stock, shares, issued 0 0
Common stock, shares, outstanding 0 0
Class B Ordinary Shares    
Common stock, par value per share $ 0.0001 $ 0.0001
Common stock, shares authorized 20,000,000 20,000,000
Common stock, shares, issued 6,468,750 6,468,750
Common stock, shares, outstanding 6,468,750 6,468,750
Class B Ordinary Shares | Over-Allotment Option | Maximum    
Shares subject to forfeiture 843,750  
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Statements Of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Formation costs and operating expenses $ 461,510 $ 273,246 $ 1,307,228 $ 796,793
Loss from operations (461,510) (273,246) (1,307,228) (796,793)
Other income:        
Interest earned on investments held in Trust Account 2,503,463 1,204,462 8,614,558 1,466,458
Change in fair value of warrant liability (831,938) 1,451,250 (552,038) 2,902,500
Other income 1,671,525 2,655,712 8,062,520 4,368,958
Net income $ 1,210,015 $ 2,382,466 $ 6,755,292 $ 3,572,165
Class A Ordinary Shares        
Other income:        
Weighted average shares outstanding, basic 18,274,134 25,875,000 23,341,378 13,364,011
Weighted average shares outstanding, diluted 18,274,134 25,875,000 23,341,378 13,364,011
Basic net income per ordinary share $ 0.05 $ 0.07 $ 0.23 $ 0.18
Diluted net income per ordinary share $ 0.05 $ 0.07 $ 0.23 $ 0.18
Class B Ordinary Shares        
Other income:        
Weighted average shares outstanding, basic [1] 6,468,750 6,468,750 6,468,750 6,682,005
Weighted average shares outstanding, diluted [1] 6,468,750 6,468,750 6,468,750 6,682,005
Basic net income per ordinary share $ 0.05 $ 0.07 $ 0.23 $ 0.18
Diluted net income per ordinary share $ 0.05 $ 0.07 $ 0.23 $ 0.18
[1] On March 22, 2022, the Company surrendered 718,750 shares of Class B ordinary shares as a result of updated terms of the proposed public offering. All share amounts and related information have been retroactively restated to reflect the surrender. Includes an aggregate of up to 843,750 shares that are subject to forfeiture if the over-allotment option is not exercised in full by the underwriter (see Note 8). On May 12, 2022, the underwriter exercised the full over-allotment option.
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Statements Of Operations (Parenthetical) - Class B Ordinary Shares - shares
1 Months Ended
Mar. 22, 2022
Mar. 31, 2022
Sep. 30, 2023
Sponsor      
Founder shares surrendered during period 718,750 718,750  
Maximum | Over-Allotment Option      
Shares subject to forfeiture 843,750 843,750 843,750
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Statement Of Changes In Shareholders' Equity (Deficit) - USD ($)
Total
Ordinary Shares
Class B Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Beginning balance at Dec. 31, 2021 $ 21,413 $ 647 $ 24,353 $ (3,587)
Beginning balance, shares at Dec. 31, 2021   6,468,750    
Net Income (loss) 0   0 0
Ending balance at Mar. 31, 2022 21,413 $ 647 24,353 (3,587)
Ending balance, shares at Mar. 31, 2022   6,468,750    
Beginning balance at Dec. 31, 2021 21,413 $ 647 24,353 (3,587)
Beginning balance, shares at Dec. 31, 2021   6,468,750    
Net Income (loss) 3,572,165      
Ending balance at Sep. 30, 2022 (1,319,949) $ 647   (1,320,596)
Ending balance, shares at Sep. 30, 2022   6,468,750    
Beginning balance at Mar. 31, 2022 21,413 $ 647 24,353 (3,587)
Beginning balance, shares at Mar. 31, 2022   6,468,750    
Excess cash received over fair value for private placement warrants 12,870,000   12,870,000  
Accretion of Class A ordinary shares subject to possible redemption (16,579,065)   (12,894,353) (3,684,712)
Net Income (loss) 1,189,699     1,189,699
Ending balance at Jun. 30, 2022 (2,497,953) $ 647 0 (2,498,600)
Ending balance, shares at Jun. 30, 2022   6,468,750    
Accretion of Class A ordinary shares subject to possible redemption (1,204,462)     (1,204,462)
Net Income (loss) 2,382,466     2,382,466
Ending balance at Sep. 30, 2022 (1,319,949) $ 647   (1,320,596)
Ending balance, shares at Sep. 30, 2022   6,468,750    
Beginning balance at Dec. 31, 2022 (399,988) $ 647 0 (400,635)
Beginning balance, shares at Dec. 31, 2022   6,468,750    
Accretion of Class A ordinary shares subject to possible redemption (2,889,862)   0 (2,889,862)
Net Income (loss) 2,012,699     2,012,699
Ending balance at Mar. 31, 2023 (1,277,151) $ 647   (1,277,798)
Ending balance, shares at Mar. 31, 2023   6,468,750    
Beginning balance at Dec. 31, 2022 (399,988) $ 647 0 (400,635)
Beginning balance, shares at Dec. 31, 2022   6,468,750    
Net Income (loss) 6,755,292      
Ending balance at Sep. 30, 2023 (2,459,254) $ 647   (2,459,901)
Ending balance, shares at Sep. 30, 2023   6,468,750    
Beginning balance at Mar. 31, 2023 (1,277,151) $ 647   (1,277,798)
Beginning balance, shares at Mar. 31, 2023   6,468,750    
Accretion of Class A ordinary shares subject to possible redemption (3,221,233)   $ 0 (3,221,233)
Net Income (loss) 3,532,578     3,532,578
Ending balance at Jun. 30, 2023 (965,806) $ 647   (966,453)
Ending balance, shares at Jun. 30, 2023   6,468,750    
Accretion of Class A ordinary shares subject to possible redemption (2,703,463)     (2,703,463)
Net Income (loss) 1,210,015     1,210,015
Ending balance at Sep. 30, 2023 $ (2,459,254) $ 647   $ (2,459,901)
Ending balance, shares at Sep. 30, 2023   6,468,750    
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Statements Of Cash Flows - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Cashflow from Operating Activities:        
Net income $ 1,210,015 $ 2,382,466 $ 6,755,292 $ 3,572,165
Adjustments to reconcile net income to net cash used in operating activities:        
Change in fair value of warrant liability 831,938 (1,451,250) 552,038 (2,902,500)
Interest earned on investments held in Trust Account (2,503,463) (1,204,462) (8,614,558) (1,466,458)
Changes in operating assets and liabilities:        
Other assets     375,510 (826,074)
Accrued expenses     329,556 78,150
Due to Sponsor     (2,989) (302,528)
Net cash used in operating activities     (605,151) (1,847,245)
Cashflow from Investing Activities:        
Investment of cash into Trust Account     172,774,717 (266,512,500)
Cash deposited in Trust Account     (200,000)  
Net cash provided by (used in) investing activities     172,574,717 (266,512,500)
Cashflow from Financing Activities:        
Payments to Redeeming Shareholders     (172,774,717)  
Proceeds from Sale of Units, net of underwriting discounts paid       253,575,000
Proceeds from promissory note – related party     200,000 0
Proceeds from sale of Private Placements Warrants       16,087,500
Advances from Sponsor       25,000
Payment of offering costs       (469,891)
Net cash (used in) provided by financing activities     (172,574,717) 269,217,609
Net Change in Cash     (605,151) 857,864
Cash at the beginning of the period     635,565 0
Cash at the end of the period $ 30,414 $ 857,864 30,414 857,864
Non-cash investing and financing activities:        
Accretion of Class A ordinary shares subject to possible redemption     8,814,558  
Deferred offering costs paid through Due to Sponsor     $ 0 $ 325,765
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Description of Organization and Business Operations
9 Months Ended
Sep. 30, 2023
Description Of Organization And Business Operations [Abstract]  
Description of Organization and Business Operations
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Investcorp India Acquisition Corp (the “Company”) is a blank check company incorporated in the Cayman Islands on February 19, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. On January 11, 2022, the Company changed its name from Investcorp Acquisition Corp. to Investcorp India Acquisition Corp.
As of September 30, 2023, and for the period from February 19, 2021 (inception) through September 30, 2023, the Company had not yet commenced any operations. All activity for the period from February 19, 2021 (inception) through September 30, 2023, relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) and identifying a target for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.
The registration statement for the Company’s Initial Public Offering was declared effective on May 9, 2022. On May 12, 2022, the Company consummated the Initial Public Offering of 22,500,000 unit (the “Units” and, with respect to the shares of Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $225,000,000. Additionally, the underwriter exercised their over-allotment option in full, resulting in an additional 3,375,000 Units issued for an aggregate amount of $33,750,000, which is described in Note 3.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 14,400,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to ICE I Holdings Pte. Ltd. (the “Sponsor”), generating gross proceeds of $14,400,000. In connection with the underwriter’s exercise of their over-allotment option, the Company also consummated the sale of an additional 1,687,500 Private Placement Warrants at $1.00 per Private Placement Warrant generating total proceeds of $1,687,500, which is described in Note 4.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (less any taxes payable on interest earned on the Trust Account) at the time of the signing a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the Proposed Offering, management has agreed that $10.30 per Unit sold in the Proposed Offering, including the proceeds from the sale of the Private Placement Warrants, will be held in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule
2a-7
under the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.
The Company provides its holders of the outstanding Public Shares (the “public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.
If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Certificate of Incorporation provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent.
 

The public shareholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.30 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These Class A ordinary shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Proposed Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”
If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.
The Company’s Sponsor has agreed (a) to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Certificate of Incorporation with respect to the Company’s
pre-Business
Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Founder Shares) into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek shareholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating to shareholders’ rights of
pre-Business
Combination activity and (d) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Proposed Offering if the Company fails to complete its Business Combination.
On August 11, 2023 shareholders of the Company held an extraordinary general meeting of shareholders (the “Extraordinary General Meeting”). At the Extraordinary General Meeting, the Company’s shareholders approved the proposal to amend the Company’s Amended and Restated Memorandum and Articles of Association to give the Company the right to extend the date by which it has to consummate a business combination from August 12, 2023 to August 12, 2024.
In connection with the Extension Amendment Proposal, the Sponsor has agreed to contribute (each such contribution, a “Contribution”) into the Company’s Trust Account the lessor or (x) an aggregate of $100,000 or (y) $0.025 per share for each Class A ordinary share included as a part of the units sold in the Company’s initial public offering (including any shares issued in exchange thereof) that are not redeemed at the Extraordinary General Meeting for each monthly period (commencing on August 12, 2023 and ending on the 12th day of each subsequent month), or portion thereof, until the earlier of the completion of the initial business combination or August 12, 2024. Additionally, the maximum aggregate Contributions to the Trust Account shall not exceed $1,200,000 based on up to twelve monthly Contributions through August 12, 2024.
At the Extraordinary General Meeting, the shareholders of record were provided the opportunity to exercise their redemption rights (the “Extension Amendment Proposal”). Holders of 16,085,554 shares of Class A ordinary shareholders exercised their right to redemption at a per share redemption price of approximately $10.74. On August 18, 2023, a total of $172,774,717 in redemption payments were made in connection with this redemption. Following the redemption, the Company had a total of 9,789,446 shares of Class A ordinary shares outstanding.
If the Company is unable to complete a Business Combination within the combination period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a
per-
share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholder’s rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. In the event the Company does not complete a Business Combination within the Combination Period, and in such event, the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Initial Offering price per Unit of $10.00.
 

The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.30 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.30 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriter of Proposed Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure its shareholders that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Liquidity, Capital Resources, and Going Concern Consideration
As of September 30, 2023, the Company had $30,414 in cash and a working capital deficit of $427,503.
The Company’s liquidity needs up to September 30, 2023, had been satisfied by funds from the Sponsor to cover certain offering expenses. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company a Working Capital Loans, as defined below (see Note 5). As of September 30, 2023, there were no amounts outstanding under any Working Capital Loans.
Prior to the completion of the Initial Public Offering, the Company lacked the liquidity it needed to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statement. However, the Company completed its Initial Public Offering, as detailed in Note 3, which generated capital in excess of the funds deposited into a trust account. This excess capital may be used by the Company for general working capital purposes.
In connection with the Company’s assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”)
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The Company originally had until August 12, 2023, 15 months from the closing of the IPO, to consummate a Business Combination. As approved by its shareholders, the Company extended the time to complete a Business Combination to August 12, 2024, 23 months from the closing of the IPO). It is uncertain that the Company will be able to consummate a Business Combination by the specified period. If a Business Combination is not consummated by August 12, 202
4, there will be a mandatory liquidation and subsequent dissolution. The liquidity condition and date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern one year from the date that this financial statement is issued. This financial statement does not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
Risks and Uncertainties
Management is currently evaluating the impact of the
COVID-19
pandemic and geopolitical instability, such as the military conflict in Ukraine and the Middle East, and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Proposed Offering, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
The Inflation Reduction Act of 2022, enacted in August 2022, imposes a 1% excise tax on the fair market value of stock repurchased by “covered corporations” beginning in 2023, with certain exceptions (the “Excise Tax”). The Excise Tax is imposed on the repurchasing corporation itself, not its shareholders. Because we are a “blank check” Cayman Islands corporations with no subsidiaries or previous merger or acquisition activity, we are not currently a “covered corporation” for this purpose. The amount of the Excise Tax is generally equal to 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, there are certain other exceptions to the Excise Tax. The U.S. Department of the Treasury has been given authority to issue regulations or other guidance to carry out, and to prevent the avoidance of, the Excise Tax. The Treasury and the IRS recently have issued preliminary guidance regarding the application of this excise tax, but there can be no assurance that this guidance will be finally adopted in its current form. A repurchase that occurs in connection with a business combination with a U.S. target company might be subject to the Excise Tax, depending on the structure of the business combination and other transactions that might be engaged in during the relevant year.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchanges Commission (“SEC”).
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of September 30, 2023 and December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Use of Credit Risk
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $30,414 and $635,565 cash and no cash equivalents as of September 30, 2023, and December 31, 2022, respectively.
Investments Held in Trust Account
As of September 30, 2023, and December 31, 2022, the Company had $106,318,563 and $270,278,722, respectively, held in money market funds, which are invested primarily in U.S. Treasury Securities.
 
Income Taxes
The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes”, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company has completed a nexus study and believes that it is appropriately filing tax returns in which it has nexus.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income Per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings per Share”. The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 843,750 Class B ordinary shares that are subject to forfeiture if the over- allotment option is not exercised by the underwriter (see Note 8). Diluted net income per share reflects the potential dilution that could occur if warrants were to be exercised or converted or otherwise resulted in issuance of Ordinary Shares that then shared in the earnings of the entity. As the exercise of the warrants are contingent upon the completion of a business combination, they have not been included in the calculation of diluted net income per share. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except share amounts) for the three and nine months ended September 30, 2023, and September 30, 2022:
 
    
For the Three Months Ended

September 30,
 
    
2023
    
2022
 
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
 
Basic and diluted net income per ordinary share
                                   
Numerator:
                                   
Allocation of net income, as adjusted
   $  893,670      $ 316,345      $ 1,905,973      $  476,493  
Denominator:
                                   
Basic and diluted weighted average shares outstanding
     18,274,134        6,468,750        25,875,000        6,468,750  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net income per ordinary share
   $  0.05      $  0.05      $ 0.07      $  0.07  
    
 
 
    
 
 
    
 
 
    
 
 
 
 

    
For the Nine Months Ended

September 30,
 
    
2023
    
2022
 
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
 
Basic and diluted net income per ordinary share
                                   
Numerator:
                                   
Allocation of net income, as adjusted
   $ 5,289,404      $ 1,465,888      $ 2,381,443      $ 1,190,722  
Denominator:
                                   
Basic and diluted weighted average shares outstanding
     23,341,378        6,468,750        13,364,011        6,682,005  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net income per ordinary share
   $  0.23      $  0.23      $ 0.18      $  0.18  
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.
 
   
Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.
 
   
Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.
 
   
Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.
Offering Costs Associated with the Initial Public Offering
The Company complied with the requirements of the ASC
340-10-S99-1
and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consists of legal, accounting, underwriting fees and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounted to $6,037,027, which was charged to shareholders’ equity upon the completion of the Initial Public Offering.
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”). Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as stockholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, the Class A ordinary shares is subject to possible redemption and is presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital (to the extent available) and accumulated deficit.
As of September 30, 2023, the Class A ordinary shares subject to possible redemption reflected in the balance sheet is reconciled in the following table:
 
Gross Proceeds
   $ 258,750,000  
Less:
        
Proceeds allocated to Public Warrants
     (2,587,500
Total stock issuance costs
     (5,967,069
Plus:
        
Accretion of carrying value to redemption value
     20,083,291  
    
 
 
 
Class A ordinary shares subject to possible redemption at December 31, 2022
  
$
270,278,722
 
Plus:
        
Accretion of carrying value to redemption value
     8,814,558  
Less:
        
Shares redeemed in August 2023
     (172,774,717
    
 
 
 
Class A ordinary shares subject to possible redemption at September 30, 2023
  
$
 106,318,563
 
    
 
 
 
Warrant Liability
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional
paid-in
capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a
non-cash
gain or loss on the statements of operations. The fair value of the warrants was estimated using a Modified Binomial Option Pricing model (see Note 9).
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or
non-current
based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
 

Recently Issued Accounting Standards
In August 2020, the FASB issued Accounting Standards Update (“ASU”)
2020-06,
Debt — Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic
815-40)
(“ASU 2020-06”)
to simplify accounting for certain financial instruments. ASU
2020-06
eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU
2020-06
amends the diluted earnings per share guidance, including the requirement to use the
if-converted
method for all convertible instruments. The new standard is effective for companies that are SEC filers (except for smaller reporting companies) for fiscal years beginning after December 15, 2021, and interim periods within that year, and two years later for other companies. Companies can early adopt the standard at the start of a fiscal year beginning after December 15, 2020. The standard can either be adopted on a modified retrospective or a full retrospective basis. The Company is still evaluating the impact on the Company’s financial statements.
Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Initial Public Offering
9 Months Ended
Sep. 30, 2023
Stockholders' Equity Note [Abstract]  
Initial Public Offering
NOTE 3. INITIAL PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company sold 25,875,000 Units at a purchase price of $10.00 per Unit. Each Unit consisted of one Class A ordinary share, $0.0001 par value, and
one-half
of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note 8).
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Private Placement
9 Months Ended
Sep. 30, 2023
Private Placement [Abstract]  
Private Placement
NOTE 4. PRIVATE PLACEMENT
The Sponsor purchased an aggregate of 16,087,500 Private Placement Warrants at a price of $1.00 per warrant, in a private placement that closed simultaneously with the closing of the Initial Public Offering.
Each Private Placement Warrant is identical to the warrants offered in the Initial Public Offering, except there will be no redemption rights or liquidating distributions from the trust account with respect to Private Placement Warrants, which will expire worthless if the Company does not consummate a Business Combination within the Combination Period.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Related Party Transactions
9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On March 12, 2021, the Company issued an aggregate of 7,187,500 Class B ordinary shares (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. In March 2022, our sponsor surrendered, for no consideration, 718,750 founder shares, resulting in our sponsor holding 6,468,750 founder shares for an aggregate purchase price of $25,000 or approximately $0.039 per share. The Founder Shares include an aggregate of up to 843,750 shares subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment was not exercised in full or in part, so that the Sponsor will collectively own, on an
as-converted
basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering.
As a result of the underwriter’s election to exercise their over-allotment option simultaneously with the Initial Public Offering, 843,750 Founder Shares are no longer subject to forfeiture.
The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 120 days after the Business Combination, the Founder Shares will be released from the
lock-up.
Promissory Note — Related Party
On March 12, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Proposed Offering pursuant to a promissory note (the “Note”). The Note is
non-interest
bearing and is payable on the earlier of (i) December 31, 2021 (which was amended to September 30, 2022, on January 25, 2022) or (ii) the consummation of the Initial Proposed Offering. As of September 30, 2023, and December 31, 2022, there were no amounts outstanding on the Note and it is no longer available to the Company.
 

Working Capital Loans
In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $3,000,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of September 30, 2023, and December 31, 2022, the Company has not drawn on the Working Capital Loans.
Due to Sponsor
The Sponsor has paid expenses on behalf of the Company prior to the Company’s Initial Public Offering. This amount is not interest bearing and due on demand by the Sponsor. As of September 30, 2023, and December 31, 2022, there was $39,435 and $42,424 due to Sponsor, respectively.
Extension Loans — related party
If the Company anticipates that it may not be able to consummate its initial business combination within 15 months, the Company may, but is not obligated to, extend the period of time to consummate a Business Combination by an additional three months on two separate occasions (for a total of up to 21 months to complete a business combination). In order to extend the time available for us to consummate a Business Combination, the Sponsor (or its affiliates or designees), upon five days advance notice prior to the applicable deadline, must deposit into the Trust Account $2,587,500 ($0.10 per share), on or prior to the date of the applicable deadline. Any such payments would be funded from the proceeds of a
non-interest-bearing
loan between the Sponsor and the Company (the “Extension Loans”). Such Extension Loans may be convertible into warrants, at a price of $1.00 per warrant at the option of the lender. The terms of the warrants would be identical to the terms of the private placement warrants. If the Company completes a Business Combination, the Company would repay such Extension Loans out of the proceeds of the trust account released to the Company. There were no amounts outstanding on the extension loans as of September 30, 2023, and December 31, 2022.
As a result of the shareholders’ vote held on August 11, 2023, the Company has agreed to contribute (each such contribution, a “Contribution”) into the Company’s Trust Account the lessor or (x) an aggregate of $100,000 or (y) $0.025 per share for each Class A ordinary share included as a part of the units sold in the Company’s IPO (including any shares issued in exchange thereof) that are not redeemed at the Meeting for each monthly period (commencing on August 12, 2023 and ending on the 12th day of each subsequent month), or portion thereof, until the earlier of the completion of the initial business combination or August 12, 2024. For the avoidance of doubt, the maximum aggregate Contributions to the Trust Account shall not exceed $1,200,000 based on up to twelve monthly Contributions through August 12, 2024.
Promissory Note
On August 9, 2023, the Sponsor agreed to loan the Company an aggregate of up to $1,200,000 to cover expenses related to the Contributions (the “2023 Note”). The note is
non-interest
bearing and is payable on the earlier of (i) August 12, 2024, or (ii) the consummation of a Business Combination. Upon receiving notice of the closing of a Business Combination, the Sponsor shall convert the unpaid principal balance of the 2023 Note into a number of
non-transferable,
non-redeemable
ordinary shares of the Company equal to (x) the principal amount of the 2023 Note being converted, divided by (y) the conversion price of $10.00, rounded up to the nearest whole number of shares. As of September 30, 2023, the outstanding principal balance was $200,000
. Subsequently, on October 10, 2023 and November 9, 2023 the Company made additional draw downs on the Promissory Note of $100,000
each month to fund month extension requirements.
Administrative Services Agreement
Commencing on the date of the Initial Public Offering and until completion of the Company’s initial business combination or liquidation, the Company will make a payment of a monthly fee of $10,000 to the Sponsor for office space, utilities and secretarial and administrative services provided to the Company. As of September 30, 2023 and December 31, 2022, there was $90,000 and $60,000 recorded in accrued expenses, respectively.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
NOTE 6. COMMITMENTS AND CONTINGENCIES
Registration Rights
The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans and Extension Loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Proposed Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to our Class A ordinary shares). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriter a
45-day
option to purchase up to 3,375,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The over-allotment option was exercised simultaneously with the Initial Public Offering.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Warrant Liability
9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Warrant Liability
NOTE 7. WARRANT LIABILITY
The Company accounts for the 29,025,000 warrants issued in connection with the Initial Public Offering (the 16,087,500 Private Warrants and the 12,937,500 Public Warrants) in accordance with the guidance contained in ASC 480 and ASC
815-40,
Derivatives and Hedging. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value. This liability is subject to
re-measurement
at each balance sheet date. With each such remeasurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations.
The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the ordinary share warrants. At that time, the portion of the warrant liability related to the ordinary share warrants will be reclassified to additional
paid-in
capital.
Warrants — Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable 30 days after the consummation of a Business Combination. The Public Warrants will expire
five years
from the consummation of a Business Combination or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.
The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. The Company will use its best efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.
Redemption of warrants when the price per Class A ordinary share equals or exceeds $
18.00
. Once the warrants become exercisable, the Company may redeem the Warrants for redemption:
 
   
in whole and not in part;
 
   
at a price of $
0.01
per Public Warrant;
 
   
upon not less than
30
days’ prior written notice of redemption to each warrant holder and
 
   
if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $
18.00
per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any
20
trading days within a
30
-trading
day period ending three business days before the Company sends the notice of redemption to the warrant holders.
The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the
30
-day
redemption period. If and when the warrants become redeemable by us, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
Redemption of warrants when the price per Class A ordinary share equals or exceeds $
10.00
. Once the Warrants become exercisable, the Company may redeem the Warrants for redemption:
 
   
in whole and not in part;
 
   
at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth under “Description of Securities — Warrants — Public Shareholders’ Warrants” based on the redemption date and the “fair market value” of our Class A ordinary shares (as defined below) except as otherwise described in “Description of Securities — Warrants — Public Shareholders’ Warrants”;
 
   
if, and only if, the closing price of our Class A ordinary shares equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Shareholders’ Warrants — Anti-dilution Adjustments”) for any 20 trading days within the
30-trading
day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and
 
   
if the closing price of our Class A ordinary shares for any
20
trading days within a
30
-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $
18.00
per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “— Warrants — Public Shareholders’ Warrants — Anti-Dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.
If and when the Public Warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of ordinary shares upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification.
The exercise price and number of Class A ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.
In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such
 
initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.
The Private Placement Warrants will be identical to the Public Warrants included in the Units being sold in the Proposed Offering, except that the Private Placement Warrants will and the ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be
non-redeemable
so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Shareholders' Deficit
9 Months Ended
Sep. 30, 2023
Stockholders' Equity Note [Abstract]  
Shareholders' Deficit
NOTE 8. SHAREHOLDERS’ DEFICIT
Preference Shares — The Company is authorized to issue 1,000,000 preference shares of $0.0001 par value. At September 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.
Class A Ordinary Shares — The Company is authorized to issue up to 479,000,000 Class A ordinary shares, $0.0001 par value. Holders of the Company’s ordinary shares are entitled to one vote for each share. At September 30, 2023, and December 31, 2022, there were 9,789,446 and 25,875,000 Class A ordinary shares issued and outstanding, respectively.
Class B Ordinary Shares — The Company is authorized to issue up to 20,000,000 Class B ordinary shares, $0.0001 par value. Holders of the Company’s ordinary shares are entitled to one vote for each share. At September 30, 2023 and December 31, 2022, there were 6,468,750 Class B ordinary shares issued and outstanding, respectively.
On March 22, 2022, the Sponsor surrendered, for no consideration, 718,750 Class B ordinary shares, resulting in our sponsor holding 6,468,750 founder shares issued and outstanding, of which an aggregate of up to 843,750 shares subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment is not exercised in full or in part, so that the Sponsor will collectively own, on an
as-converted
basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. As a result of the underwriter’s election to exercise their over-allotment option simultaneously with the Initial Public Offering, 843,750 Founder Shares are no longer subject to forfeiture.
The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the completion of our Business Combination on a
one-for-one
basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional Class A ordinary shares, or equity linked securities, are issued or deemed issued in connection with the initial Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as converted basis, 20% of the sum of the total number of all ordinary shares outstanding as of the Initial Public Offering plus all Class A ordinary shares and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be issued, to any seller in a Business Combination, and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their Class B ordinary shares into an equal number of Class A ordinary shares, subject to adjustment as provided above, at any time.
The Company may issue additional ordinary shares or preference shares to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements
NOTE 9. FAIR VALUE MEASUREMENTS
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
  Level 1:  
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
 
 
Level 2:  
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
 
  Level 3:  
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
As of September 30, 2023, and December 31, 2022, investments held in the Trust Account were comprised of $106,318,563 and $270,278,722 in money market funds, which are invested primarily in U.S. Treasury Securities, respectively. The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
    
Level
    
September 30, 2023
    
December 31, 2022
 
Assets:
                          
Investments held in Trust Account
     1      $ 106,318,563      $ 270,278,722  
Liabilities:
                          
Public Warrants
     1      $ 905,625      $ 675,338  
Private Warrants
     3      $ 1,126,125      $ 804,375  
Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. During the period there were no transfers to/from Levels 1 and 3.
The Company established the initial fair value of the warrants on May 12, 2022, the date of the consummation of the Company’s IPO. The Company used a Binomial Option Pricing model to value the warrants. The Company allocated the proceeds received from (i) the sale of the Units (which is inclusive of one share of Class A ordinary shares and
one-half
of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of Class B ordinary shares, first to the warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A ordinary shares subject to possible redemption (temporary equity), Class A ordinary shares (permanent equity) and Class B ordinary shares (permanent equity) based on their relative fair values at the initial measurement date.
The following table provides quantitative information regarding Level 3 fair value measurements:
 
    
September 30,
2023
   
December 31,
2022
 
    
Private
Warrants
   
Private
Warrants
 
Stock Price
   $  10.81     $  10.34  
Exercise Price
   $  11.50     $  11.50  
Risk-free rate of interest
     4.60 %     3.99 %
Volatility
     0.50 %     0.50 %
Term
     1.5 years       2.8 years  
The Private Placement Warrants were initially and subsequently valued using a Binomial Option Pricing model, which is considered to be a Level 3 fair value measurement. The fair value of Public Warrants issued in connection with the Initial Public Offering were initially measured using a Binomial Option Pricing model and at September 30, 2023 and December 31, 2022 are measured based on the listed market price of such warrants, a Level 1 measurement.
 
 
The Binomial Option Pricing model’s primary unobservable input utilized in determining the fair value of the Warrants is the expected volatility as of the IPO date was derived from observable warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing.
The following table presents a summary of the changes in the fair value of the Private Placement Warrants, Level 3 liabilities, measured on a recurring basis.

 
 
  
Private Warrants
 
Fair value as of January 1, 2022
  
$
—  
 
Initial measurement on May 12, 2022 warrants issued
  
 
3,217,500
 
Changes in fair value (1)
  
 
(804,375
 
  
 
 
 
Fair value as of June 30, 2022
  
$
2,413,125
 
Changes in fair value (1)
  
 
(804,375
 
  
 
 
 
Fair value as of September 30, 2022
  
$
1,608,750
 
 
  
 
 
 
 
Fair value as of January 1, 2023
  
$
804,375
 
Changes in fair value (1)
  
 
321,750
 
 
  
 
 
 
Fair Value as of March 3
1
, 2023
  
$
1,126,125
 
 
  
 
 
 
Change in fair value (1)
  
 
(482,625
 
  
 
 
 
Fair Value as of June 30, 2023
  
$
643,500
 
 
  
 
 
 
Change in fair value (1)
  
 
482,625
 
 
  
 
 
 
Fair value as of September 30, 2023
  
$
1,126,125
 
 
  
 
 
 
 
(1)
Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the statements of operations.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent Events
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events
NOTE 10. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date
that
the unaudited condensed financial statements were issued. Based upon this review, other than below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.
On October 10, 2023 and November 9, 2023 the Company made additional draw downs on the Promissory Note (“2023 Note”) of $100,000
each month to fund month extension requirements.
On October 11, 2023 and November 13, 2023 the Company deposited $100,000
each month into the Trust Account in order to effect the third and fourth subsequent one month extensions of the Revised Extension Deadline, which extended the deadline to consummate the Business Combination to December 12, 2023. 
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchanges Commission (“SEC”).
Emerging Growth Company
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of September 30, 2023 and December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Use of Credit Risk
Use of Credit Risk
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $30,414 and $635,565 cash and no cash equivalents as of September 30, 2023, and December 31, 2022, respectively.
Investments Held in Trust Account
Investments Held in Trust Account
As of September 30, 2023, and December 31, 2022, the Company had $106,318,563 and $270,278,722, respectively, held in money market funds, which are invested primarily in U.S. Treasury Securities.
Income Taxes
Income Taxes
The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes”, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company has completed a nexus study and believes that it is appropriately filing tax returns in which it has nexus.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income Per Ordinary Share
Net Income Per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings per Share”. The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 843,750 Class B ordinary shares that are subject to forfeiture if the over- allotment option is not exercised by the underwriter (see Note 8). Diluted net income per share reflects the potential dilution that could occur if warrants were to be exercised or converted or otherwise resulted in issuance of Ordinary Shares that then shared in the earnings of the entity. As the exercise of the warrants are contingent upon the completion of a business combination, they have not been included in the calculation of diluted net income per share. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except share amounts) for the three and nine months ended September 30, 2023, and September 30, 2022:
 
    
For the Three Months Ended

September 30,
 
    
2023
    
2022
 
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
 
Basic and diluted net income per ordinary share
                                   
Numerator:
                                   
Allocation of net income, as adjusted
   $  893,670      $ 316,345      $ 1,905,973      $  476,493  
Denominator:
                                   
Basic and diluted weighted average shares outstanding
     18,274,134        6,468,750        25,875,000        6,468,750  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net income per ordinary share
   $  0.05      $  0.05      $ 0.07      $  0.07  
    
 
 
    
 
 
    
 
 
    
 
 
 
 

    
For the Nine Months Ended

September 30,
 
    
2023
    
2022
 
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
 
Basic and diluted net income per ordinary share
                                   
Numerator:
                                   
Allocation of net income, as adjusted
   $ 5,289,404      $ 1,465,888      $ 2,381,443      $ 1,190,722  
Denominator:
                                   
Basic and diluted weighted average shares outstanding
     23,341,378        6,468,750        13,364,011        6,682,005  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net income per ordinary share
   $  0.23      $  0.23      $ 0.18      $  0.18  
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.
 
   
Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.
 
   
Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.
 
   
Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.
Offering Costs Associated with the Initial Public Offering
Offering Costs Associated with the Initial Public Offering
The Company complied with the requirements of the ASC
340-10-S99-1
and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consists of legal, accounting, underwriting fees and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounted to $6,037,027, which was charged to shareholders’ equity upon the completion of the Initial Public Offering.
Class A Ordinary Shares Subject to Possible Redemption
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”). Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as stockholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, the Class A ordinary shares is subject to possible redemption and is presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital (to the extent available) and accumulated deficit.
As of September 30, 2023, the Class A ordinary shares subject to possible redemption reflected in the balance sheet is reconciled in the following table:
 
Gross Proceeds
   $ 258,750,000  
Less:
        
Proceeds allocated to Public Warrants
     (2,587,500
Total stock issuance costs
     (5,967,069
Plus:
        
Accretion of carrying value to redemption value
     20,083,291  
    
 
 
 
Class A ordinary shares subject to possible redemption at December 31, 2022
  
$
270,278,722
 
Plus:
        
Accretion of carrying value to redemption value
     8,814,558  
Less:
        
Shares redeemed in August 2023
     (172,774,717
    
 
 
 
Class A ordinary shares subject to possible redemption at September 30, 2023
  
$
 106,318,563
 
    
 
 
 
Warrants Liability
Warrant Liability
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional
paid-in
capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a
non-cash
gain or loss on the statements of operations. The fair value of the warrants was estimated using a Modified Binomial Option Pricing model (see Note 9).
Derivative Financial Instruments
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or
non-current
based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Recently Issued Accounting Standards
Recently Issued Accounting Standards
In August 2020, the FASB issued Accounting Standards Update (“ASU”)
2020-06,
Debt — Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic
815-40)
(“ASU 2020-06”)
to simplify accounting for certain financial instruments. ASU
2020-06
eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU
2020-06
amends the diluted earnings per share guidance, including the requirement to use the
if-converted
method for all convertible instruments. The new standard is effective for companies that are SEC filers (except for smaller reporting companies) for fiscal years beginning after December 15, 2021, and interim periods within that year, and two years later for other companies. Companies can early adopt the standard at the start of a fiscal year beginning after December 15, 2020. The standard can either be adopted on a modified retrospective or a full retrospective basis. The Company is still evaluating the impact on the Company’s financial statements.
Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Share
The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except share amounts) for the three and nine months ended September 30, 2023, and September 30, 2022:
 
    
For the Three Months Ended

September 30,
 
    
2023
    
2022
 
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
 
Basic and diluted net income per ordinary share
                                   
Numerator:
                                   
Allocation of net income, as adjusted
   $  893,670      $ 316,345      $ 1,905,973      $  476,493  
Denominator:
                                   
Basic and diluted weighted average shares outstanding
     18,274,134        6,468,750        25,875,000        6,468,750  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net income per ordinary share
   $  0.05      $  0.05      $ 0.07      $  0.07  
    
 
 
    
 
 
    
 
 
    
 
 
 
 

    
For the Nine Months Ended

September 30,
 
    
2023
    
2022
 
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
    
Class A,
Ordinary
Shares
    
Class B,
Ordinary
Shares
 
Basic and diluted net income per ordinary share
                                   
Numerator:
                                   
Allocation of net income, as adjusted
   $ 5,289,404      $ 1,465,888      $ 2,381,443      $ 1,190,722  
Denominator:
                                   
Basic and diluted weighted average shares outstanding
     23,341,378        6,468,750        13,364,011        6,682,005  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net income per ordinary share
   $  0.23      $  0.23      $ 0.18      $  0.18  
    
 
 
    
 
 
    
 
 
    
 
 
 
Schedule of Class A Ordinary Shares Subject to Possible Redemption Reflected in Balance Sheet
As of September 30, 2023, the Class A ordinary shares subject to possible redemption reflected in the balance sheet is reconciled in the following table:
 
Gross Proceeds
   $ 258,750,000  
Less:
        
Proceeds allocated to Public Warrants
     (2,587,500
Total stock issuance costs
     (5,967,069
Plus:
        
Accretion of carrying value to redemption value
     20,083,291  
    
 
 
 
Class A ordinary shares subject to possible redemption at December 31, 2022
  
$
270,278,722
 
Plus:
        
Accretion of carrying value to redemption value
     8,814,558  
Less:
        
Shares redeemed in August 2023
     (172,774,717
    
 
 
 
Class A ordinary shares subject to possible redemption at September 30, 2023
  
$
 106,318,563
 
    
 
 
 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Schedule of Company's Liabilities Measured at Fair Value on a Recurring Basis The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
    
Level
    
September 30, 2023
    
December 31, 2022
 
Assets:
                          
Investments held in Trust Account
     1      $ 106,318,563      $ 270,278,722  
Liabilities:
                          
Public Warrants
     1      $ 905,625      $ 675,338  
Private Warrants
     3      $ 1,126,125      $ 804,375  
Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs
The following table provides quantitative information regarding Level 3 fair value measurements:
 
    
September 30,
2023
   
December 31,
2022
 
    
Private
Warrants
   
Private
Warrants
 
Stock Price
   $  10.81     $  10.34  
Exercise Price
   $  11.50     $  11.50  
Risk-free rate of interest
     4.60 %     3.99 %
Volatility
     0.50 %     0.50 %
Term
     1.5 years       2.8 years  
Schedule of Change in Fair Value of Private Placement Warrants, Level 3 Liabilities, Measured on a Recurring Basis
The following table presents a summary of the changes in the fair value of the Private Placement Warrants, Level 3 liabilities, measured on a recurring basis.

 
 
  
Private Warrants
 
Fair value as of January 1, 2022
  
$
—  
 
Initial measurement on May 12, 2022 warrants issued
  
 
3,217,500
 
Changes in fair value (1)
  
 
(804,375
 
  
 
 
 
Fair value as of June 30, 2022
  
$
2,413,125
 
Changes in fair value (1)
  
 
(804,375
 
  
 
 
 
Fair value as of September 30, 2022
  
$
1,608,750
 
 
  
 
 
 
 
Fair value as of January 1, 2023
  
$
804,375
 
Changes in fair value (1)
  
 
321,750
 
 
  
 
 
 
Fair Value as of March 3
1
, 2023
  
$
1,126,125
 
 
  
 
 
 
Change in fair value (1)
  
 
(482,625
 
  
 
 
 
Fair Value as of June 30, 2023
  
$
643,500
 
 
  
 
 
 
Change in fair value (1)
  
 
482,625
 
 
  
 
 
 
Fair value as of September 30, 2023
  
$
1,126,125
 
 
  
 
 
 
 
(1)
Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the statements of operations.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Description of Organization and Business Operations - Additional Information (Details)
9 Months Ended
Aug. 11, 2023
USD ($)
Day
$ / shares
shares
Aug. 31, 2022
May 12, 2022
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
Summary Of Significant Accounting Policies [Line Items]          
Entity incorporation, date of incorporation       Feb. 19, 2021  
Fair market value in trust account, percentage       80.00%  
Restricted investments term       185 days  
Prior upon such consummation of business combination tangible assets       $ 5,000,001  
Redemption of shares for pro rata portion of amount in trust account | $ / shares       $ 10.3  
Cash       $ 30,414 $ 635,565
Working capital       427,503  
Percentage of Excise Tax   1.00%      
Percentage of Fair Market Value of Shares Repurchased   1.00%      
Temporary equity, shares outstanding | shares 9,789,446        
Temporary equity, redemption price per share | $ / shares $ 10.74        
Payments for repurchase of common stock $ 172,774,717     $ 172,774,717  
Business Combinations          
Summary Of Significant Accounting Policies [Line Items]          
Percentage of voting interests acquired       50.00%  
Sponsor | Agreement To Contribute To The Trust Account          
Summary Of Significant Accounting Policies [Line Items]          
Commitment to contribute to the trust account per month $ 100,000        
Inception date for contribution to the trust account Aug. 12, 2023        
Number Of Contributions To The Trust Account | Day 12        
End date for contribution to the trust account Aug. 12, 2024        
Aggregate commitment to contribute to the trust account $ 1,200,000        
Commitment to contribute to the trust account per share | $ / shares $ 0.025        
Sponsor | Private Placement Warrants          
Summary Of Significant Accounting Policies [Line Items]          
Class of warrants and rights issued during the period | shares     14,400,000 16,087,500  
Class of warrants and rights issued price per warrant | $ / shares     $ 1 $ 1  
Proceeds from issuance of private placement     $ 14,400,000    
Initial Public Offering          
Summary Of Significant Accounting Policies [Line Items]          
Class of warrants and rights issued during the period | shares       29,025,000  
Initial Public Offering | Private Placement Warrants          
Summary Of Significant Accounting Policies [Line Items]          
Class of warrants and rights issued during the period | shares       16,087,500  
Over-Allotment Option | Sponsor | Private Placement Warrants          
Summary Of Significant Accounting Policies [Line Items]          
Class of warrants and rights issued during the period | shares     1,687,500    
Class of warrants and rights issued price per warrant | $ / shares     $ 1    
Proceeds from issuance of private placement     $ 1,687,500    
Proposed Offering          
Summary Of Significant Accounting Policies [Line Items]          
Shares issued, price per share | $ / shares       $ 10.3  
Proposed Offering | Maximum          
Summary Of Significant Accounting Policies [Line Items]          
Interest to pay dissolution expenses       $ 100,000  
Per share value of restricted investments | $ / shares       $ 10  
Proposed Offering | Sponsor          
Summary Of Significant Accounting Policies [Line Items]          
Per share value of restricted investments | $ / shares       $ 10.3  
Class A Ordinary Shares          
Summary Of Significant Accounting Policies [Line Items]          
Temporary equity shares redeemable | shares 16,085,554        
Class A Ordinary Shares | Initial Public Offering          
Summary Of Significant Accounting Policies [Line Items]          
Stock shares issued during the period, shares | shares     22,500,000 25,875,000  
Shares issued, price per share | $ / shares     $ 10 $ 10  
Restricted cash received in advance related to the Initial Public Offering     $ 225,000,000    
Class A Ordinary Shares | Over-Allotment Option          
Summary Of Significant Accounting Policies [Line Items]          
Stock shares issued during the period, shares | shares     3,375,000    
Stock shares issued during the period, value     $ 33,750,000    
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Mar. 31, 2022
Mar. 22, 2022
Summary Of Significant Accounting Policies [Line Items]        
Cash, FDIC insured amount $ 250,000      
Cash 30,414 $ 635,565    
Cash equivalents 0 0    
Investments held in Trust Account 106,318,563 $ 270,278,722    
Initial Public Offering        
Summary Of Significant Accounting Policies [Line Items]        
Offering costs $ 6,037,027      
Class B Ordinary Shares | Over-Allotment Option | Maximum        
Summary Of Significant Accounting Policies [Line Items]        
Shares subject to forfeiture 843,750   843,750 843,750
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies - Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Share (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Class A Ordinary Shares        
Numerator:        
Allocation of net income, as adjusted $ 893,670 $ 1,905,973 $ 5,289,404 $ 2,381,443
Denominator        
Weighted average shares outstanding, basic 18,274,134 25,875,000 23,341,378 13,364,011
Weighted average shares outstanding, diluted 18,274,134 25,875,000 23,341,378 13,364,011
Basic net income per ordinary share $ 0.05 $ 0.07 $ 0.23 $ 0.18
Diluted net income per ordinary share $ 0.05 $ 0.07 $ 0.23 $ 0.18
Class B Ordinary Shares        
Numerator:        
Allocation of net income, as adjusted $ 316,345 $ 476,493 $ 1,465,888 $ 1,190,722
Denominator        
Weighted average shares outstanding, basic [1] 6,468,750 6,468,750 6,468,750 6,682,005
Weighted average shares outstanding, diluted [1] 6,468,750 6,468,750 6,468,750 6,682,005
Basic net income per ordinary share $ 0.05 $ 0.07 $ 0.23 $ 0.18
Diluted net income per ordinary share $ 0.05 $ 0.07 $ 0.23 $ 0.18
[1] On March 22, 2022, the Company surrendered 718,750 shares of Class B ordinary shares as a result of updated terms of the proposed public offering. All share amounts and related information have been retroactively restated to reflect the surrender. Includes an aggregate of up to 843,750 shares that are subject to forfeiture if the over-allotment option is not exercised in full by the underwriter (see Note 8). On May 12, 2022, the underwriter exercised the full over-allotment option.
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies - Schedule of Class A Ordinary Shares Subject to Possible Redemption Reflected in Balance Sheet (Details) - USD ($)
9 Months Ended 12 Months Ended
Aug. 11, 2023
Sep. 30, 2023
Dec. 31, 2022
Accounting Policies [Abstract]      
Gross Proceeds     $ 258,750,000
Proceeds allocated to Public Warrants     (2,587,500)
Total stock issuance costs     (5,967,069)
Accretion of carrying value to redemption value   $ 8,814,558 20,083,291
Shares redeemed in August 2023 $ (172,774,717) (172,774,717)  
Class A ordinary shares subject to possible redemption   $ 106,318,563 $ 270,278,722
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Initial Public Offering - Additional Information (Details) - Class A Ordinary Shares - $ / shares
9 Months Ended
May 12, 2022
Sep. 30, 2023
Dec. 31, 2022
Initial Public Offering [Line Items]      
Common stock, par value per share   $ 0.0001 $ 0.0001
Public Warrant      
Initial Public Offering [Line Items]      
Warrant exercise price per share   $ 11.5  
Initial Public Offering      
Initial Public Offering [Line Items]      
Stock shares issued during the period, shares 22,500,000 25,875,000  
Shares issued, price per share $ 10 $ 10  
Common stock, par value per share   $ 0.0001  
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Private Placement - Additional Information (Details) - Sponsor - Private Placement Warrants - $ / shares
9 Months Ended
May 12, 2022
Sep. 30, 2023
Private Placement [Line Items]    
Class of warrants and rights issued during the period 14,400,000 16,087,500
Class of warrants and rights issued price per warrant $ 1 $ 1
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Related Party Transactions - Additional Information (Details)
1 Months Ended 9 Months Ended
Nov. 09, 2023
USD ($)
Oct. 10, 2023
USD ($)
Aug. 11, 2023
USD ($)
Day
$ / shares
Mar. 22, 2022
shares
Mar. 12, 2021
USD ($)
shares
Mar. 31, 2022
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
Aug. 09, 2023
USD ($)
$ / shares
Dec. 31, 2022
USD ($)
shares
Related Party Transaction [Line Items]                    
Shares no longer subject to forfeiture | shares           843,750        
Due to sponsor             $ 39,435     $ 42,424
Business combination option to extend period             In order to extend the time available for us to consummate a Business Combination, the Sponsor (or its affiliates or designees), upon five days advance notice prior to the applicable deadline, must deposit into the Trust Account $2,587,500 ($0.10 per share), on or prior to the date of the applicable deadline.      
Warrant price per warrant | $ / shares             $ 1      
Office space, utilities and secretarial and administrative services             $ 10,000      
Accrued expense             536,304     206,748
Proceeds from notes payable             200,000 $ 0    
Extension Loans                    
Related Party Transaction [Line Items]                    
Loans outstanding             0     0
Administrative Services Agreement                    
Related Party Transaction [Line Items]                    
Accrued expense             $ 90,000     $ 60,000
Class B Ordinary Shares                    
Related Party Transaction [Line Items]                    
Common stock, shares, outstanding | shares             6,468,750     6,468,750
Class B Ordinary Shares | Over-Allotment Option                    
Related Party Transaction [Line Items]                    
Percentage of founder shares own on converted basis           20.00%        
Class B Ordinary Shares | Over-Allotment Option | Maximum                    
Related Party Transaction [Line Items]                    
Shares subject to forfeiture | shares       843,750   843,750 843,750      
Sponsor                    
Related Party Transaction [Line Items]                    
Restrictions on transfer period of time after business combination completion             1 year      
Share price | $ / shares             $ 12      
Threshold trading days             20 days      
Threshold consecutive trading days             30 days      
Threshold period after business combination in which specified trading days within any specified trading day period commences             120 days      
Debt instrument face value                 $ 1,200,000  
Debt instrument conversion price per share | $ / shares                 $ 10  
Due to sponsor             $ 39,435     $ 42,424
Long-term debt, gross                 $ 200,000  
Sponsor | Unsecured Promissory Note                    
Related Party Transaction [Line Items]                    
Debt instrument face value         $ 300,000          
Sponsor | Working Capital Loans                    
Related Party Transaction [Line Items]                    
Working capital loans convertible into warrants             $ 3,000,000      
Debt instrument conversion price per share | $ / shares             $ 1      
Sponsor | Agreement To Contribute To The Trust Account                    
Related Party Transaction [Line Items]                    
Commitement to contribute to the trust account per month     $ 100,000              
Aggregate commitement to contribute to the trust account     $ 1,200,000              
inception date for contribution to the trust account     Aug. 12, 2023              
End date for contribution to the trust account     Aug. 12, 2024              
Number of contributions to the trust account | Day     12              
Commitement to contribute to the trust account per share | $ / shares     $ 0.025              
Sponsor | Two Thousand and Twenty Three Promissory Note | Subsequent Event                    
Related Party Transaction [Line Items]                    
Debt instrument face value $ 100,000 $ 100,000                
Proceeds from notes payable $ 100,000 $ 100,000                
Sponsor | Class B Ordinary Shares                    
Related Party Transaction [Line Items]                    
Issuance of Class B ordinary shares to Sponsor, shares | shares         7,187,500          
Issuance of Class B ordinary shares to Sponsor         $ 25,000 $ 25,000        
Founder shares surrendered during period | shares       718,750   718,750        
Consideration paid for founder shares         $ 0          
Common stock, shares, outstanding | shares       6,468,750   6,468,750        
Sale of stock price per share | $ / shares           $ 0.039        
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments and Contingencies - Additional Information (Details) - Over-Allotment Option - shares
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Other Commitments [Line Items]    
Term of option for underwriters to purchase additional Units to cover over-allotments 45 days  
Common stock shares subscribed but unissued   3,375,000
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Warrant Liability - Additional Information (Details)
9 Months Ended
Sep. 30, 2023
$ / shares
shares
Class Of Warrant Or Right [Line Items]  
Adjustment of exercise price of warrants based on market value and newly issued price 115.00%
Private Placement Warrants  
Class Of Warrant Or Right [Line Items]  
Period to exercise warrants after business combination 30 days
Public Warrant  
Class Of Warrant Or Right [Line Items]  
Period to exercise warrants after business combination 30 days
Expiration of warrants from consummation of business combination or earlier upon redemption or liquidation 5 years
Period to file registration statement after Business Combination 15 days
Period for registration statement to become effective 60 days
Threshold trading days 60.00%
Threshold trading days determining volume weighted average price 20 days
Public Warrant | Class A Ordinary Shares  
Class Of Warrant Or Right [Line Items]  
Threshold issue price per share $ 9.2
Public Warrant | Exceeds $18.00  
Class Of Warrant Or Right [Line Items]  
Share price 18
Warrant redemption price $ 0.01
Minimum notice period for redemption of warrants 30 days
Threshold trading days 20 days
Threshold consecutive trading days 30 days
Threshold Number Of Business Days Before Sending Notice Of Redemption To Warrant Holders 3 days
Stock price trigger for redemption of public warrants $ 18
Adjustment of redemption price of stock based on market value and newly issued price 180.00%
Public Warrant | Exceeds $10.00  
Class Of Warrant Or Right [Line Items]  
Share price $ 10
Warrant redemption price $ 0.1
Minimum notice period for redemption of warrants 30 days
Threshold trading days 20 days
Threshold consecutive trading days 30 days
Threshold Number Of Business Days Before Sending Notice Of Redemption To Warrant Holders 3 days
Public Warrant | Exceeds $10.00 | Maximum  
Class Of Warrant Or Right [Line Items]  
Share price $ 18
Initial Public Offering  
Class Of Warrant Or Right [Line Items]  
Class of warrants and rights issued during the period | shares 29,025,000
Initial Public Offering | Private Placement Warrants  
Class Of Warrant Or Right [Line Items]  
Class of warrants and rights issued during the period | shares 16,087,500
Initial Public Offering | Public Warrant  
Class Of Warrant Or Right [Line Items]  
Class of warrants and rights issued during the period | shares 12,937,500
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Shareholders' Deficit - Additional Information (Details) - $ / shares
1 Months Ended 9 Months Ended
Mar. 22, 2022
Mar. 31, 2022
Sep. 30, 2023
Dec. 31, 2022
Class Of Stock [Line Items]        
Preferred stock, par value per share     $ 0.0001 $ 0.0001
Preferred stock, shares authorized     1,000,000 1,000,000
Preferred stock, shares issued     0 0
Preferred stock, shares outstanding     0 0
Class A Ordinary Shares        
Class Of Stock [Line Items]        
Common stock, shares authorized     479,000,000 479,000,000
Common stock, par value per share     $ 0.0001 $ 0.0001
Stock conversion basis on consummation of the initial business combination     one vote for each share  
Common stock, shares, issued     0 0
Common stock, shares, outstanding     0 0
Class A Ordinary Shares | Common Stock        
Class Of Stock [Line Items]        
Common stock, shares, issued     9,789,446 25,875,000
Common stock, shares, outstanding     9,789,446 25,875,000
Class B Ordinary Shares        
Class Of Stock [Line Items]        
Common stock, shares authorized     20,000,000 20,000,000
Common stock, par value per share     $ 0.0001 $ 0.0001
Stock conversion basis on consummation of the initial business combination     one vote for each share  
Common stock, shares, issued     6,468,750 6,468,750
Common stock, shares, outstanding     6,468,750 6,468,750
Class B Ordinary Shares | Common Stock        
Class Of Stock [Line Items]        
Common stock, shares, issued     6,468,750 6,468,750
Common stock, shares, outstanding     6,468,750 6,468,750
Class B Ordinary Shares | Over-Allotment Option | Maximum        
Class Of Stock [Line Items]        
Shares subject to forfeiture 843,750 843,750 843,750  
Class B Ordinary Shares | Sponsor        
Class Of Stock [Line Items]        
Common stock, shares, outstanding 6,468,750 6,468,750    
Founder shares surrendered during period 718,750 718,750    
Percentage of common stock issued and outstanding 20.00%      
Percentage of common stock outstanding 20.00%      
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Additional Information (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments held in Trust Account $ 106,318,563 $ 270,278,722
U.S. Treasury Securities Money Market Fund    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments held in Trust Account $ 106,318,563 $ 270,278,722
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Schedule of Company's Liabilities Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Recurring - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Level 1 | Investments held in Trust Account - U.S. Treasury Securities Money Market Fund    
Assets:    
Investments held in Trust Account $ 106,318,563 $ 270,278,722
Public Warrant | Level 1    
Liabilities:    
Warrant liability 905,625 675,338
Private Warrants | Level 3    
Liabilities:    
Warrant liability $ 1,126,125 $ 804,375
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs (Details) - Level 3
Sep. 30, 2023
yr
Dec. 31, 2022
yr
Stock Price    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Liability, Measurement Input 10.81 10.34
Exercise Price    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Liability, Measurement Input 11.5 11.5
Risk-free Rate of Interest    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Liability, Measurement Input 4.6 3.99
Volatility    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Liability, Measurement Input 0.5 0.5
Term    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Liability, Measurement Input 1.5 2.8
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Schedule of Change in Fair Value of Private Placement Warrants, Level 3 Liabilities, Measured on a Recurring Basis (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Sep. 30, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Fair Value, Net Derivative Asset (Liability), Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]           Formations Costs And Operating Expenses
Private Warrants | Level 3            
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Fair value , beginning balance $ 643,500 $ 1,126,125 $ 804,375 $ 2,413,125 $ 0 $ 804,375
Initial measurement on May 12, 2022 warrants issued         3,217,500  
Changes in fair value [1] 482,625 (482,625) 321,750 (804,375) (804,375)  
Fair value , ending balance $ 1,126,125 $ 643,500 $ 1,126,125 $ 1,608,750 $ 2,413,125 $ 1,126,125
[1] Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the statements of operations.
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent Events - Additional Information (Details) - USD ($)
9 Months Ended
Nov. 13, 2023
Nov. 09, 2023
Oct. 11, 2023
Oct. 10, 2023
Aug. 11, 2023
Sep. 30, 2023
Sep. 30, 2022
Aug. 09, 2023
Subsequent Event [Line Items]                
Cash deposited Into Trust Account         $ 172,774,717 $ 172,774,717    
Proceeds from notes payable           $ 200,000 $ 0  
Sponsor                
Subsequent Event [Line Items]                
Debt instrument face amount               $ 1,200,000
Subsequent Event                
Subsequent Event [Line Items]                
Cash deposited Into Trust Account $ 100,000   $ 100,000          
Subsequent Event | Sponsor | Two Thousand and Twenty Three Promissory Note                
Subsequent Event [Line Items]                
Debt instrument face amount   $ 100,000   $ 100,000        
Proceeds from notes payable   $ 100,000   $ 100,000        
XML 46 d559923d10q_htm.xml IDEA: XBRL DOCUMENT 0001852889 2022-12-31 0001852889 2023-09-30 0001852889 2022-07-01 2022-09-30 0001852889 2023-07-01 2023-09-30 0001852889 2023-01-01 2023-09-30 0001852889 2022-01-01 2022-09-30 0001852889 2022-01-01 2022-12-31 0001852889 2022-04-01 2022-06-30 0001852889 2023-01-01 2023-03-31 0001852889 2023-04-01 2023-06-30 0001852889 2022-03-01 2022-03-31 0001852889 2022-01-01 2022-03-31 0001852889 2022-08-31 2022-08-31 0001852889 2023-08-11 0001852889 2023-08-11 2023-08-11 0001852889 2021-12-31 0001852889 2022-09-30 0001852889 2022-03-31 0001852889 2023-06-30 0001852889 2022-06-30 0001852889 2023-03-31 0001852889 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001852889 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001852889 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001852889 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-07-01 2022-09-30 0001852889 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001852889 us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001852889 us-gaap:CommonClassBMember 2023-01-01 2023-09-30 0001852889 ivca:PublicWarrantsMember us-gaap:IPOMember 2023-01-01 2023-09-30 0001852889 ivca:PrivatePlacementWarrantsMember us-gaap:IPOMember 2023-01-01 2023-09-30 0001852889 us-gaap:IPOMember 2023-01-01 2023-09-30 0001852889 us-gaap:CommonClassAMember us-gaap:IPOMember 2023-01-01 2023-09-30 0001852889 ivca:PrivatePlacementWarrantsMember ivca:SponsorMember 2023-01-01 2023-09-30 0001852889 us-gaap:OverAllotmentOptionMember 2023-01-01 2023-09-30 0001852889 ivca:PublicWarrantsMember 2023-01-01 2023-09-30 0001852889 ivca:PrivatePlacementWarrantsMember 2023-01-01 2023-09-30 0001852889 ivca:PublicWarrantsMember ivca:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsEighteenPointZeroZeroMember 2023-01-01 2023-09-30 0001852889 ivca:PublicWarrantsMember ivca:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsTenPointZeroZeroMember 2023-01-01 2023-09-30 0001852889 ivca:SponsorMember 2023-01-01 2023-09-30 0001852889 ivca:PublicWarrantsMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001852889 srt:MaximumMember ivca:ProposedOfferingMember 2023-01-01 2023-09-30 0001852889 ivca:SponsorMember ivca:ProposedOfferingMember 2023-01-01 2023-09-30 0001852889 ivca:WorkingCapitalLoansMember ivca:SponsorMember 2023-01-01 2023-09-30 0001852889 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001852889 ivca:ClassaOrdinaryShareAndRedeemableWarrantMember 2023-01-01 2023-09-30 0001852889 us-gaap:CommonClassBMember 2023-07-01 2023-09-30 0001852889 us-gaap:CommonClassAMember 2023-07-01 2023-09-30 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-07-01 2023-09-30 0001852889 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001852889 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001852889 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001852889 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001852889 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001852889 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2022-05-12 2022-05-12 0001852889 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-05-12 2022-05-12 0001852889 ivca:PrivatePlacementWarrantsMember ivca:SponsorMember 2022-05-12 2022-05-12 0001852889 ivca:PrivatePlacementWarrantsMember ivca:SponsorMember us-gaap:OverAllotmentOptionMember 2022-05-12 2022-05-12 0001852889 ivca:SponsorMember us-gaap:CommonClassBMember 2021-03-12 2021-03-12 0001852889 ivca:SponsorMember us-gaap:CommonClassBMember 2022-03-01 2022-03-31 0001852889 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2022-03-01 2022-03-31 0001852889 ivca:AgreementToContributeToTheTrustAccountMember ivca:SponsorMember 2023-08-11 2023-08-11 0001852889 ivca:SponsorMember us-gaap:CommonClassBMember 2022-03-22 2022-03-22 0001852889 us-gaap:SubsequentEventMember 2023-10-11 2023-10-11 0001852889 us-gaap:SubsequentEventMember 2023-11-13 2023-11-13 0001852889 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001852889 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-04-01 2023-06-30 0001852889 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001852889 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001852889 us-gaap:CommonClassAMember 2023-09-30 0001852889 us-gaap:USTreasurySecuritiesMember 2023-09-30 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001852889 ivca:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001852889 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2023-09-30 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2023-09-30 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-09-30 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember 2023-09-30 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2023-09-30 0001852889 us-gaap:CommonClassAMember us-gaap:IPOMember 2023-09-30 0001852889 us-gaap:CommonClassBMember 2023-09-30 0001852889 ivca:ProposedOfferingMember 2023-09-30 0001852889 ivca:PublicWarrantsMember us-gaap:CommonClassAMember 2023-09-30 0001852889 us-gaap:IPOMember 2023-09-30 0001852889 ivca:PublicWarrantsMember ivca:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsEighteenPointZeroZeroMember 2023-09-30 0001852889 srt:MaximumMember ivca:PublicWarrantsMember ivca:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsTenPointZeroZeroMember 2023-09-30 0001852889 ivca:PublicWarrantsMember ivca:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsTenPointZeroZeroMember 2023-09-30 0001852889 srt:MaximumMember us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2023-09-30 0001852889 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-09-30 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-09-30 0001852889 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-09-30 0001852889 ivca:SponsorMember 2023-09-30 0001852889 ivca:WorkingCapitalLoansMember ivca:SponsorMember 2023-09-30 0001852889 ivca:ExtensionLoansMember 2023-09-30 0001852889 ivca:AdministrativeServicesAgreementMember 2023-09-30 0001852889 us-gaap:CommonClassAMember 2022-12-31 0001852889 us-gaap:USTreasurySecuritiesMember 2022-12-31 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852889 ivca:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852889 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001852889 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001852889 us-gaap:OverAllotmentOptionMember 2022-12-31 0001852889 us-gaap:CommonClassBMember 2022-12-31 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001852889 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001852889 ivca:SponsorMember 2022-12-31 0001852889 ivca:ExtensionLoansMember 2022-12-31 0001852889 ivca:AdministrativeServicesAgreementMember 2022-12-31 0001852889 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-05-12 0001852889 ivca:SponsorMember us-gaap:CommonClassBMember 2022-03-31 0001852889 srt:MaximumMember us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2022-03-31 0001852889 ivca:UnsecuredPromissoryNoteMember ivca:SponsorMember 2021-03-12 0001852889 ivca:AgreementToContributeToTheTrustAccountMember ivca:SponsorMember 2023-08-11 0001852889 us-gaap:CommonClassAMember 2023-08-11 0001852889 srt:MaximumMember us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2022-03-22 0001852889 ivca:SponsorMember us-gaap:CommonClassBMember 2022-03-22 0001852889 us-gaap:CommonClassAMember 2023-11-30 0001852889 us-gaap:CommonClassBMember 2023-11-30 0001852889 ivca:SponsorMember 2023-08-09 0001852889 ivca:TwoThousandAndTwentyThreePromissoryNoteMember ivca:SponsorMember us-gaap:SubsequentEventMember 2023-10-10 0001852889 ivca:TwoThousandAndTwentyThreePromissoryNoteMember ivca:SponsorMember us-gaap:SubsequentEventMember 2023-11-09 0001852889 ivca:TwoThousandAndTwentyThreePromissoryNoteMember ivca:SponsorMember us-gaap:SubsequentEventMember 2023-10-10 2023-10-10 0001852889 ivca:TwoThousandAndTwentyThreePromissoryNoteMember ivca:SponsorMember us-gaap:SubsequentEventMember 2023-11-09 2023-11-09 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-06-30 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001852889 us-gaap:RetainedEarningsMember 2022-09-30 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-09-30 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001852889 us-gaap:RetainedEarningsMember 2023-09-30 0001852889 us-gaap:RetainedEarningsMember 2022-12-31 0001852889 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001852889 us-gaap:RetainedEarningsMember 2023-03-31 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001852889 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001852889 us-gaap:RetainedEarningsMember 2021-12-31 0001852889 us-gaap:RetainedEarningsMember 2022-03-31 0001852889 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001852889 us-gaap:RetainedEarningsMember 2022-06-30 0001852889 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001852889 us-gaap:RetainedEarningsMember 2023-06-30 0001852889 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-06-30 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001852889 ivca:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-06-30 iso4217:USD shares utr:Day utr:Year pure iso4217:USD shares utr:Y 0001852889 --12-31 false Q3 00-0000000 Cricket Square Elgin Avenue 10-Q true 2023-09-30 2023 false 001-41383 INVESTCORP INDIA ACQUISITION CORP E9 Century Yard PO Box 1111 George Town KY KY1-1102 302 738-7210 Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant IVCAU NASDAQ Class A ordinary shares, par value $0.0001 per share IVCA NASDAQ Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share IVCAW NASDAQ Yes Yes Non-accelerated Filer true true false true 9789446 6468750 http://fasb.org/us-gaap/2023#RelatedPartyMember http://fasb.org/us-gaap/2023#RelatedPartyMember P3D P3D http://www.ivcau.com/20230930#FormationsCostsAndOperatingExpenses 30414 635565 317822 509987 348236 1145552 0 183345 106318563 270278722 106666799 271607619 536304 206748 200000 39435 42424 775739 249172 2031751 1479713 2807409 1728885 9789446 25875000 106318563 270278722 0.0001 0.0001 1000000 1000000 0 0 0 0 0 0 0.0001 0.0001 479000000 479000000 0 0 0 0 0 0 0.0001 0.0001 20000000 20000000 6468750 6468750 6468750 6468750 647 647 0 0 -2459901 -400635 -2459254 -399988 106666799 271607619 718750 843750 461510 273246 1307228 796793 -461510 -273246 -1307228 -796793 2503463 1204462 8614558 1466458 831938 -1451250 552038 -2902500 1671525 2655712 8062520 4368958 1210015 2382466 6755292 3572165 18274134 18274134 25875000 25875000 23341378 23341378 13364011 13364011 0.05 0.05 0.07 0.07 0.23 0.23 0.18 0.18 6468750 6468750 6468750 6468750 6468750 6468750 6682005 6682005 0.05 0.05 0.07 0.07 0.23 0.23 0.18 0.18 718750 843750 6468750 647 0 -400635 -399988 0 -2889862 -2889862 2012699 2012699 6468750 647 -1277798 -1277151 0 -3221233 -3221233 3532578 3532578 6468750 647 -966453 -965806 -2703463 -2703463 1210015 1210015 6468750 647 -2459901 -2459254 6468750 647 24353 -3587 21413 0 0 0 6468750 647 24353 -3587 21413 12870000 12870000 -12894353 -3684712 -16579065 1189699 1189699 6468750 647 0 -2498600 -2497953 -1204462 -1204462 2382466 2382466 6468750 647 -1320596 -1319949 6755292 3572165 552038 -2902500 8614558 1466458 -375510 826074 329556 78150 2989 302528 -605151 -1847245 -172774717 266512500 200000 172574717 -266512500 172774717 253575000 200000 0 16087500 25000 469891 -172574717 269217609 -605151 857864 635565 0 30414 857864 8814558 0 325765 <div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div id="fin559923_6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</div></div></div></div> <div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investcorp India Acquisition Corp (the “Company”) is a blank check company incorporated in the Cayman Islands on February 19, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. On January 11, 2022, the Company changed its name from Investcorp Acquisition Corp. to Investcorp India Acquisition Corp.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As of September 30, 2023, and for the period from February 19, 2021 (inception) through September 30, 2023, the Company had not yet commenced any operations. All activity for the period from February 19, 2021 (inception) through September 30, 2023, relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) and identifying a target for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.</div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The registration statement for the Company’s Initial Public Offering was declared effective on May 9, 2022. On May 12, 2022, the Company consummated the Initial Public Offering of 22,500,000 unit (the “Units” and, with respect to the shares of Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $225,000,000. Additionally, the underwriter exercised their over-allotment option in full, resulting in an additional 3,375,000 Units issued for an aggregate amount of $33,750,000, which is described in Note 3.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 14,400,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to ICE I Holdings Pte. Ltd. (the “Sponsor”), generating gross proceeds of $14,400,000. In connection with the underwriter’s exercise of their over-allotment option, the Company also consummated the sale of an additional 1,687,500 Private Placement Warrants at $1.00 per Private Placement Warrant generating total proceeds of $1,687,500, which is described in Note 4.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (less any taxes payable on interest earned on the Trust Account) at the time of the signing a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the Proposed Offering, management has agreed that $10.30 per Unit sold in the Proposed Offering, including the proceeds from the sale of the Private Placement Warrants, will be held in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-7</div> under the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.</div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company provides its holders of the outstanding Public Shares (the “public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Certificate of Incorporation provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent.</div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The public shareholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.30 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These Class A ordinary shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Proposed Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company’s Sponsor has agreed (a) to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Certificate of Incorporation with respect to the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-Business</div> Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Founder Shares) into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek shareholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating to shareholders’ rights of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-Business</div> Combination activity and (d) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Proposed Offering if the Company fails to complete its Business Combination.</div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On August 11, 2023 shareholders of the Company held an extraordinary general meeting of shareholders (the “Extraordinary General Meeting”). At the Extraordinary General Meeting, the Company’s shareholders approved the proposal to amend the Company’s Amended and Restated Memorandum and Articles of Association to give the Company the right to extend the date by which it has to consummate a business combination from August 12, 2023 to August 12, 2024. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In connection with the Extension Amendment Proposal, the Sponsor has agreed to contribute (each such contribution, a “Contribution”) into the Company’s Trust Account the lessor or (x) an aggregate of $100,000 or (y) $0.025 per share for each Class A ordinary share included as a part of the units sold in the Company’s initial public offering (including any shares issued in exchange thereof) that are not redeemed at the Extraordinary General Meeting for each monthly period (commencing on August 12, 2023 and ending on the 12th day of each subsequent month), or portion thereof, until the earlier of the completion of the initial business combination or August 12, 2024. Additionally, the maximum aggregate Contributions to the Trust Account shall not exceed $1,200,000 based on up to twelve monthly Contributions through August 12, 2024. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At the Extraordinary General Meeting, the shareholders of record were provided the opportunity to exercise their redemption rights (the “Extension Amendment Proposal”). Holders of 16,085,554 shares of Class A ordinary shareholders exercised their right to redemption at a per share redemption price of approximately $10.74. On August 18, 2023, a total of $172,774,717 in redemption payments were made in connection with this redemption. Following the redemption, the Company had a total of 9,789,446 shares of Class A ordinary shares outstanding. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">If the Company is unable to complete a Business Combination within the combination period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-</div> share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholder’s rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. In the event the Company does not complete a Business Combination within the Combination Period, and in such event, the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Initial Offering price per Unit of $10.00.</div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.30 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.30 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriter of Proposed Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure its shareholders that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liquidity, Capital Resources, and Going Concern Consideration</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2023, the Company had $30,414 in cash and a working capital deficit of $427,503.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s liquidity needs up to September 30, 2023, had been satisfied by funds from the Sponsor to cover certain offering expenses. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company a Working Capital Loans, as defined below (see Note 5). As of September 30, 2023, there were no amounts outstanding under any Working Capital Loans.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prior to the completion of the Initial Public Offering, the Company lacked the liquidity it needed to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statement. However, the Company completed its Initial Public Offering, as detailed in Note 3, which generated capital in excess of the funds deposited into a trust account. This excess capital may be used by the Company for general working capital purposes.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="null;text-indent: 0px;;display:inline;">In connection with the Company’s assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2014-15,</div> “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The Company originally had until August 12, 2023, 15 months from the closing of the IPO, to consummate a Business Combination. As approved by its shareholders, the Company extended the time to complete a Business Combination to August 12, 2024, 23 months from the closing of the IPO). It is uncertain that the Company will be able to consummate a Business Combination by the specified period. If a Business Combination is not consummated by August 12, 202<div style="text-decoration: line-through; letter-spacing: 0px; top: 0px;;display:inline;"></div>4, there will be a mandatory liquidation and subsequent dissolution. The liquidity condition and date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern one year from the date that this financial statement is issued. This financial statement does not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risks and Uncertainties</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="null;text-indent: 0px;;display:inline;">Management is currently evaluating the impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and geopolitical instability, such as the military conflict in Ukraine and the Middle East, and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Proposed Offering, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Inflation Reduction Act of 2022, enacted in August 2022, imposes a 1% excise tax on the fair market value of stock repurchased by “covered corporations” beginning in 2023, with certain exceptions (the “Excise Tax”). The Excise Tax is imposed on the repurchasing corporation itself, not its shareholders. Because we are a “blank check” Cayman Islands corporations with no subsidiaries or previous merger or acquisition activity, we are not currently a “covered corporation” for this purpose. The amount of the Excise Tax is generally equal to 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, there are certain other exceptions to the Excise Tax. The U.S. Department of the Treasury has been given authority to issue regulations or other guidance to carry out, and to prevent the avoidance of, the Excise Tax. The Treasury and the IRS recently have issued preliminary guidance regarding the application of this excise tax, but there can be no assurance that this guidance will be finally adopted in its current form. A repurchase that occurs in connection with a business combination with a U.S. target company might be subject to the Excise Tax, depending on the structure of the business combination and other transactions that might be engaged in during the relevant year. </div></div> 2021-02-19 22500000 10 225000000 3375000 33750000 14400000 1 14400000 1687500 1 1687500 0.80 0.50 10.3 P185D 5000001 10.3 100000 0.025 2023-08-12 12 2024-08-12 1200000 16085554 10.74 172774717 9789446 100000 10 10.3 10.3 30414 427503 0.01 0.01 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchanges Commission (“SEC”).</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Emerging Growth Company</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of September 30, 2023 and December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Credit Risk</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and Cash Equivalents</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $30,414 and $635,565 cash and no cash equivalents as of September 30, 2023, and December 31, 2022, respectively.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments Held in Trust Account</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2023, and December 31, 2022, the Company had $106,318,563 and $270,278,722, respectively, held in money market funds, which are invested primarily in U.S. Treasury Securities.</div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes”, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company has completed a nexus study and believes that it is appropriately filing tax returns in which it has nexus.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Income Per Ordinary Share</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings per Share”. The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 843,750 Class B ordinary shares that are subject to forfeiture if the over- allotment option is not exercised by the underwriter (see Note 8). Diluted net income per share reflects the potential dilution that could occur if warrants were to be exercised or converted or otherwise resulted in issuance of Ordinary Shares that then shared in the earnings of the entity. As the exercise of the warrants are contingent upon the completion of a business combination, they have not been included in the calculation of diluted net income per share. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except share amounts) for the three and nine months ended September 30, 2023, and September 30, 2022:</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 56%;"></td> <td style="width: 4%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 4%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 4%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 4%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em;">Basic and diluted net income per ordinary share</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net income, as adjusted</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 893,670</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">316,345</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,905,973</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 476,493</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,274,134</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,468,750</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,875,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,468,750</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.05</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.05</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.07</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.07</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 56%;"></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Nine Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em;">Basic and diluted net income per ordinary share</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net income, as adjusted</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,289,404</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,465,888</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,381,443</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,190,722</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,341,378</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,468,750</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,364,011</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,682,005</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.23</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.23</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.18</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.18</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value of Financial Instruments</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.</div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offering Costs Associated with the Initial Public Offering</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company complied with the requirements of the ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-10-S99-1</div></div></div> and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consists of legal, accounting, underwriting fees and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounted to $6,037,027, which was charged to shareholders’ equity upon the completion of the Initial Public Offering.</div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A Ordinary Shares Subject to Possible Redemption</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”). Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as stockholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, the Class A ordinary shares is subject to possible redemption and is presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.</div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital (to the extent available) and accumulated deficit.</div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2023, the Class A ordinary shares subject to possible redemption reflected in the balance sheet is reconciled in the following table:</div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%; font-family: &quot;Times New Roman&quot;;"></td> <td style="width: 4%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td> <td style="font-family: &quot;Times New Roman&quot;;"></td> <td style="font-family: &quot;Times New Roman&quot;;"></td> <td style="font-family: &quot;Times New Roman&quot;;"></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross Proceeds</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">258,750,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proceeds allocated to Public Warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,587,500</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total stock issuance costs</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,967,069</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,083,291</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption at December 31, 2022</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">270,278,722</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,814,558</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares redeemed in August 2023</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(172,774,717</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption at September 30, 2023</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 106,318,563</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant Liability</div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> gain or loss on the statements of operations. The fair value of the warrants was estimated using a Modified Binomial Option Pricing model (see Note 9).</div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative Financial Instruments</div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recently Issued Accounting Standards</div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In August 2020, the FASB issued Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> Debt — Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40)</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(“ASU 2020-06”)</div> to simplify accounting for certain financial instruments. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> amends the diluted earnings per share guidance, including the requirement to use the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method for all convertible instruments. The new standard is effective for companies that are SEC filers (except for smaller reporting companies) for fiscal years beginning after December 15, 2021, and interim periods within that year, and two years later for other companies. Companies can early adopt the standard at the start of a fiscal year beginning after December 15, 2020. The standard can either be adopted on a modified retrospective or a full retrospective basis. The Company is still evaluating the impact on the Company’s financial statements.</div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchanges Commission (“SEC”).</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Emerging Growth Company</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of September 30, 2023 and December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</div></div> 250000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Credit Risk</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and Cash Equivalents</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $30,414 and $635,565 cash and no cash equivalents as of September 30, 2023, and December 31, 2022, respectively.</div></div> 30414 635565 0 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments Held in Trust Account</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2023, and December 31, 2022, the Company had $106,318,563 and $270,278,722, respectively, held in money market funds, which are invested primarily in U.S. Treasury Securities.</div></div> 106318563 270278722 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes”, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company has completed a nexus study and believes that it is appropriately filing tax returns in which it has nexus.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Income Per Ordinary Share</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings per Share”. The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 843,750 Class B ordinary shares that are subject to forfeiture if the over- allotment option is not exercised by the underwriter (see Note 8). Diluted net income per share reflects the potential dilution that could occur if warrants were to be exercised or converted or otherwise resulted in issuance of Ordinary Shares that then shared in the earnings of the entity. As the exercise of the warrants are contingent upon the completion of a business combination, they have not been included in the calculation of diluted net income per share. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except share amounts) for the three and nine months ended September 30, 2023, and September 30, 2022:</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 56%;"></td> <td style="width: 4%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 4%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 4%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 4%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em;">Basic and diluted net income per ordinary share</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net income, as adjusted</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 893,670</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">316,345</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,905,973</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 476,493</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,274,134</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,468,750</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,875,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,468,750</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.05</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.05</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.07</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.07</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 56%;"></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Nine Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em;">Basic and diluted net income per ordinary share</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net income, as adjusted</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,289,404</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,465,888</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,381,443</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,190,722</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,341,378</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,468,750</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,364,011</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,682,005</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.23</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.23</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.18</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.18</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 843750 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except share amounts) for the three and nine months ended September 30, 2023, and September 30, 2022:</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 56%;"></td> <td style="width: 4%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 4%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 4%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 4%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em;">Basic and diluted net income per ordinary share</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net income, as adjusted</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 893,670</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">316,345</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,905,973</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 476,493</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,274,134</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,468,750</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,875,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,468,750</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.05</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.05</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.07</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.07</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 56%;"></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Nine Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B,<br/> Ordinary<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em;">Basic and diluted net income per ordinary share</div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net income, as adjusted</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,289,404</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,465,888</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,381,443</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,190,722</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,341,378</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,468,750</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,364,011</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,682,005</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.23</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.23</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.18</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 0.18</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 893670 316345 1905973 476493 18274134 18274134 6468750 6468750 25875000 25875000 6468750 6468750 0.05 0.05 0.05 0.05 0.07 0.07 0.07 0.07 5289404 1465888 2381443 1190722 23341378 23341378 6468750 6468750 13364011 13364011 6682005 6682005 0.23 0.23 0.23 0.23 0.18 0.18 0.18 0.18 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value of Financial Instruments</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.</div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.</div></div> </td> </tr> </table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offering Costs Associated with the Initial Public Offering</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company complied with the requirements of the ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-10-S99-1</div></div></div> and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consists of legal, accounting, underwriting fees and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounted to $6,037,027, which was charged to shareholders’ equity upon the completion of the Initial Public Offering.</div> 6037027 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A Ordinary Shares Subject to Possible Redemption</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”). Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as stockholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, the Class A ordinary shares is subject to possible redemption and is presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.</div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital (to the extent available) and accumulated deficit.</div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2023, the Class A ordinary shares subject to possible redemption reflected in the balance sheet is reconciled in the following table:</div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%; font-family: &quot;Times New Roman&quot;;"></td> <td style="width: 4%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td> <td style="font-family: &quot;Times New Roman&quot;;"></td> <td style="font-family: &quot;Times New Roman&quot;;"></td> <td style="font-family: &quot;Times New Roman&quot;;"></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross Proceeds</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">258,750,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proceeds allocated to Public Warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,587,500</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total stock issuance costs</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,967,069</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,083,291</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption at December 31, 2022</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">270,278,722</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,814,558</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares redeemed in August 2023</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(172,774,717</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption at September 30, 2023</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 106,318,563</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2023, the Class A ordinary shares subject to possible redemption reflected in the balance sheet is reconciled in the following table:</div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%; font-family: &quot;Times New Roman&quot;;"></td> <td style="width: 4%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td> <td style="font-family: &quot;Times New Roman&quot;;"></td> <td style="font-family: &quot;Times New Roman&quot;;"></td> <td style="font-family: &quot;Times New Roman&quot;;"></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross Proceeds</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">258,750,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proceeds allocated to Public Warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,587,500</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total stock issuance costs</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,967,069</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,083,291</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption at December 31, 2022</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">270,278,722</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,814,558</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares redeemed in August 2023</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(172,774,717</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption at September 30, 2023</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 106,318,563</div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 258750000 2587500 5967069 20083291 270278722 8814558 172774717 106318563 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant Liability</div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> gain or loss on the statements of operations. The fair value of the warrants was estimated using a Modified Binomial Option Pricing model (see Note 9).</div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative Financial Instruments</div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recently Issued Accounting Standards</div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In August 2020, the FASB issued Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> Debt — Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40)</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(“ASU 2020-06”)</div> to simplify accounting for certain financial instruments. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> amends the diluted earnings per share guidance, including the requirement to use the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method for all convertible instruments. The new standard is effective for companies that are SEC filers (except for smaller reporting companies) for fiscal years beginning after December 15, 2021, and interim periods within that year, and two years later for other companies. Companies can early adopt the standard at the start of a fiscal year beginning after December 15, 2020. The standard can either be adopted on a modified retrospective or a full retrospective basis. The Company is still evaluating the impact on the Company’s financial statements.</div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 3. INITIAL PUBLIC OFFERING</div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Pursuant to the Initial Public Offering, the Company sold 25,875,000 Units at a purchase price of $10.00 per Unit. Each Unit consisted of one Class A ordinary share, $0.0001 par value, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-half</div> of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note 8).</div> 25875000 10 0.0001 11.5 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 4. PRIVATE PLACEMENT</div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor purchased an aggregate of 16,087,500 Private Placement Warrants at a price of $1.00 per warrant, in a private placement that closed simultaneously with the closing of the Initial Public Offering.</div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Each Private Placement Warrant is identical to the warrants offered in the Initial Public Offering, except there will be no redemption rights or liquidating distributions from the trust account with respect to Private Placement Warrants, which will expire worthless if the Company does not consummate a Business Combination within the Combination Period.</div></div> 16087500 1 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 5. RELATED PARTY TRANSACTIONS</div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Founder Shares</div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On March 12, 2021, the Company issued an aggregate of 7,187,500 Class B ordinary shares (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. In March 2022, our sponsor surrendered, for no consideration, 718,750 founder shares, resulting in our sponsor holding 6,468,750 founder shares for an aggregate purchase price of $25,000 or approximately $0.039 per share. The Founder Shares include an aggregate of up to 843,750 shares subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment was not exercised in full or in part, so that the Sponsor will collectively own, on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering.</div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a result of the underwriter’s election to exercise their over-allotment option simultaneously with the Initial Public Offering, 843,750 Founder Shares are no longer subject to forfeiture.</div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period commencing at least 120 days after the Business Combination, the Founder Shares will be released from the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">lock-up.</div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Promissory Note — Related Party</div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On March 12, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Proposed Offering pursuant to a promissory note (the “Note”). The Note is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing and is payable on the earlier of (i) December 31, 2021 (which was amended to September 30, 2022, on January 25, 2022) or (ii) the consummation of the Initial Proposed Offering. As of September 30, 2023, and December 31, 2022, there were no amounts outstanding on the Note and it is no longer available to the Company.</div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><br/></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Working Capital Loans</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $3,000,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of September 30, 2023, and December 31, 2022, the Company has not drawn on the Working Capital Loans.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Due to Sponsor</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor has paid expenses on behalf of the Company prior to the Company’s Initial Public Offering. This amount is not interest bearing and due on demand by the Sponsor. As of September 30, 2023, and December 31, 2022, there was $39,435 and $42,424 due to Sponsor, respectively.</div></div> <div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">Extension Loans — related party</div></div></div></div> <div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">If the Company anticipates that it may not be able to consummate its initial business combination within 15 months, the Company may, but is not obligated to, extend the period of time to consummate a Business Combination by an additional three months on two separate occasions (for a total of up to 21 months to complete a business combination). In order to extend the time available for us to consummate a Business Combination, the Sponsor (or its affiliates or designees), upon five days advance notice prior to the applicable deadline, must deposit into the Trust Account $2,587,500 ($0.10 per share), on or prior to the date of the applicable deadline. Any such payments would be funded from the proceeds of a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest-bearing</div> loan between the Sponsor and the Company (the “Extension Loans”). Such Extension Loans may be convertible into warrants, at a price of $1.00 per warrant at the option of the lender. The terms of the warrants would be identical to the terms of the private placement warrants. If the Company completes a Business Combination, the Company would repay such Extension Loans out of the proceeds of the trust account released to the Company. There were no amounts outstanding on the extension loans as of September 30, 2023, and December 31, 2022.</div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a result of the shareholders’ vote held on August 11, 2023, the Company has agreed to contribute (each such contribution, a “Contribution”) into the Company’s Trust Account the lessor or (x) an aggregate of $100,000 or (y) $0.025 per share for each Class A ordinary share included as a part of the units sold in the Company’s IPO (including any shares issued in exchange thereof) that are not redeemed at the Meeting for each monthly period (commencing on August 12, 2023 and ending on the 12th day of each subsequent month), or portion thereof, until the earlier of the completion of the initial business combination or August 12, 2024. For the avoidance of doubt, the maximum aggregate Contributions to the Trust Account shall not exceed $1,200,000 based on up to twelve monthly Contributions through August 12, 2024. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Promissory Note </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On August 9, 2023, the Sponsor agreed to loan the Company an aggregate of up to $1,200,000 to cover expenses related to the Contributions (the “2023 Note”). The note is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">non-interest</div> bearing and is payable on the earlier of (i) August 12, 2024, or (ii) the consummation of a Business Combination. Upon receiving notice of the closing of a Business Combination, the Sponsor shall convert the unpaid principal balance of the 2023 Note into a number of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">non-transferable,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">non-redeemable</div> ordinary shares of the Company equal to (x) the principal amount of the 2023 Note being converted, divided by (y) the conversion price of $10.00, rounded up to the nearest whole number of shares. As of September 30, 2023, the outstanding principal balance was $200,000<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">. Subsequently, on October 10, 2023 and November 9, 2023 the Company made additional draw downs on the Promissory Note of $100,000 <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">each month to fund month extension requirements.</div></div></div> <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Administrative Services Agreement</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Commencing on the date of the Initial Public Offering and until completion of the Company’s initial business combination or liquidation, the Company will make a payment of a monthly fee of $10,000 to the Sponsor for office space, utilities and secretarial and administrative services provided to the Company. As of September 30, 2023 and December 31, 2022, there was $90,000 and $60,000 recorded in accrued expenses, respectively.</div></div> 7187500 25000 0 718750 6468750 25000 0.039 843750 0.20 843750 P1Y 12 P20D P30D P120D 300000 3000000 1 39435 42424 In order to extend the time available for us to consummate a Business Combination, the Sponsor (or its affiliates or designees), upon five days advance notice prior to the applicable deadline, must deposit into the Trust Account $2,587,500 ($0.10 per share), on or prior to the date of the applicable deadline. 1 0 0 100000 0.025 2023-08-12 12 2024-08-12 1200000 1200000 10 200000 100000 100000 100000 100000 10000 90000 60000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 6. COMMITMENTS AND CONTINGENCIES</div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Registration Rights</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans and Extension Loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Proposed Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to our Class A ordinary shares). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underwriting Agreement</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company granted the underwriter a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">45-day</div> option to purchase up to 3,375,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The over-allotment option was exercised simultaneously with the Initial Public Offering.</div> P45D 3375000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 7. WARRANT LIABILITY</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company accounts for the 29,025,000 warrants issued in connection with the Initial Public Offering (the 16,087,500 Private Warrants and the 12,937,500 Public Warrants) in accordance with the guidance contained in ASC 480 and ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40,</div> Derivatives and Hedging. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value. This liability is subject to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> at each balance sheet date. With each such remeasurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations.</div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the ordinary share warrants. At that time, the portion of the warrant liability related to the ordinary share warrants will be reclassified to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital.</div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants — Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable 30 days after the consummation of a Business Combination. The Public Warrants will expire <div style="letter-spacing: 0px; top: 0px;;display:inline;">five years</div> from the consummation of a Business Combination or earlier upon redemption or liquidation.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. The Company will use its best efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redemption of warrants when the price per Class A ordinary share equals or exceeds $<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">18.00</div></div>. Once the warrants become exercisable, the Company may redeem the Warrants for redemption:</div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part;</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $<div style="letter-spacing: 0px; top: 0px;;display:inline;">0.01</div> per Public Warrant;</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">upon not less than <div style="letter-spacing: 0px; top: 0px;;display:inline;">30</div> days’ prior written notice of redemption to each warrant holder and</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="break-inside: avoid; font-size: 0px;"> <td style="width: 5%;"></td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $<div style="letter-spacing: 0px; top: 0px;;display:inline;">18.00</div> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any <div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div> trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">30</div>-trading</div> day period ending <span style="-sec-ix-hidden:hidden94666672">three</span> business days before the Company sends the notice of redemption to the warrant holders.</div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">30</div>-day</div> redemption period. If and when the warrants become redeemable by us, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.</div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redemption of warrants when the price per Class A ordinary share equals or exceeds $<div style="letter-spacing: 0px; top: 0px;;display:inline;">10.00</div>. Once the Warrants become exercisable, the Company may redeem the Warrants for redemption:</div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part;</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth under “Description of Securities — Warrants — Public Shareholders’ Warrants” based on the redemption date and the “fair market value” of our Class A ordinary shares (as defined below) except as otherwise described in “Description of Securities — Warrants — Public Shareholders’ Warrants”;</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the closing price of our Class A ordinary shares equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Shareholders’ Warrants — Anti-dilution Adjustments”) for any 20 trading days within the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending <span style="-sec-ix-hidden:hidden94666673">three</span> trading days before the Company sends the notice of redemption to the warrant holders; and</div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if the closing price of our Class A ordinary shares for any <div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div> trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">30</div>-trading</div> day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $<div style="letter-spacing: 0px; top: 0px;;display:inline;">18.00</div> per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “— Warrants — Public Shareholders’ Warrants — Anti-Dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.</div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If and when the Public Warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of ordinary shares upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The exercise price and number of Class A ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Private Placement Warrants will be identical to the Public Warrants included in the Units being sold in the Proposed Offering, except that the Private Placement Warrants will and the ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</div> 29025000 16087500 12937500 P30D P5Y P15D P60D 18 0.01 P30D 18 P20D P30D 10 0.1 P30D 10 P20D P30D 18 9.2 0.60 P20D 9.2 1.15 18 1.80 P30D <div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 8. SHAREHOLDERS’ DEFICIT </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preference Shares — The Company is authorized to issue 1,000,000 preference shares of $0.0001 par value. At September 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A Ordinary Shares — The Company is authorized to issue up to 479,000,000 Class A ordinary shares, $0.0001 par value. Holders of the Company’s ordinary shares are entitled to one vote for each share. At September 30, 2023, and December 31, 2022, there were 9,789,446 and 25,875,000 Class A ordinary shares issued and outstanding, respectively. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class B Ordinary Shares — The Company is authorized to issue up to 20,000,000 Class B ordinary shares, $0.0001 par value. Holders of the Company’s ordinary shares are entitled to one vote for each share. At September 30, 2023 and December 31, 2022, there were 6,468,750 Class B ordinary shares issued and outstanding, respectively.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">On March 22, 2022, the Sponsor surrendered, for no consideration, 718,750 Class B ordinary shares, resulting in our sponsor holding 6,468,750 founder shares issued and outstanding, of which an aggregate of up to 843,750 shares subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment is not exercised in full or in part, so that the Sponsor will collectively own, on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. As a result of the underwriter’s election to exercise their over-allotment option simultaneously with the Initial Public Offering, 843,750 Founder Shares are no longer subject to forfeiture.</div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the completion of our Business Combination on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional Class A ordinary shares, or equity linked securities, are issued or deemed issued in connection with the initial Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as converted basis, 20% of the sum of the total number of all ordinary shares outstanding as of the Initial Public Offering plus all Class A ordinary shares and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be issued, to any seller in a Business Combination, and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their Class B ordinary shares into an equal number of Class A ordinary shares, subject to adjustment as provided above, at any time.</div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company may issue additional ordinary shares or preference shares to complete its Business Combination or under an employee incentive plan after completion of its Business Combination. </div></div> 1000000 1000000 0.0001 0.0001 0 0 0 0 479000000 479000000 0.0001 0.0001 one vote for each share 9789446 9789446 25875000 25875000 20000000 20000000 0.0001 0.0001 one vote for each share 6468750 6468750 6468750 6468750 718750 6468750 843750 0.20 843750 0.20 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 9. FAIR VALUE MEASUREMENTS</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:</div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">Level 1:  </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="break-inside: avoid; font-size: 0px;"> <td style="width: 4%;"></td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;">Level 2:  </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">Level 3:  </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2023, and December 31, 2022, investments held in the Trust Account were comprised of $106,318,563 and $270,278,722 in money market funds, which are invested primarily in U.S. Treasury Securities, respectively. The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 59%;"></td> <td style="width: 6%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 6%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 6%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Investments held in Trust Account</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">106,318,563</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">270,278,722</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Public Warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">905,625</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">675,338</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Private Warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,126,125</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">804,375</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. During the period there were no transfers to/from Levels 1 and 3.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company established the initial fair value of the warrants on May 12, 2022, the date of the consummation of the Company’s IPO. The Company used a Binomial Option Pricing model to value the warrants. The Company allocated the proceeds received from (i) the sale of the Units (which is inclusive of one share of Class A ordinary shares and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-half</div> of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of Class B ordinary shares, first to the warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A ordinary shares subject to possible redemption (temporary equity), Class A ordinary shares (permanent equity) and Class B ordinary shares (permanent equity) based on their relative fair values at the initial measurement date.</div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides quantitative information regarding Level 3 fair value measurements:</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 73%;"></td> <td style="width: 9%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 8%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Private</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants</div></div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Private</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants</div></div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock Price</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 10.81</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 10.34</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercise Price</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 11.50</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 11.50</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate of interest</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.60</td> <td style="vertical-align: bottom; white-space: nowrap;">%</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.99</td> <td style="vertical-align: bottom; white-space: nowrap;">%</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.50</td> <td style="vertical-align: bottom; white-space: nowrap;">%</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.50</td> <td style="vertical-align: bottom; white-space: nowrap;">%</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Term</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.5 years</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.8 years</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Placement Warrants were initially and subsequently valued using a Binomial Option Pricing model, which is considered to be a Level 3 fair value measurement. The fair value of Public Warrants issued in connection with the Initial Public Offering were initially measured using a Binomial Option Pricing model and at September 30, 2023 and December 31, 2022 are measured based on the listed market price of such warrants, a Level 1 measurement.</div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Binomial Option Pricing model’s primary unobservable input utilized in determining the fair value of the Warrants is the expected volatility as of the IPO date was derived from observable warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents a summary of the changes in the fair value of the Private Placement Warrants, Level 3 liabilities, measured on a recurring basis.</div> <br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 10pt; width: 554.875px; border: 0px; margin: 0px auto; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 421.083px;"></td> <td style="vertical-align: bottom; width: 46.5208px;"></td> <td></td> <td></td> <td></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 8pt;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Warrants</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of January 1, 2022</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"> </td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Initial measurement on May 12, 2022 warrants issued</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,217,500</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in fair value (1)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(804,375</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of June 30, 2022</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2,413,125</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in fair value (1)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(804,375</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of September 30, 2022</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,608,750</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr></table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 10pt; width: 554.875px; border: 0px; margin: 0px auto; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 459.99px;"></td> <td style="vertical-align: bottom; width: 27.1042px;"></td> <td></td> <td></td> <td></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of January 1, 2023</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">804,375</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in fair value (1)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">321,750</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value as of March 3<div style="display:inline;">1</div>, 2023</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,126,125</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value (1)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(482,625</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value as of June 30, 2023</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">643,500</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden94680000">Change</span> in fair value (1)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">482,625</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of September 30, 2023</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,126,125</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr></table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the statements of operations.</div></div></td></tr></table> 106318563 270278722 The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:<div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 59%;"></td> <td style="width: 6%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 6%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 6%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Investments held in Trust Account</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">106,318,563</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">270,278,722</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Public Warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">905,625</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">675,338</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Private Warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,126,125</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">804,375</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr></table> 106318563 270278722 905625 675338 1126125 804375 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides quantitative information regarding Level 3 fair value measurements:</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 73%;"></td> <td style="width: 9%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 8%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Private</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants</div></div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Private</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants</div></div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock Price</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 10.81</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 10.34</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercise Price</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 11.50</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 11.50</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate of interest</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.60</td> <td style="vertical-align: bottom; white-space: nowrap;">%</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.99</td> <td style="vertical-align: bottom; white-space: nowrap;">%</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.50</td> <td style="vertical-align: bottom; white-space: nowrap;">%</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.50</td> <td style="vertical-align: bottom; white-space: nowrap;">%</td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Term</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.5 years</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.8 years</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr></table> 10.81 10.34 11.5 11.5 4.6 3.99 0.5 0.5 1.5 2.8 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents a summary of the changes in the fair value of the Private Placement Warrants, Level 3 liabilities, measured on a recurring basis.</div> <br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 10pt; width: 554.875px; border: 0px; margin: 0px auto; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 421.083px;"></td> <td style="vertical-align: bottom; width: 46.5208px;"></td> <td></td> <td></td> <td></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 8pt;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Warrants</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of January 1, 2022</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"> </td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Initial measurement on May 12, 2022 warrants issued</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,217,500</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in fair value (1)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(804,375</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of June 30, 2022</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2,413,125</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in fair value (1)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(804,375</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of September 30, 2022</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,608,750</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr></table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 10pt; width: 554.875px; border: 0px; margin: 0px auto; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 459.99px;"></td> <td style="vertical-align: bottom; width: 27.1042px;"></td> <td></td> <td></td> <td></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of January 1, 2023</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">804,375</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in fair value (1)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">321,750</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value as of March 3<div style="display:inline;">1</div>, 2023</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,126,125</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value (1)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(482,625</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value as of June 30, 2023</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">643,500</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden94680000">Change</span> in fair value (1)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">482,625</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of September 30, 2023</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,126,125</div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr></table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the statements of operations.</div></div></td></tr></table> 0 3217500 -804375 2413125 -804375 1608750 804375 321750 1126125 -482625 643500 482625 1126125 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 10. SUBSEQUENT EVENTS</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date <div style="letter-spacing: 0px; top: 0px;;display:inline;">that</div> the unaudited condensed financial statements were issued. Based upon this review, other than below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.</div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">On October 10, 2023 and November 9, 2023 the Company made additional draw downs on the Promissory Note (“2023 Note”) of $100,000 </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">each month to fund month extension requirements. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">On October 11, 2023 and November 13, 2023 the Company deposited $100,000 <div style="letter-spacing: 0px; top: 0px;;display:inline;">each month into the Trust Account in order to effect the third and fourth subsequent one month extensions of the Revised Extension Deadline, which extended the deadline to consummate the Business Combination to December 12, 2023. </div> </div></div> 100000 100000 100000 100000 100000 100000 On March 22, 2022, the Company surrendered 718,750 shares of Class B ordinary shares as a result of updated terms of the proposed public offering. All share amounts and related information have been retroactively restated to reflect the surrender. Includes an aggregate of up to 843,750 shares that are subject to forfeiture if the over-allotment option is not exercised in full by the underwriter (see Note 8). On May 12, 2022, the underwriter exercised the full over-allotment option. Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the statements of operations. EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 48 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 155 209 1 true 34 0 false 7 false false R1.htm 1001 - Document - Cover Page Sheet http://www.ivcau.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Condensed Balance Sheets Sheet http://www.ivcau.com/role/CondensedBalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Condensed Statements Of Operations Sheet http://www.ivcau.com/role/CondensedStatementsOfOperations Condensed Statements Of Operations Statements 4 false false R5.htm 1005 - Statement - Condensed Statements Of Operations (Parenthetical) Sheet http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical Condensed Statements Of Operations (Parenthetical) Statements 5 false false R6.htm 1006 - Statement - Condensed Statement Of Changes In Shareholders' Equity (Deficit) Sheet http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit Condensed Statement Of Changes In Shareholders' Equity (Deficit) Statements 6 false false R7.htm 1007 - Statement - Condensed Statements Of Cash Flows Sheet http://www.ivcau.com/role/CondensedStatementsOfCashFlows Condensed Statements Of Cash Flows Statements 7 false false R8.htm 1008 - Disclosure - Description of Organization and Business Operations Sheet http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperations Description of Organization and Business Operations Notes 8 false false R9.htm 1009 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.ivcau.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 1010 - Disclosure - Initial Public Offering Sheet http://www.ivcau.com/role/InitialPublicOffering Initial Public Offering Notes 10 false false R11.htm 1011 - Disclosure - Private Placement Sheet http://www.ivcau.com/role/PrivatePlacement Private Placement Notes 11 false false R12.htm 1012 - Disclosure - Related Party Transactions Sheet http://www.ivcau.com/role/RelatedPartyTransactions Related Party Transactions Notes 12 false false R13.htm 1013 - Disclosure - Commitments and Contingencies Sheet http://www.ivcau.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 13 false false R14.htm 1014 - Disclosure - Warrant Liability Sheet http://www.ivcau.com/role/WarrantLiability Warrant Liability Notes 14 false false R15.htm 1015 - Disclosure - Shareholders' Deficit Sheet http://www.ivcau.com/role/ShareholdersDeficit Shareholders' Deficit Notes 15 false false R16.htm 1016 - Disclosure - Fair Value Measurements Sheet http://www.ivcau.com/role/FairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 1017 - Disclosure - Subsequent Events Sheet http://www.ivcau.com/role/SubsequentEvents Subsequent Events Notes 17 false false R18.htm 1018 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.ivcau.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 1019 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.ivcau.com/role/SummaryOfSignificantAccountingPolicies 19 false false R20.htm 1020 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.ivcau.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.ivcau.com/role/FairValueMeasurements 20 false false R21.htm 1021 - Disclosure - Description of Organization and Business Operations - Additional Information (Details) Sheet http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails Description of Organization and Business Operations - Additional Information (Details) Details 21 false false R22.htm 1022 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 22 false false R23.htm 1023 - Disclosure - Summary of Significant Accounting Policies - Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Share (Details) Sheet http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails Summary of Significant Accounting Policies - Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Share (Details) Details 23 false false R24.htm 1024 - Disclosure - Summary of Significant Accounting Policies - Schedule of Class A Ordinary Shares Subject to Possible Redemption Reflected in Balance Sheet (Details) Sheet http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails Summary of Significant Accounting Policies - Schedule of Class A Ordinary Shares Subject to Possible Redemption Reflected in Balance Sheet (Details) Details 24 false false R25.htm 1025 - Disclosure - Initial Public Offering - Additional Information (Details) Sheet http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails Initial Public Offering - Additional Information (Details) Details 25 false false R26.htm 1026 - Disclosure - Private Placement - Additional Information (Details) Sheet http://www.ivcau.com/role/PrivatePlacementAdditionalInformationDetails Private Placement - Additional Information (Details) Details 26 false false R27.htm 1027 - Disclosure - Related Party Transactions - Additional Information (Details) Sheet http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails Related Party Transactions - Additional Information (Details) Details 27 false false R28.htm 1028 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.ivcau.com/role/CommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 28 false false R29.htm 1029 - Disclosure - Warrant Liability - Additional Information (Details) Sheet http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails Warrant Liability - Additional Information (Details) Details 29 false false R30.htm 1030 - Disclosure - Shareholders' Deficit - Additional Information (Details) Sheet http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails Shareholders' Deficit - Additional Information (Details) Details 30 false false R31.htm 1031 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://www.ivcau.com/role/FairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 31 false false R32.htm 1032 - Disclosure - Fair Value Measurements - Schedule of Company's Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails Fair Value Measurements - Schedule of Company's Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 32 false false R33.htm 1033 - Disclosure - Fair Value Measurements - Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs (Details) Sheet http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails Fair Value Measurements - Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs (Details) Details 33 false false R34.htm 1034 - Disclosure - Fair Value Measurements - Schedule of Change in Fair Value of Private Placement Warrants, Level 3 Liabilities, Measured on a Recurring Basis (Details) Sheet http://www.ivcau.com/role/FairValueMeasurementsScheduleOfChangeInFairValueOfPrivatePlacementWarrantsLevel3LiabilitiesMeasuredOnARecurringBasisDetails Fair Value Measurements - Schedule of Change in Fair Value of Private Placement Warrants, Level 3 Liabilities, Measured on a Recurring Basis (Details) Details 34 false false R35.htm 1035 - Disclosure - Subsequent Events - Additional Information (Details) Sheet http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails Subsequent Events - Additional Information (Details) Details 35 false false All Reports Book All Reports d559923d10q.htm ivca-20230930.xsd ivca-20230930_cal.xml ivca-20230930_def.xml ivca-20230930_lab.xml ivca-20230930_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 53 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d559923d10q.htm": { "nsprefix": "ivca", "nsuri": "http://www.ivcau.com/20230930", "dts": { "inline": { "local": [ "d559923d10q.htm" ] }, "schema": { "local": [ "ivca-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "ivca-20230930_cal.xml" ] }, "definitionLink": { "local": [ "ivca-20230930_def.xml" ] }, "labelLink": { "local": [ "ivca-20230930_lab.xml" ] }, "presentationLink": { "local": [ "ivca-20230930_pre.xml" ] } }, "keyStandard": 139, "keyCustom": 70, "axisStandard": 14, "axisCustom": 0, "memberStandard": 20, "memberCustom": 14, "hidden": { "total": 11, "http://www.ivcau.com/20230930": 2, "http://xbrl.sec.gov/dei/2023": 6, "http://fasb.org/us-gaap/2023": 3 }, "contextCount": 155, "entityCount": 1, "segmentCount": 34, "elementCount": 334, "unitCount": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 378, "http://xbrl.sec.gov/dei/2023": 40 }, "report": { "R1": { "role": "http://www.ivcau.com/role/CoverPage", "longName": "1001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.ivcau.com/role/CondensedBalanceSheets", "longName": "1002 - Statement - Condensed Balance Sheets", "shortName": "Condensed Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:OtherAssetsCurrent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "unique": true } }, "R3": { "role": "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "longName": "1003 - Statement - Condensed Balance Sheets (Parenthetical)", "shortName": "Condensed Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis", "name": "ivca:TemporaryEquitySharesSubjectToPossibleRedemption", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "unique": true } }, "R4": { "role": "http://www.ivcau.com/role/CondensedStatementsOfOperations", "longName": "1004 - Statement - Condensed Statements Of Operations", "shortName": "Condensed Statements Of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "ivca:FormationsCostsAndOperatingExpenses", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "ivca:FormationsCostsAndOperatingExpenses", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical", "longName": "1005 - Statement - Condensed Statements Of Operations (Parenthetical)", "shortName": "Condensed Statements Of Operations (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "P03_22_2022To03_22_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "name": "ivca:FounderSharesSurrenderedDuringPeriod", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true }, "uniqueAnchor": null }, "R6": { "role": "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit", "longName": "1006 - Statement - Condensed Statement Of Changes In Shareholders' Equity (Deficit)", "shortName": "Condensed Statement Of Changes In Shareholders' Equity (Deficit)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "PAsOn12_31_2021", "name": "us-gaap:StockholdersEquity", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "unique": true } }, "R7": { "role": "http://www.ivcau.com/role/CondensedStatementsOfCashFlows", "longName": "1007 - Statement - Condensed Statements Of Cash Flows", "shortName": "Condensed Statements Of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "P07_01_2023To09_30_2023", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:IncreaseDecreaseInOtherOperatingAssets", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "unique": true } }, "R8": { "role": "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperations", "longName": "1008 - Disclosure - Description of Organization and Business Operations", "shortName": "Description of Organization and Business Operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.ivcau.com/role/SummaryOfSignificantAccountingPolicies", "longName": "1009 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.ivcau.com/role/InitialPublicOffering", "longName": "1010 - Disclosure - Initial Public Offering", "shortName": "Initial Public Offering", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "ivca:InitialPublicOfferingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "ivca:InitialPublicOfferingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.ivcau.com/role/PrivatePlacement", "longName": "1011 - Disclosure - Private Placement", "shortName": "Private Placement", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "ivca:PrivatePlacementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "ivca:PrivatePlacementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.ivcau.com/role/RelatedPartyTransactions", "longName": "1012 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.ivcau.com/role/CommitmentsAndContingencies", "longName": "1013 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.ivcau.com/role/WarrantLiability", "longName": "1014 - Disclosure - Warrant Liability", "shortName": "Warrant Liability", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:DerivativesAndFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:DerivativesAndFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.ivcau.com/role/ShareholdersDeficit", "longName": "1015 - Disclosure - Shareholders' Deficit", "shortName": "Shareholders' Deficit", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.ivcau.com/role/FairValueMeasurements", "longName": "1016 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.ivcau.com/role/SubsequentEvents", "longName": "1017 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "1018 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "18", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "1019 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.ivcau.com/role/FairValueMeasurementsTables", "longName": "1020 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "longName": "1021 - Disclosure - Description of Organization and Business Operations - Additional Information (Details)", "shortName": "Description of Organization and Business Operations - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "21", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "dei:EntityIncorporationDateOfIncorporation", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "us-gaap:NatureOfOperations", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "dei:EntityIncorporationDateOfIncorporation", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "us-gaap:NatureOfOperations", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "longName": "1022 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)", "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "22", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:CashFDICInsuredAmount", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "div", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:CashFDICInsuredAmount", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "div", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "longName": "1023 - Disclosure - Summary of Significant Accounting Policies - Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Share (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "23", "firstAnchor": { "contextRef": "P07_01_2023To09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P07_01_2023To09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails", "longName": "1024 - Disclosure - Summary of Significant Accounting Policies - Schedule of Class A Ordinary Shares Subject to Possible Redemption Reflected in Balance Sheet (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Class A Ordinary Shares Subject to Possible Redemption Reflected in Balance Sheet (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:ProceedsFromIssuanceOfCommonStock", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ivca:ReconciledOfCommonStockReflectedInBalanceSheetTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:ProceedsFromIssuanceOfCommonStock", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ivca:ReconciledOfCommonStockReflectedInBalanceSheetTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails", "longName": "1025 - Disclosure - Initial Public Offering - Additional Information (Details)", "shortName": "Initial Public Offering - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "PAsOn09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "ivca:InitialPublicOfferingTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "unique": true } }, "R26": { "role": "http://www.ivcau.com/role/PrivatePlacementAdditionalInformationDetails", "longName": "1026 - Disclosure - Private Placement - Additional Information (Details)", "shortName": "Private Placement - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "P05_12_2022To05_12_2022_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "name": "ivca:ClassOfWarrantsAndRightsIssuedDuringThePeriod", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "div", "us-gaap:NatureOfOperations", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true }, "uniqueAnchor": null }, "R27": { "role": "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "longName": "1027 - Disclosure - Related Party Transactions - Additional Information (Details)", "shortName": "Related Party Transactions - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "P03_01_2022To03_31_2022", "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P03_01_2022To03_31_2022", "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.ivcau.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "longName": "1028 - Disclosure - Commitments and Contingencies - Additional Information (Details)", "shortName": "Commitments and Contingencies - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023_OverAllotmentOptionMemberusgaapSubsidiarySaleOfStockAxis", "name": "ivca:OptionForUnderwritersToPurchaseAdditionalUnitsTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023_OverAllotmentOptionMemberusgaapSubsidiarySaleOfStockAxis", "name": "ivca:OptionForUnderwritersToPurchaseAdditionalUnitsTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails", "longName": "1029 - Disclosure - Warrant Liability - Additional Information (Details)", "shortName": "Warrant Liability - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "ivca:ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023", "name": "ivca:ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails", "longName": "1030 - Disclosure - Shareholders' Deficit - Additional Information (Details)", "shortName": "Shareholders' Deficit - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis", "name": "ivca:StockConversionBasisOnConsummationOfTheInitialBusinessCombination", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "unique": true } }, "R31": { "role": "http://www.ivcau.com/role/FairValueMeasurementsAdditionalInformationDetails", "longName": "1031 - Disclosure - Fair Value Measurements - Additional Information (Details)", "shortName": "Fair Value Measurements - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:AssetsHeldInTrustNoncurrent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023_USTreasurySecuritiesMemberusgaapFairValueByAssetClassAxis", "name": "us-gaap:AssetsHeldInTrustNoncurrent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "unique": true } }, "R32": { "role": "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "longName": "1032 - Disclosure - Fair Value Measurements - Schedule of Company's Liabilities Measured at Fair Value on a Recurring Basis (Details)", "shortName": "Fair Value Measurements - Schedule of Company's Liabilities Measured at Fair Value on a Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "PAsOn09_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_USTreasurySecuritiesMemberusgaapFairValueByAssetClassAxis", "name": "us-gaap:InvestmentsFairValueDisclosure", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_USTreasurySecuritiesMemberusgaapFairValueByAssetClassAxis", "name": "us-gaap:InvestmentsFairValueDisclosure", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails", "longName": "1033 - Disclosure - Fair Value Measurements - Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "PAsOn09_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfChangeInFairValueOfPrivatePlacementWarrantsLevel3LiabilitiesMeasuredOnARecurringBasisDetails", "longName": "1034 - Disclosure - Fair Value Measurements - Schedule of Change in Fair Value of Private Placement Warrants, Level 3 Liabilities, Measured on a Recurring Basis (Details)", "shortName": "Fair Value Measurements - Schedule of Change in Fair Value of Private Placement Warrants, Level 3 Liabilities, Measured on a Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivateWarrantsMemberusgaapClassOfWarrantOrRightAxis", "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivateWarrantsMemberusgaapClassOfWarrantOrRightAxis", "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "unique": true } }, "R35": { "role": "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails", "longName": "1035 - Disclosure - Subsequent Events - Additional Information (Details)", "shortName": "Subsequent Events - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "P08_11_2023To08_11_2023", "name": "us-gaap:PaymentsForRepurchaseOfCommonStock", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "P11_13_2023To11_13_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "name": "us-gaap:PaymentsForRepurchaseOfCommonStock", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d559923d10q.htm", "unique": true } } }, "tag": { "us-gaap_OtherCommitmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsAbstract", "lang": { "en-us": { "role": { "label": "Other Commitments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares", "terseLabel": "Warrant liability", "documentation": "The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date." } } }, "auth_ref": [ "r34" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "terseLabel": "Redeemable Warrants", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r420", "r421", "r424", "r425", "r426", "r427" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Gross", "definitionGuidance": "Long-term debt, gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r15", "r87", "r179" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r431" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfOperations", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted", "verboseLabel": "Diluted net income per ordinary share", "terseLabel": "Diluted net income per ordinary share", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r113", "r128", "r129", "r130", "r131", "r132", "r139", "r143", "r144", "r145", "r146", "r236", "r237", "r287", "r297", "r405" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.ivcau.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r266", "r268" ] }, "us-gaap_WarrantsAndRightsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstanding", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Warrants and Rights Outstanding", "terseLabel": "Warrant liability", "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r17", "r119", "r157", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r225", "r226", "r227", "r248", "r335", "r406", "r430", "r452", "r460", "r461" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r433" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r255", "r267" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r255", "r267" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r255", "r267" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument face value", "verboseLabel": "Debt instrument face amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r54", "r55", "r175", "r256", "r409", "r410" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Ordinary Shares", "verboseLabel": "Common Stock", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r420", "r421", "r422", "r424", "r425", "r426", "r427", "r443", "r444", "r456", "r471", "r473" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Cash, FDIC Insured Amount", "terseLabel": "Cash, FDIC insured amount", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Shareholders' Deficit", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r67", "r88", "r295", "r418", "r442", "r448", "r458" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r255", "r267" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS' DEFICIT" } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://www.ivcau.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails", "http://www.ivcau.com/role/PrivatePlacementAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfOperations", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares outstanding, diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r138", "r145" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Stock shares issued during the period, value", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r8", "r61", "r62", "r82", "r314", "r381", "r395", "r429" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets", "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit", "http://www.ivcau.com/role/CondensedStatementsOfOperations", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r123", "r124", "r125", "r147", "r274", "r304", "r326", "r329", "r330", "r331", "r332", "r333", "r334", "r337", "r340", "r341", "r342", "r343", "r344", "r346", "r347", "r348", "r349", "r351", "r352", "r353", "r354", "r355", "r357", "r360", "r361", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r381", "r423" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Asset Class [Domain]", "documentation": "Class of asset." } } }, "auth_ref": [ "r11" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_OverAllotmentOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OverAllotmentOptionMember", "presentation": [ "http://www.ivcau.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Over-Allotment Option [Member]", "terseLabel": "Over-Allotment Option", "documentation": "Right given to the underwriter to sell additional shares over the initial allotment." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfOperations", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares outstanding, basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r136", "r145" ] }, "us-gaap_ProceedsFromNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromNotesPayable", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Notes Payable", "terseLabel": "Proceeds from promissory note \u2013 related party", "verboseLabel": "Proceeds from notes payable", "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r22" ] }, "us-gaap_USTreasurySecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "USTreasurySecuritiesMember", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "US Treasury Securities [Member]", "definitionGuidance": "U.S. Treasury Securities Money Market Fund", "terseLabel": "Investments held in Trust Account - U.S. Treasury Securities Money Market Fund", "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)." } } }, "auth_ref": [ "r404", "r412", "r414", "r468" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Allocation of net income, as adjusted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r114", "r128", "r129", "r130", "r131", "r136", "r137", "r142", "r145", "r150", "r152", "r154", "r156", "r407" ] }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleList", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfChangeInFairValueOfPrivatePlacementWarrantsLevel3LiabilitiesMeasuredOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Net Derivative Asset (Liability), Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value using unobservable input (level 3)." } } }, "auth_ref": [ "r244" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r432" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Price Volatility [Member]", "terseLabel": "Volatility", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r457" ] }, "us-gaap_MeasurementInputSharePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputSharePriceMember", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Share Price [Member]", "terseLabel": "Stock Price", "documentation": "Measurement input using share price of saleable stock." } } }, "auth_ref": [ "r457" ] }, "ivca_ClassaOrdinaryShareAndRedeemableWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ClassaOrdinaryShareAndRedeemableWarrantMember", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "ClassA Ordinary Share And Redeemable Warrant [Member]", "terseLabel": "Class A Ordinary Share and Redeemable Warrant", "documentation": "ClassA Ordinary Share And Redeemable Warrant Member." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders' Deficit" } } }, "auth_ref": [] }, "ivca_SponsorMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "SponsorMember", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/PrivatePlacementAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails", "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Sponsor [Member]", "verboseLabel": "Sponsor", "documentation": "Sponsor." } } }, "auth_ref": [] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Risk Free Interest Rate [Member]", "terseLabel": "Risk-free Rate of Interest", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r457" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfOperations": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 }, "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows", "http://www.ivcau.com/role/CondensedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Investment Income, Interest", "terseLabel": "Interest earned on investments held in Trust Account", "negatedLabel": "Interest earned on investments held in Trust Account", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r69", "r151" ] }, "ivca_WarrantsLiabilityPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "WarrantsLiabilityPolicyTextBlock", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Warrants Liability", "documentation": "Warrants liability." } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets", "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit", "http://www.ivcau.com/role/CondensedStatementsOfOperations", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "terseLabel": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r123", "r124", "r125", "r147", "r274", "r304", "r326", "r329", "r330", "r331", "r332", "r333", "r334", "r337", "r340", "r341", "r342", "r343", "r344", "r346", "r347", "r348", "r349", "r351", "r352", "r353", "r354", "r355", "r357", "r360", "r361", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r381", "r423" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Domain]", "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [] }, "ivca_CommonStockSubjectToPossibleRedemptionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "CommonStockSubjectToPossibleRedemptionPolicyTextBlock", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Common Stock Subject to Possible Redemption [Policy Text Block]", "terseLabel": "Class A Ordinary Shares Subject to Possible Redemption", "documentation": "Common stock subject to possible redemption." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "auth_ref": [] }, "ivca_UseOfCreditRiskPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "UseOfCreditRiskPolicyTextBlock", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Credit Risk [Policy Text Block]", "terseLabel": "Use of Credit Risk", "documentation": "Use of credit risk." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.ivcau.com/role/ShareholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "Shareholders' Deficit", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r79", "r118", "r181", "r183", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r195", "r198", "r234", "r384", "r386", "r399" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r86", "r101", "r119", "r150", "r153", "r155", "r157", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r224", "r226", "r248", "r288", "r350", "r418", "r430", "r452", "r453", "r460" ] }, "ivca_EmergingGrowthCompanyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "EmergingGrowthCompanyPolicyTextBlock", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Emerging Growth Company Policy [Text Block]", "terseLabel": "Emerging Growth Company", "documentation": "Emerging growth company." } } }, "auth_ref": [] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Value, Issued", "terseLabel": "Preference shares, $0.0001 par value; 1,000,000 shares authorized; none outstanding", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r61", "r291", "r418" ] }, "ivca_SummaryOfSignificantAccountingPoliciesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "SummaryOfSignificantAccountingPoliciesTable", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Summary Of Significant Accounting Policies [Table]", "terseLabel": "Summary Of Significant Accounting Policies [Table]", "documentation": "Summary of significant accounting policies." } } }, "auth_ref": [] }, "ivca_ReconciledOfCommonStockReflectedInBalanceSheetTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ReconciledOfCommonStockReflectedInBalanceSheetTableTextBlock", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Reconciled Of Common Stock Reflected In Balance Sheet [Table Text Block]", "terseLabel": "Schedule of Class A Ordinary Shares Subject to Possible Redemption Reflected in Balance Sheet", "documentation": "Reconciled of common stock reflected in balance sheet." } } }, "auth_ref": [] }, "us-gaap_IPOMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IPOMember", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "IPO [Member]", "terseLabel": "Initial Public Offering", "documentation": "First sale of stock by a private company to the public." } } }, "auth_ref": [] }, "ivca_OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Offering Costs Associated with the Initial Public Offering [Policy Text Block]", "terseLabel": "Offering Costs Associated with the Initial Public Offering", "documentation": "Offering costs associated with the initial public offering." } } }, "auth_ref": [] }, "ivca_InvestmentOfCashIntoTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "InvestmentOfCashIntoTrustAccount", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Investment Of Cash Into Trust Account", "negatedLabel": "Investment of cash into Trust Account", "documentation": "Investment of cash into trust account." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r432" ] }, "ivca_FounderSharesSurrenderedDuringPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "FounderSharesSurrenderedDuringPeriod", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Founder Shares Surrendered During Period", "terseLabel": "Founder shares surrendered during period", "documentation": "Founder shares surrendered during period." } } }, "auth_ref": [] }, "ivca_CommonStockSubjectToForfeiture": { "xbrltype": "sharesItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "CommonStockSubjectToForfeiture", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock Subject To Forfeiture", "terseLabel": "Shares subject to forfeiture", "documentation": "Common stock subject to forfeiture." } } }, "auth_ref": [] }, "ivca_TemporaryEquitySharesSubjectToPossibleRedemption": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "TemporaryEquitySharesSubjectToPossibleRedemption", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Temporary Equity Shares Subject to Possible Redemption", "terseLabel": "Shares subject to possible redemption", "documentation": "Temporary Equity Shares Subject to Possible Redemption" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilityMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityMeasurementInput", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Liability, Measurement Input", "documentation": "Value of input used to measure derivative liability." } } }, "auth_ref": [ "r243" ] }, "ivca_PrivatePlacementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PrivatePlacementTextBlock", "presentation": [ "http://www.ivcau.com/role/PrivatePlacement" ], "lang": { "en-us": { "role": { "label": "Private Placement [Text Block]", "terseLabel": "Private Placement", "documentation": "Private placement." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets", "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit", "http://www.ivcau.com/role/CondensedStatementsOfOperations", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.ivcau.com/role/CoverPage", "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails", "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r94", "r102", "r103", "r104", "r119", "r139", "r140", "r143", "r145", "r148", "r149", "r157", "r166", "r168", "r169", "r170", "r173", "r174", "r182", "r183", "r186", "r189", "r196", "r248", "r306", "r307", "r308", "r309", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r326", "r337", "r359", "r381", "r394", "r395", "r396", "r397", "r398", "r438", "r441", "r446" ] }, "ivca_AdjustmentsToAdditionalPaidInCapitalAccretionOfClassAOrdinarySharesSubjectToPossibleRedemption": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "AdjustmentsToAdditionalPaidInCapitalAccretionOfClassAOrdinarySharesSubjectToPossibleRedemption", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Adjustments to Additional Paid in Capital Accretion of Class A Ordinary Shares Subject to Possible Redemption", "terseLabel": "Accretion of Class A ordinary shares subject to possible redemption", "documentation": "Adjustments to additional paid in capital accretion of class A ordinary shares subject to possible redemption." } } }, "auth_ref": [] }, "us-gaap_DeferredOfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredOfferingCosts", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Offering Costs", "verboseLabel": "Offering costs", "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period." } } }, "auth_ref": [ "r449" ] }, "ivca_FormationsCostsAndOperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "FormationsCostsAndOperatingExpenses", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Formations Costs And Operating Expenses", "terseLabel": "Formation costs and operating expenses", "documentation": "Formations costs and operating expenses." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r436" ] }, "ivca_AdjustmentsToAdditionalPaidInCapitalExcessCashReceivedOverFvForPrivatePlacementWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "AdjustmentsToAdditionalPaidInCapitalExcessCashReceivedOverFvForPrivatePlacementWarrants", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Adjustments to Additional Paid in Capital, Excess Cash Received over FV for Private Placement Warrants", "terseLabel": "Excess cash received over fair value for private placement warrants", "documentation": "Adjustments to additional paid in capital, excess cash received over FV for private placement warrants." } } }, "auth_ref": [] }, "ivca_ProceedsFromSaleOfPrivatePlacementsWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ProceedsFromSaleOfPrivatePlacementsWarrants", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds From Sale Of Private Placements Warrants", "terseLabel": "Proceeds from sale of Private Placements Warrants", "documentation": "Proceeds from sale of private placements warrants." } } }, "auth_ref": [] }, "ivca_AdvanceFromSponsor": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "AdvanceFromSponsor", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Advance From Sponsor", "terseLabel": "Advances from Sponsor", "documentation": "Advance from sponsor." } } }, "auth_ref": [] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Share Price", "terseLabel": "Share price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r432" ] }, "ivca_AccretionOfOrdinarySharesSubjectToPossibleRedemption": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "AccretionOfOrdinarySharesSubjectToPossibleRedemption", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accretion of Ordinary Shares Subject to Possible Redemption", "verboseLabel": "Accretion of Class A ordinary shares subject to possible redemption", "documentation": "Accretion of ordinary shares subject to possible redemption." } } }, "auth_ref": [] }, "ivca_DeferredOfferingCostsPaidThroughDueToSponsor": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "DeferredOfferingCostsPaidThroughDueToSponsor", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Deferred Offering Costs Paid Through Due To Sponsor", "terseLabel": "Deferred offering costs paid through Due to Sponsor", "documentation": "Deferred offering costs paid through Due to Sponsor." } } }, "auth_ref": [] }, "us-gaap_InvestmentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Investments, Fair Value Disclosure", "terseLabel": "Investments held in Trust Account", "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method." } } }, "auth_ref": [ "r239" ] }, "ivca_DescriptionOfOrganizationAndBusinessOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "DescriptionOfOrganizationAndBusinessOperationsAbstract", "lang": { "en-us": { "role": { "label": "Description Of Organization And Business Operations [Abstract]", "documentation": "Description of organization and business operations." } } }, "auth_ref": [] }, "ivca_IncreaseDecreaseInDueToSponsor": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "IncreaseDecreaseInDueToSponsor", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase Decrease In Due To Sponsor", "negatedLabel": "Due to Sponsor", "documentation": "Increase (decrease) in due to sponsor." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "ivca_InitialPublicOfferingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "InitialPublicOfferingTextBlock", "presentation": [ "http://www.ivcau.com/role/InitialPublicOffering" ], "lang": { "en-us": { "role": { "label": "Initial Public Offering [Text Block]", "terseLabel": "Initial Public Offering", "documentation": "Initial public offering." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ivca_PrivatePlacementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PrivatePlacementAbstract", "lang": { "en-us": { "role": { "label": "Private Placement [Abstract]", "documentation": "Private placement." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "ivca_InvestmentsHeldInTrustAccountPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "InvestmentsHeldInTrustAccountPolicyTextBlock", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Investments Held in Trust Account [Policy Text Block]", "terseLabel": "Investments Held in Trust Account", "documentation": "Investments held in trust account." } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails": { "parentTag": "ivca_CommonStockSubjectToPossibleRedemption", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Accretion to Redemption Value, Adjustment", "terseLabel": "Accretion of carrying value to redemption value", "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders." } } }, "auth_ref": [] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Price Per Share", "terseLabel": "Shares issued, price per share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Share", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r447" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Issued Accounting Standards", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule Of Stock By Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r36", "r37", "r38", "r39", "r40", "r41", "r42", "r80", "r81", "r82", "r102", "r103", "r104", "r148", "r182", "r183", "r184", "r186", "r189", "r194", "r196", "r306", "r307", "r308", "r309", "r411", "r438", "r441" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used in) provided by financing activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r115" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cashflow from Financing Activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r115" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cashflow from Investing Activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r72", "r73", "r74" ] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cashflow from Operating Activities:" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Issuance of Class B ordinary shares to Sponsor", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Issuance of Class B ordinary shares to Sponsor, shares", "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r61", "r182" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets", "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/PrivatePlacementAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails", "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Related Party [Domain]", "terseLabel": "Related Party", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r206", "r261", "r262", "r330", "r331", "r332", "r333", "r334", "r355", "r357", "r388" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r59", "r92" ] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassAMember", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets", "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementsOfOperations", "http://www.ivcau.com/role/CoverPage", "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Common Class A", "terseLabel": "Class A Ordinary Shares", "documentation": "Classification of common stock representing ownership interest in a corporation." } } }, "auth_ref": [ "r473" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Assets, Noncurrent", "terseLabel": "Other assets \u2013 non-current", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r100" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r61", "r337" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r61", "r337", "r356", "r473", "r474" ] }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsNoteDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Warrants and Rights Note Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails", "http://www.ivcau.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r239", "r240", "r245" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfOperations", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic", "verboseLabel": "Basic net income per ordinary share", "terseLabel": "Basic net income per ordinary share", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r113", "r128", "r129", "r130", "r131", "r132", "r136", "r139", "r143", "r144", "r145", "r146", "r236", "r237", "r287", "r297", "r405" ] }, "us-gaap_AssetsFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosureAbstract", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "auth_ref": [] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Non-cash investing and financing activities:" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r10" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value per share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r61", "r182" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "terseLabel": "Commitments and Contingencies (Note 6)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r20", "r58", "r289", "r336" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r10" ] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt", "terseLabel": "Loans outstanding", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r15", "r87", "r177", "r180", "r409", "r410", "r469" ] }, "us-gaap_FairValueAdjustmentOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAdjustmentOfWarrants", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfOperations": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0, "order": 3.0 }, "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows", "http://www.ivcau.com/role/CondensedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of warrant liability", "verboseLabel": "Change in fair value of warrant liability", "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability." } } }, "auth_ref": [ "r0", "r4" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r75", "r117" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r64", "r82", "r294", "r302", "r303", "r310", "r338", "r418" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodStartLabel": "Cash at the beginning of the period", "periodEndLabel": "Cash at the end of the period", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r25", "r72", "r116" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_AdministrativeFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdministrativeFeesExpense", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Administrative Fees Expense", "terseLabel": "Office space, utilities and secretarial and administrative services", "documentation": "Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost." } } }, "auth_ref": [ "r56", "r357", "r472" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid." } } }, "auth_ref": [ "r3" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net Change in Cash", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r72" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r211", "r212", "r213", "r314", "r443", "r444", "r445", "r456", "r473" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Stock shares issued during the period, shares", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r8", "r61", "r62", "r82", "r306", "r381", "r395" ] }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityRedemptionPricePerShare", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Redemption Price Per Share", "verboseLabel": "Temporary equity, redemption price per share", "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r14", "r35" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfChangeInFairValueOfPrivatePlacementWarrantsLevel3LiabilitiesMeasuredOnARecurringBasisDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails", "http://www.ivcau.com/role/FairValueMeasurementsTables", "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails", "http://www.ivcau.com/role/PrivatePlacementAdditionalInformationDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "terseLabel": "Class of Warrant or Right", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r43" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash equivalents", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r439", "r470" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r241" ] }, "us-gaap_FairValueInputsLevel12And3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel12And3Member", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfChangeInFairValueOfPrivatePlacementWarrantsLevel3LiabilitiesMeasuredOnARecurringBasisDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1, Level 2, and Level 3", "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3)." } } }, "auth_ref": [ "r455" ] }, "dei_EntityIncorporationDateOfIncorporation": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationDateOfIncorporation", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, Date of Incorporation", "terseLabel": "Entity incorporation, date of incorporation", "documentation": "Date when an entity was incorporated" } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Change in Fair Value of Private Placement Warrants, Level 3 Liabilities, Measured on a Recurring Basis", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r11", "r53" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfChangeInFairValueOfPrivatePlacementWarrantsLevel3LiabilitiesMeasuredOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3." } } }, "auth_ref": [ "r11", "r53" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Shares no longer subject to forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r8", "r61", "r62", "r82" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfChangeInFairValueOfPrivatePlacementWarrantsLevel3LiabilitiesMeasuredOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r178", "r200", "r205", "r240", "r269", "r412", "r413", "r414" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://www.ivcau.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails", "http://www.ivcau.com/role/PrivatePlacementAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockPricePerShare", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale of stock price per share", "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction." } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "terseLabel": "Additional Paid-in Capital", "verboseLabel": "Equity Components", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r8", "r21", "r95", "r110", "r111", "r112", "r123", "r124", "r125", "r127", "r133", "r135", "r147", "r158", "r159", "r198", "r211", "r212", "r213", "r221", "r222", "r228", "r229", "r230", "r231", "r232", "r233", "r235", "r249", "r250", "r251", "r252", "r253", "r254", "r257", "r299", "r300", "r301", "r314", "r381" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfChangeInFairValueOfPrivatePlacementWarrantsLevel3LiabilitiesMeasuredOnARecurringBasisDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r178", "r200", "r201", "r202", "r203", "r204", "r205", "r240", "r271", "r409", "r410", "r412", "r413", "r414" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r95", "r123", "r124", "r125", "r127", "r133", "r135", "r158", "r159", "r211", "r212", "r213", "r221", "r222", "r228", "r230", "r231", "r233", "r235", "r299", "r301", "r314", "r473" ] }, "us-gaap_ClassOfWarrantOrRightTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightTable", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Table]", "terseLabel": "Class Of Warrant Or Right [Table]", "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r43" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfChangeInFairValueOfPrivatePlacementWarrantsLevel3LiabilitiesMeasuredOnARecurringBasisDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails", "http://www.ivcau.com/role/FairValueMeasurementsTables", "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails", "http://www.ivcau.com/role/PrivatePlacementAdditionalInformationDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Domain]", "terseLabel": "Class of Warrant or Right", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Liabilities, Current", "verboseLabel": "Accrued expenses", "terseLabel": "Accrued expense", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r18" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "terseLabel": "Equity Component", "verboseLabel": "Equity Component", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r8", "r95", "r110", "r111", "r112", "r123", "r124", "r125", "r127", "r133", "r135", "r147", "r158", "r159", "r198", "r211", "r212", "r213", "r221", "r222", "r228", "r229", "r230", "r231", "r232", "r233", "r235", "r249", "r250", "r251", "r252", "r253", "r254", "r257", "r299", "r300", "r301", "r314", "r381" ] }, "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]", "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share." } } }, "auth_ref": [ "r29", "r32", "r139", "r140", "r143" ] }, "us-gaap_MeasurementInputExercisePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExercisePriceMember", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Exercise Price [Member]", "terseLabel": "Exercise Price", "documentation": "Measurement input using agreed upon price for exchange of underlying asset." } } }, "auth_ref": [ "r457" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Income Per Ordinary Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r30", "r31" ] }, "us-gaap_MeasurementInputExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExpectedTermMember", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Expected Term [Member]", "terseLabel": "Term", "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date." } } }, "auth_ref": [ "r457" ] }, "us-gaap_EarningsPerShareDilutedLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedLineItems", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r139", "r140", "r143" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets", "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/PrivatePlacementAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails", "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Related Party [Axis]", "terseLabel": "Related Party", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r206", "r261", "r262", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r330", "r331", "r332", "r333", "r334", "r355", "r357", "r388", "r459" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares, issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r62" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails": { "parentTag": "ivca_CommonStockSubjectToPossibleRedemption", "weight": -1.0, "order": 1.0 }, "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows", "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Payments to Redeeming Shareholders", "verboseLabel": "Payments for repurchase of common stock", "negatedTerseLabel": "Shares redeemed in August 2023", "terseLabel": "Cash deposited Into Trust Account", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r24" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common Stock, Value, Issued", "terseLabel": "Common stock", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r62", "r292", "r418" ] }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpenseAbstract", "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income:" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r62", "r337" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating Income (Loss)", "totalLabel": "Loss from operations", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r150", "r152", "r154", "r156", "r407" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares, outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r8", "r62", "r337", "r356", "r473", "r474" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails": { "parentTag": "ivca_CommonStockSubjectToPossibleRedemption", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Common Stock", "verboseLabel": "Gross Proceeds", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r2" ] }, "us-gaap_NotesPayableCurrentRelatedPartyTypeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableCurrentRelatedPartyTypeExtensibleEnumeration", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Notes Payable, Current, Related Party, Type [Extensible Enumeration]", "documentation": "Indicates type of related party for notes payable classified as current." } } }, "auth_ref": [ "r459" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r109", "r215", "r216", "r217", "r218", "r219", "r220", "r305" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value per share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r62" ] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance or Sale of Equity", "verboseLabel": "Proceeds from Sale of Units, net of underwriting discounts paid", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r2", "r306" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceInitialPublicOffering", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Restricted cash received in advance related to the Initial Public Offering", "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public." } } }, "auth_ref": [ "r2" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesSubscribedButUnissued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesSubscribedButUnissued", "presentation": [ "http://www.ivcau.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Subscribed but Unissued", "terseLabel": "Common stock shares subscribed but unissued", "documentation": "Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds." } } }, "auth_ref": [ "r62" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid in capital", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r63" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense)", "totalLabel": "Other income", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r70" ] }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfPrivatePlacement", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Proceeds from issuance of private placement", "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r238", "r247" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash used in operating activities:" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfChangeInFairValueOfPrivatePlacementWarrantsLevel3LiabilitiesMeasuredOnARecurringBasisDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r178", "r200", "r201", "r202", "r203", "r204", "r205", "r269", "r270", "r271", "r409", "r410", "r412", "r413", "r414" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsOfStockIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfStockIssuanceCosts", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments of Stock Issuance Costs", "negatedLabel": "Payment of offering costs", "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security." } } }, "auth_ref": [ "r23" ] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r238" ] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "ivca_SummaryOfSignificantAccountingPoliciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "SummaryOfSignificantAccountingPoliciesLineItems", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Summary Of Significant Accounting Policies [Line Items]", "terseLabel": "Summary Of Significant Accounting Policies [Line Items]", "documentation": "Summary of significant accounting policies." } } }, "auth_ref": [] }, "ivca_ClassOfWarrantsAndRightsIssuedPricePerWarrant": { "xbrltype": "perShareItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ClassOfWarrantsAndRightsIssuedPricePerWarrant", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/PrivatePlacementAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class Of Warrants And Rights Issued Price Per Warrant", "terseLabel": "Class of warrants and rights issued price per warrant", "documentation": "Class of warrants and rights issued price per warrant." } } }, "auth_ref": [] }, "ivca_PercentageOfFairMarketValueOfSharesRepurchased": { "xbrltype": "percentItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PercentageOfFairMarketValueOfSharesRepurchased", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Percentage of Fair Market Value of Shares Repurchased", "documentation": "Percentage of fair market value of shares repurchased." } } }, "auth_ref": [] }, "ivca_IssuanceCostsRelatedToClassCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "IssuanceCostsRelatedToClassCommonStock", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails": { "parentTag": "ivca_CommonStockSubjectToPossibleRedemption", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "Issuance Costs Related To Class Common Stock", "negatedLabel": "Total stock issuance costs", "documentation": "Issuance costs related to class common stock." } } }, "auth_ref": [] }, "ivca_InitialPublicOfferingTable": { "xbrltype": "stringItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "InitialPublicOfferingTable", "presentation": [ "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Initial Public Offering [Table]", "terseLabel": "Initial Public Offering [Table]", "documentation": "Initial public offering." } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireRestrictedInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireRestrictedInvestments", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Restricted Investments", "negatedLabel": "Cash deposited in Trust Account", "documentation": "The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions." } } }, "auth_ref": [ "r71" ] }, "ivca_PublicWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PublicWarrantsMember", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Public Warrants [Member]", "terseLabel": "Public Warrant", "documentation": "Public warrants." } } }, "auth_ref": [] }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Series of Individually Immaterial Business Acquisitions [Member]", "terseLabel": "Business Combinations", "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period." } } }, "auth_ref": [ "r46" ] }, "ivca_InitialPublicOfferingLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "InitialPublicOfferingLineItems", "presentation": [ "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Initial Public Offering [Line Items]", "terseLabel": "Initial Public Offering [Line Items]", "documentation": "Initial Public Offering." } } }, "auth_ref": [] }, "ivca_PriorUponSuchConsummationOfBusinessCombinationTangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PriorUponSuchConsummationOfBusinessCombinationTangibleAssets", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Prior Upon Such Consummation Of Business Combination Tangible Assets", "terseLabel": "Prior upon such consummation of business combination tangible assets", "documentation": "Prior upon such consummation of business combination tangible assets." } } }, "auth_ref": [] }, "ivca_FairMarketValueInTrustAccountPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "FairMarketValueInTrustAccountPercentage", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Fair Market Value In Trust Account Percentage", "terseLabel": "Fair market value in trust account, percentage", "documentation": "Fair market value in trust account percentage." } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Liabilities, Current", "terseLabel": "Due to Sponsor", "verboseLabel": "Due to sponsor", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r18", "r418" ] }, "ivca_PercentageOfExciseTax": { "xbrltype": "percentItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PercentageOfExciseTax", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Percentage of Excise Tax", "documentation": "Percentage of\u00a0excise\u00a0tax." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r3" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of voting interests acquired", "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination." } } }, "auth_ref": [ "r45" ] }, "ivca_RestrictedInvestmentsTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "RestrictedInvestmentsTerm", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Investments Term", "terseLabel": "Restricted investments term", "documentation": "Restricted investments term." } } }, "auth_ref": [] }, "ivca_ClassOfWarrantsAndRightsIssuedDuringThePeriod": { "xbrltype": "sharesItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ClassOfWarrantsAndRightsIssuedDuringThePeriod", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/PrivatePlacementAdditionalInformationDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class Of Warrants And Rights Issued During The Period", "terseLabel": "Class of warrants and rights issued during the period", "documentation": "Class of warrants and rights issued during the period." } } }, "auth_ref": [] }, "ivca_RedemptionOfSharesForProRataPortionOfAmountInTrustAccount": { "xbrltype": "perShareItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "RedemptionOfSharesForProRataPortionOfAmountInTrustAccount", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Redemption Of Shares For Pro Rata Portion Of Amount In Trust Account", "terseLabel": "Redemption of shares for pro rata portion of amount in trust account", "documentation": "Redemption of shares for pro rata portion of amount in trust account." } } }, "auth_ref": [] }, "ivca_InterestToPayDissolutionExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "InterestToPayDissolutionExpenses", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Interest To Pay Dissolution Expenses", "terseLabel": "Interest to pay dissolution expenses", "documentation": "Interest to pay dissolution expenses." } } }, "auth_ref": [] }, "ivca_WorkingCapitalEarningsDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "WorkingCapitalEarningsDeficit", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Working Capital Earnings Deficit", "terseLabel": "Working capital", "documentation": "Working capital earnings (deficit)." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r44", "r46", "r223", "r415", "r416" ] }, "ivca_InceptionDateForContributionToTheTrustAccount": { "xbrltype": "dateItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "InceptionDateForContributionToTheTrustAccount", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Inception Date For Contribution To The Trust Account", "verboseLabel": "Inception date for contribution to the trust account", "definitionGuidance": "inception date for contribution to the trust account", "documentation": "Inception date for contribution to the trust account." } } }, "auth_ref": [] }, "us-gaap_TemporaryEquitySharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquitySharesOutstanding", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Shares Outstanding", "definitionGuidance": "Temporary equity, shares outstanding", "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r60" ] }, "ivca_PerShareValueOfRestrictedInvestments": { "xbrltype": "perShareItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PerShareValueOfRestrictedInvestments", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Per Share Value Of Restricted Investments", "terseLabel": "Per share value of restricted investments", "documentation": "Per share value of restricted investments." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r255", "r267" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]", "terseLabel": "Numerator:" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r223", "r415", "r416" ] }, "ivca_NumberOfContributionsToTheTrustAccount": { "xbrltype": "integerItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "NumberOfContributionsToTheTrustAccount", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number Of Contributions To The Trust Account", "terseLabel": "Number of contributions to the trust account", "documentation": "Number of contributions to the trust account." } } }, "auth_ref": [] }, "ivca_EndDateForContributionToTheTrustAccount": { "xbrltype": "dateItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "EndDateForContributionToTheTrustAccount", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "End Date For Contribution To The Trust Account", "verboseLabel": "End date for contribution to the trust account", "terseLabel": "End date for contribution to the trust account", "documentation": "End date for contribution to the trust account." } } }, "auth_ref": [] }, "ivca_AggregateCommitmentToContributeToTheTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "AggregateCommitmentToContributeToTheTrustAccount", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Commitment To Contribute To The Trust Account", "verboseLabel": "Aggregate commitment to contribute to the trust account", "documentation": "Aggregate commitment to contribute to the trust account." } } }, "auth_ref": [] }, "ivca_TemporaryEquitySharesRedeemable": { "xbrltype": "sharesItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "TemporaryEquitySharesRedeemable", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Temporary Equity Shares Redeemable", "verboseLabel": "Temporary equity shares redeemable", "documentation": "Temporary equity shares redeemable." } } }, "auth_ref": [] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Assets, Current", "terseLabel": "Other assets \u2013 current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r105", "r418" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Company's Liabilities Measured at Fair Value on a Recurring Basis", "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r51", "r85" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets", "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r25", "r99", "r403" ] }, "ivca_AgreementToContributeToTheTrustAccountMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "AgreementToContributeToTheTrustAccountMember", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Agreement To Contribute To The Trust Account [Member]", "terseLabel": "Agreement To Contribute To The Trust Account", "documentation": "Agreement to contribute to the trust account." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r26" ] }, "ivca_CommitmentToContributeToTheTrustAccountPerMonth": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "CommitmentToContributeToTheTrustAccountPerMonth", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Commitment To Contribute To The Trust Account Per Month", "verboseLabel": "Commitment to contribute to the trust account per month", "documentation": "Commitment to contribute to the trust account per month." } } }, "auth_ref": [] }, "us-gaap_DerivativesAndFairValueTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesAndFairValueTextBlock", "presentation": [ "http://www.ivcau.com/role/WarrantLiability" ], "lang": { "en-us": { "role": { "label": "Derivatives and Fair Value [Text Block]", "terseLabel": "Warrant Liability", "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities." } } }, "auth_ref": [ "r83", "r84" ] }, "ivca_CommitmentToContributeToTheTrustAccountPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "CommitmentToContributeToTheTrustAccountPerShare", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Commitment To Contribute To The Trust Account Per Share", "terseLabel": "Commitment to contribute to the trust account per share", "documentation": "Commitment to contribute to the trust account per share." } } }, "auth_ref": [] }, "ivca_ProposedOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ProposedOfferingMember", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Proposed Offering [Member]", "terseLabel": "Proposed Offering", "documentation": "Proposed offering." } } }, "auth_ref": [] }, "ivca_PrivatePlacementWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PrivatePlacementWarrantsMember", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/PrivatePlacementAdditionalInformationDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants", "documentation": "Private placement warrants." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockLineItems", "presentation": [ "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Line Items]", "terseLabel": "Class Of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r102", "r103", "r104", "r148", "r182", "r183", "r184", "r186", "r189", "r194", "r196", "r306", "r307", "r308", "r309", "r411", "r438", "r441" ] }, "ivca_CommonStockSubjectToPossibleRedemption": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "CommonStockSubjectToPossibleRedemption", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "Common stock subject to possible redemption", "totalLabel": "Class A ordinary shares subject to possible redemption", "documentation": "Common stock subject to possible redemption." } } }, "auth_ref": [] }, "ivca_AdjustmentsToAdditionalPaidInCapitalProceedsAllocatedToPublicWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "AdjustmentsToAdditionalPaidInCapitalProceedsAllocatedToPublicWarrants", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails": { "parentTag": "ivca_CommonStockSubjectToPossibleRedemption", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionReflectedInBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "Adjustments To Additional Paid In Capital Proceeds Allocated To Public Warrants", "negatedLabel": "Proceeds allocated to Public Warrants", "documentation": "Adjustments to additional paid in capital proceeds allocated to public warrants." } } }, "auth_ref": [] }, "ivca_EarningsPerSharesBasicAndDilutedOtherDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "EarningsPerSharesBasicAndDilutedOtherDisclosuresAbstract", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "lang": { "en-us": { "role": { "label": "Earnings Per Shares Basic And Diluted Other Disclosures Abstract", "terseLabel": "Denominator", "documentation": "Earnings per shares basic and diluted other disclosures." } } }, "auth_ref": [] }, "ivca_ExpirationOfWarrantsFromConsummationOfBusinessCombinationOrEarlierUponRedemptionOrLiquidation": { "xbrltype": "durationItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ExpirationOfWarrantsFromConsummationOfBusinessCombinationOrEarlierUponRedemptionOrLiquidation", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Expiration Of Warrants From Consummation Of Business Combination Or Earlier Upon Redemption Or Liquidation", "terseLabel": "Expiration of warrants from consummation of business combination or earlier upon redemption or liquidation", "documentation": "Expiration of warrants from consummation of business combination or earlier upon redemption or liquidation." } } }, "auth_ref": [] }, "ivca_MinimumNoticePeriodForRedemptionOfWarrants": { "xbrltype": "durationItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "MinimumNoticePeriodForRedemptionOfWarrants", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Minimum Notice Period For Redemption Of Warrants", "terseLabel": "Minimum notice period for redemption of warrants", "documentation": "Minimum notice period for redemption of warrants." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsTable", "presentation": [ "http://www.ivcau.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Table]", "terseLabel": "Other Commitments [Table]", "documentation": "Disclosure of information about obligations resulting from other commitments." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "ivca_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTriggerPrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTriggerPrice", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class Of Warrant Or Right Redemption Of Warrants Or Rights Stock Price Trigger Price", "terseLabel": "Stock price trigger for redemption of public warrants", "documentation": "Class of warrant or right redemption of warrants or rights stock price trigger price." } } }, "auth_ref": [] }, "ivca_PeriodToFileRegistrationStatementAfterBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PeriodToFileRegistrationStatementAfterBusinessCombination", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Period To File Registration Statement After Business Combination", "terseLabel": "Period to file registration statement after Business Combination", "documentation": "Period to file registration statement after business combination." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current", "totalLabel": "Total current liabilities", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r19", "r98", "r119", "r157", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r225", "r226", "r227", "r248", "r418", "r452", "r460", "r461" ] }, "ivca_PeriodToExerciseWarrantsAfterBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PeriodToExerciseWarrantsAfterBusinessCombination", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Period To Exercise Warrants After Business Combination", "terseLabel": "Period to exercise warrants after business combination", "documentation": "Period to exercise warrants after business combination." } } }, "auth_ref": [] }, "ivca_ClassOfWarrantOrRightRedemptionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ClassOfWarrantOrRightRedemptionPrice", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class Of Warrant Or Right Redemption Price", "terseLabel": "Warrant redemption price", "documentation": "Class of warrant or right redemption price." } } }, "auth_ref": [] }, "ivca_ConsiderationForSurrenderedFounderShares": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ConsiderationForSurrenderedFounderShares", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Consideration For Surrendered Founder Shares", "terseLabel": "Consideration paid for founder shares", "documentation": "Consideration for surrendered founder shares." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r56", "r57", "r362", "r363", "r366" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfOperations", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperations" ], "lang": { "en-us": { "role": { "label": "Nature of Operations [Text Block]", "terseLabel": "Description of Organization and Business Operations", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r91", "r93" ] }, "ivca_PrivatePlacementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PrivatePlacementLineItems", "presentation": [ "http://www.ivcau.com/role/PrivatePlacementAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Private Placement [Line Items]", "terseLabel": "Private Placement [Line Items]", "documentation": "Private placement." } } }, "auth_ref": [] }, "ivca_PeriodForRegistrationStatementToBecomeEffective": { "xbrltype": "durationItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PeriodForRegistrationStatementToBecomeEffective", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Period For Registration Statement To Become Effective", "terseLabel": "Period for registration statement to become effective", "documentation": "Period for registration statement to become effective." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r258", "r259", "r260", "r262", "r265", "r311", "r312", "r313", "r364", "r365", "r366", "r385", "r387" ] }, "ivca_PrivatePlacementTable": { "xbrltype": "stringItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PrivatePlacementTable", "presentation": [ "http://www.ivcau.com/role/PrivatePlacementAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Private Placement [Table]", "terseLabel": "Private Placement [Table]", "documentation": "Private placement." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r432" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.ivcau.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r77", "r160", "r161", "r400", "r451" ] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r362", "r363", "r366" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r435" ] }, "ivca_CommitementToContributeToTheTrustAccountPerMonth": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "CommitementToContributeToTheTrustAccountPerMonth", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Commitement To Contribute To The Trust Account Per Month", "terseLabel": "Commitement to contribute to the trust account per month", "documentation": "Commitement to contribute to the trust account per month." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r432" ] }, "ivca_ThresholdConsecutiveTradingDays": { "xbrltype": "durationItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ThresholdConsecutiveTradingDays", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days", "documentation": "Threshold consecutive trading days." } } }, "auth_ref": [] }, "ivca_WarrantPricePerWarrant": { "xbrltype": "perShareItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "WarrantPricePerWarrant", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Warrant Price Per Warrant", "terseLabel": "Warrant price per warrant", "documentation": "Warrant price per warrant." } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r432" ] }, "ivca_PercentageOfFounderSharesOwnOnConvertedBasis": { "xbrltype": "percentItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PercentageOfFounderSharesOwnOnConvertedBasis", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Percentage Of Founder Shares Own On Converted Basis", "terseLabel": "Percentage of founder shares own on converted basis", "documentation": "Percentage of founder shares own on converted basis." } } }, "auth_ref": [] }, "ivca_OptionForUnderwritersToPurchaseAdditionalUnitsTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "OptionForUnderwritersToPurchaseAdditionalUnitsTerm", "presentation": [ "http://www.ivcau.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Option For Underwriters To Purchase Additional Units Term", "terseLabel": "Term of option for underwriters to purchase additional Units to cover over-allotments", "documentation": "Option for underwriters to purchase additional units term." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r261", "r262", "r459" ] }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfChangeInFairValueOfPrivatePlacementWarrantsLevel3LiabilitiesMeasuredOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings", "terseLabel": "Changes in fair value", "documentation": "Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r244", "r246" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r432" ] }, "ivca_CommitementToContributeToTheTrustAccountPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "CommitementToContributeToTheTrustAccountPerShare", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Commitement To Contribute To The Trust Account Per Share", "verboseLabel": "Commitement to contribute to the trust account per share", "documentation": "Commitement to contribute to the trust account per share." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsLineItems", "presentation": [ "http://www.ivcau.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Line Items]", "terseLabel": "Other Commitments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r437" ] }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfChangeInFairValueOfPrivatePlacementWarrantsLevel3LiabilitiesMeasuredOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs", "periodStartLabel": "Fair value , beginning balance", "periodEndLabel": "Fair value , ending balance", "documentation": "Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r12", "r51" ] }, "ivca_AggregateCommitementToContributeToTheTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "AggregateCommitementToContributeToTheTrustAccount", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Commitement To Contribute To The Trust Account", "terseLabel": "Aggregate commitement to contribute to the trust account", "documentation": "Aggregate commitement to contribute to the trust account." } } }, "auth_ref": [] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Notes Payable, Current", "terseLabel": "Promissory note \u2013 related party", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r16" ] }, "ivca_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion": { "xbrltype": "durationItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Restrictions On Transfer Period Of Time After Business Combination Completion", "terseLabel": "Restrictions on transfer period of time after business combination completion", "documentation": "Restrictions on transfer period of time after business combination completion." } } }, "auth_ref": [] }, "ivca_ExtensionLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ExtensionLoansMember", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Extension Loans [Member]", "verboseLabel": "Extension Loans", "documentation": "Extension loans." } } }, "auth_ref": [] }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfChangeInFairValueOfPrivatePlacementWarrantsLevel3LiabilitiesMeasuredOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues", "terseLabel": "Initial measurement on May 12, 2022 warrants issued", "documentation": "Amount of issuances of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r12", "r52" ] }, "ivca_BusinessCombinationOptionToExtendPeriod": { "xbrltype": "stringItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "BusinessCombinationOptionToExtendPeriod", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination Option To Extend Period", "terseLabel": "Business combination option to extend period", "documentation": "Business combination option to extend period." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Warrant exercise price per share", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r197" ] }, "ivca_ThresholdTradingDays": { "xbrltype": "durationItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ThresholdTradingDays", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Threshold Trading Days", "terseLabel": "Threshold trading days", "documentation": "Threshold trading days." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r434" ] }, "ivca_WorkingCapitalLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "WorkingCapitalLoansMember", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Working Capital Loans [Member]", "terseLabel": "Working Capital Loans", "documentation": "Working capital loans." } } }, "auth_ref": [] }, "ivca_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences": { "xbrltype": "durationItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Threshold Period After Business Combination In Which Specified Trading Days Within Any Specified Trading Day Period Commences", "terseLabel": "Threshold period after business combination in which specified trading days within any specified trading day period commences", "documentation": "Threshold period after business combination in which specified trading days within any specified trading day period commences." } } }, "auth_ref": [] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r51", "r53" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfChangeInFairValueOfPrivatePlacementWarrantsLevel3LiabilitiesMeasuredOnARecurringBasisDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r178", "r200", "r201", "r202", "r203", "r204", "r205", "r240", "r269", "r270", "r271", "r409", "r410", "r412", "r413", "r414" ] }, "us-gaap_CommonClassBMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassBMember", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets", "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit", "http://www.ivcau.com/role/CondensedStatementsOfOperations", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.ivcau.com/role/CoverPage", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "lang": { "en-us": { "role": { "label": "Common Class B [Member]", "terseLabel": "Class B Ordinary Shares", "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation." } } }, "auth_ref": [ "r473" ] }, "ivca_AdministrativeServicesAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "AdministrativeServicesAgreementMember", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Administrative Services Agreement [Member]", "terseLabel": "Administrative Services Agreement", "documentation": "Administrative services agreement." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.ivcau.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_DerivativesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesPolicyTextBlock", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative Financial Instruments", "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities." } } }, "auth_ref": [ "r9", "r47", "r48", "r49", "r50", "r122" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_RelatedAndNonrelatedPartyStatusDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedAndNonrelatedPartyStatusDomain", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Party Status [Domain]", "documentation": "Related and nonrelated party status." } } }, "auth_ref": [ "r120", "r121", "r261", "r262", "r263", "r264", "r330", "r331", "r332", "r333", "r334", "r355", "r357", "r423" ] }, "ivca_UnsecuredPromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "UnsecuredPromissoryNoteMember", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Unsecured Promissory Note [Member]", "terseLabel": "Unsecured Promissory Note", "documentation": "Unsecured promissory note." } } }, "auth_ref": [] }, "us-gaap_RelatedAndNonrelatedPartyStatusAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedAndNonrelatedPartyStatusAxis", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Party Status [Axis]", "documentation": "Information by related and nonrelated party status." } } }, "auth_ref": [ "r120", "r121", "r261", "r262", "r263", "r264", "r330", "r331", "r332", "r333", "r334", "r355", "r357", "r423" ] }, "ivca_TwoThousandAndTwentyThreePromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "TwoThousandAndTwentyThreePromissoryNoteMember", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand and Twenty Three Promissory Note [Member]", "terseLabel": "Two Thousand and Twenty Three Promissory Note", "documentation": "Two thousand and twenty three promissory note." } } }, "auth_ref": [] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r239", "r240", "r242", "r243", "r247" ] }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionConvertedInstrumentAmount1", "crdr": "credit", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Conversion, Converted Instrument, Amount", "terseLabel": "Working capital loans convertible into warrants", "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r27", "r28" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r6", "r13" ] }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleConversionPrice1", "presentation": [ "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Debt instrument conversion price per share", "documentation": "The price per share of the conversion feature embedded in the debt instrument." } } }, "auth_ref": [ "r78", "r176" ] }, "us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Axis]", "terseLabel": "Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms", "documentation": "Represents settlement terms for the group of mandatorily redeemable securities, including the description and the details of all terms for each outstanding financial instrument and each settlement option." } } }, "auth_ref": [ "r5", "r7", "r33" ] }, "us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instruments Subject to Mandatory Redemption, Financial Instrument [Domain]", "terseLabel": "Financial Instruments Subject to Mandatory Redemption, Financial Instrument", "documentation": "Identifying description of each financial instrument that embodies an unconditional obligation requiring the issuer to redeem the securities by transferring the assets at a specified or determinable date (or dates) or upon an event that is certain to occur. Examples are preferred stock or trust preferred securities, each of which has redemption rights beyond the control of the issuer on a specified date or upon an event that is certain to occur." } } }, "auth_ref": [ "r5", "r7" ] }, "ivca_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice": { "xbrltype": "durationItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Threshold Number Of Specified Trading Days Determining Volume Weighted Average Trading Price", "terseLabel": "Threshold trading days determining volume weighted average price", "documentation": "Threshold trading days determining volume weighted average price." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightLineItems", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Line Items]", "terseLabel": "Class Of Warrant Or Right [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ivca_ThresholdIssuePriceForCapitalRaisingInConnectionWithTheClosingOfABusinessCombination": { "xbrltype": "perShareItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ThresholdIssuePriceForCapitalRaisingInConnectionWithTheClosingOfABusinessCombination", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Threshold Issue Price For Capital Raising In Connection With The Closing Of A Business Combination", "terseLabel": "Threshold issue price per share", "documentation": "Threshold issue price per share." } } }, "auth_ref": [] }, "ivca_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice": { "xbrltype": "percentItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class Of Warrant Or Right Adjustment Of Exercise Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price", "terseLabel": "Adjustment of exercise price of warrants based on market value and newly issued price", "documentation": "Adjustment of exercise price of warrants based on market value and newly issued price." } } }, "auth_ref": [] }, "ivca_PercentageOfGrossProceedsOnEquityProceeds": { "xbrltype": "percentItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PercentageOfGrossProceedsOnEquityProceeds", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Percentage Of Gross Proceeds On Equity Proceeds", "terseLabel": "Threshold trading days", "documentation": "Percentage of gross proceeds on total equity proceeds." } } }, "auth_ref": [] }, "ivca_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice": { "xbrltype": "percentItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class Of Warrant Or Right Adjustment Of Redemption Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price", "terseLabel": "Adjustment of redemption price of stock based on market value and newly issued price", "documentation": "Class of warrant or right, adjustment of redemption price of warrants or rights, percent based on market value and newly issued price." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsDetails", "http://www.ivcau.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r239", "r240", "r245" ] }, "ivca_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders": { "xbrltype": "durationItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Threshold Number Of Business Days Before Sending Notice Of Redemption To Warrant Holders", "terseLabel": "Threshold Number Of Business Days Before Sending Notice Of Redemption To Warrant Holders", "documentation": "Threshold number of business days before sending notice of redemption to warrant holders." } } }, "auth_ref": [] }, "ivca_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsTenPointZeroZeroMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsTenPointZeroZeroMember", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Redemption Of Warrants When Price Per Share Of Class Common Stock A Equals Or Exceeds Ten Point Zero Zero [Member]", "terseLabel": "Exceeds $10.00", "documentation": "Redemption of warrants when price per share of class common stock a equals or exceeds 10.00." } } }, "auth_ref": [] }, "ivca_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsEighteenPointZeroZeroMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockAEqualsOrExceedsEighteenPointZeroZeroMember", "presentation": [ "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Redemption Of Warrants When Price Per Share Of Class Common Stock A Equals Or Exceeds Eighteen Point Zero Zero [Member]", "terseLabel": "Exceeds $18.00", "documentation": "Redemption of warrants when price per share of class common stock a equals or exceeds 18.00." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosureAbstract", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "auth_ref": [] }, "ivca_PercentageOfCommonStockIssuedAndOutstanding": { "xbrltype": "percentItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PercentageOfCommonStockIssuedAndOutstanding", "presentation": [ "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Percentage Of Common Stock Issued And Outstanding", "terseLabel": "Percentage of common stock issued and outstanding", "documentation": "Percentage of common stock issued and outstanding." } } }, "auth_ref": [] }, "ivca_PercentageOfCommonStockOutstanding": { "xbrltype": "percentItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PercentageOfCommonStockOutstanding", "presentation": [ "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Percentage Of Common Stock Outstanding", "terseLabel": "Percentage of common stock outstanding", "documentation": "Percentage of common stock outstanding." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets", "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit", "http://www.ivcau.com/role/CondensedStatementsOfOperations", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.ivcau.com/role/CoverPage", "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/InitialPublicOfferingAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails", "http://www.ivcau.com/role/SubsequentEventsAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r94", "r102", "r103", "r104", "r119", "r139", "r140", "r143", "r145", "r148", "r149", "r157", "r166", "r168", "r169", "r170", "r173", "r174", "r182", "r183", "r186", "r189", "r196", "r248", "r306", "r307", "r308", "r309", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r326", "r337", "r359", "r381", "r394", "r395", "r396", "r397", "r398", "r438", "r441", "r446" ] }, "ivca_StockConversionBasisOnConsummationOfTheInitialBusinessCombination": { "xbrltype": "stringItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "StockConversionBasisOnConsummationOfTheInitialBusinessCombination", "presentation": [ "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Stock Conversion Basis On Consummation Of The Initial Business Combination", "terseLabel": "Stock conversion basis on consummation of the initial business combination", "documentation": "Stock conversion basis on consummation of the initial business combination." } } }, "auth_ref": [] }, "ivca_PrivateWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.ivcau.com/20230930", "localname": "PrivateWarrantsMember", "presentation": [ "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfChangeInFairValueOfPrivatePlacementWarrantsLevel3LiabilitiesMeasuredOnARecurringBasisDetails", "http://www.ivcau.com/role/FairValueMeasurementsScheduleOfCompanysLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Private Warrants [Member]", "terseLabel": "Private Warrants", "documentation": "Private warrants." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets", "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Shareholders' Deficit", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r62", "r65", "r66", "r76", "r339", "r356", "r382", "r383", "r418", "r430", "r442", "r448", "r458", "r473" ] }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityCarryingAmountAttributableToParent", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "verboseLabel": "Class A common stock: 9,789,446 and 25,875,000 shares subject to possible redemption at September 30, 2023 and December 31, 2022, respectively", "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r166", "r168", "r169", "r170", "r173", "r174", "r214", "r293" ] }, "us-gaap_AssetsHeldInTrustNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsHeldInTrustNoncurrent", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets", "http://www.ivcau.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Assets Held-in-trust, Noncurrent", "terseLabel": "Investments held in Trust Account", "verboseLabel": "Investments held in Trust Account", "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited." } } }, "auth_ref": [ "r440" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.ivcau.com/role/CondensedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 }, "http://www.ivcau.com/role/CondensedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.ivcau.com/role/CondensedStatementOfChangesInShareholdersEquityDeficit", "http://www.ivcau.com/role/CondensedStatementsOfCashFlows", "http://www.ivcau.com/role/CondensedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net income", "terseLabel": "Net Income (loss)", "verboseLabel": "Net income", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r68", "r74", "r89", "r96", "r107", "r108", "r112", "r119", "r126", "r128", "r129", "r130", "r131", "r134", "r135", "r141", "r150", "r152", "r154", "r156", "r157", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r237", "r248", "r296", "r358", "r379", "r380", "r407", "r428", "r452" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement" } } }, "auth_ref": [ "r162", "r163", "r164", "r165", "r199", "r207", "r208", "r209", "r210", "r272", "r273", "r298", "r327", "r328", "r389", "r390", "r391", "r392", "r393", "r401", "r402", "r408", "r411", "r417", "r419", "r422", "r450", "r454", "r463", "r464", "r465", "r466", "r467" ] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "presentation": [ "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Cash", "terseLabel": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r90", "r290", "r325", "r345", "r418", "r430", "r439" ] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.ivcau.com/role/CondensedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current", "totalLabel": "Total current assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r97", "r106", "r119", "r157", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r224", "r226", "r248", "r418", "r452", "r453", "r460" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "auth_ref": [ "r162", "r163", "r164", "r165", "r207", "r273", "r298", "r327", "r328", "r389", "r390", "r391", "r392", "r393", "r401", "r402", "r408", "r411", "r417", "r419", "r454", "r462", "r463", "r464", "r465", "r466", "r467" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheetsParenthetical", "http://www.ivcau.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.ivcau.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails", "http://www.ivcau.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "http://www.ivcau.com/role/ShareholdersDeficitAdditionalInformationDetails", "http://www.ivcau.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.ivcau.com/role/WarrantLiabilityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement" } } }, "auth_ref": [ "r162", "r163", "r164", "r165", "r199", "r207", "r208", "r209", "r210", "r272", "r273", "r298", "r327", "r328", "r389", "r390", "r391", "r392", "r393", "r401", "r402", "r408", "r411", "r417", "r419", "r422", "r450", "r454", "r463", "r464", "r465", "r466", "r467" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.ivcau.com/role/CondensedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "13", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481648/480-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481648/480-10-50-2" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(27)", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "45", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481679/480-10-45-2A" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481648/480-10-50-2" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//820/tableOfContent" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(n))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.E.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r406": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r407": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r408": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r409": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r410": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r411": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r412": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r415": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r416": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r417": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r418": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r419": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r420": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r422": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r426": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r427": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r428": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r429": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r430": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r431": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r432": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r433": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r435": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r437": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r438": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r439": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r440": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r441": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r442": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r443": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r444": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r445": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r446": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r447": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r448": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r449": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480341/340-10-S99-1" }, "r450": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r451": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r452": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r453": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r454": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r455": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r456": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r457": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r458": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r459": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r460": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r461": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r462": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r463": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r464": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r465": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r466": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r467": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r468": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2" }, "r469": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r470": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r471": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r472": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r473": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r474": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 54 0001193125-23-286491-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-286491-xbrl.zip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

77F0EPAD7!H"7AL.A[XJ(/;8>Z.F@C4:Q37]&F;<; M,Y*&8'%&9^?6A?5WX"=,#;>N$M&Q/B5>QT*W\3 "K/B>7*FWZ$AU.-(4!O^*+?6+JS:[J7QHJW#1S?^G MH/"C8]V.G."'Y=X+%WY* PJH"3L-R8%1?".NO)/*!%M>HHP;&S@\C.Z

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end